Project
GNF SymAtlas + NCI-60 cancer cell lines, human (Su, 2004; Ross, 2000)
Navigation
Downloads
Results for IKZF1
Z-value: 1.88
Motif logo
Transcription factors associated with IKZF1
| Gene Symbol | Gene ID | Gene Info |
|---|---|---|
|
IKZF1
|
ENSG00000185811.19 | IKZF1 |
Activity-expression correlation:
| Gene | Promoter | Pearson corr. coef. | P-value | Plot |
|---|---|---|---|---|
| IKZF1 | hg38_v1_chr7_+_50308672_50308769 | -0.44 | 1.1e-11 | Click! |
Activity profile of IKZF1 motif
Sorted Z-values of IKZF1 motif
Network of associatons between targets according to the STRING database.
First level regulatory network of IKZF1
Gene Ontology Analysis
Gene overrepresentation in biological process category:
| Log-likelihood per target | Total log-likelihood | Term | Description |
|---|---|---|---|
| 11.7 | 35.2 | GO:0060623 | regulation of chromosome condensation(GO:0060623) |
| 11.5 | 34.5 | GO:1901860 | positive regulation of mitochondrial DNA metabolic process(GO:1901860) |
| 9.4 | 37.7 | GO:0055014 | atrial cardiac muscle cell differentiation(GO:0055011) atrial cardiac muscle cell development(GO:0055014) |
| 8.8 | 35.3 | GO:1902463 | protein localization to cell leading edge(GO:1902463) |
| 8.5 | 42.4 | GO:0003065 | positive regulation of heart rate by epinephrine(GO:0003065) |
| 7.1 | 35.7 | GO:0019087 | transformation of host cell by virus(GO:0019087) |
| 7.0 | 48.7 | GO:0030421 | defecation(GO:0030421) |
| 6.5 | 51.6 | GO:0003433 | chondrocyte development involved in endochondral bone morphogenesis(GO:0003433) |
| 6.4 | 25.7 | GO:0010900 | negative regulation of phosphatidylcholine catabolic process(GO:0010900) |
| 6.2 | 68.7 | GO:0050703 | interleukin-1 alpha secretion(GO:0050703) |
| 6.1 | 55.2 | GO:0031444 | slow-twitch skeletal muscle fiber contraction(GO:0031444) |
| 6.1 | 24.3 | GO:2000255 | negative regulation of male germ cell proliferation(GO:2000255) |
| 6.0 | 36.0 | GO:1901164 | negative regulation of trophoblast cell migration(GO:1901164) |
| 5.9 | 5.9 | GO:1903630 | regulation of aminoacyl-tRNA ligase activity(GO:1903630) |
| 5.8 | 29.0 | GO:1902766 | skeletal muscle satellite cell migration(GO:1902766) |
| 5.6 | 22.6 | GO:1903803 | glutamine secretion(GO:0010585) L-glutamine import(GO:0036229) L-glutamine import into cell(GO:1903803) |
| 5.6 | 16.9 | GO:0015920 | lipopolysaccharide transport(GO:0015920) |
| 5.5 | 16.6 | GO:0044878 | mitotic cytokinesis checkpoint(GO:0044878) |
| 5.5 | 16.5 | GO:0006097 | glyoxylate cycle(GO:0006097) |
| 5.4 | 21.5 | GO:0006238 | CMP salvage(GO:0006238) CMP biosynthetic process(GO:0009224) CMP metabolic process(GO:0046035) |
| 5.3 | 15.9 | GO:0061713 | neural crest cell migration involved in heart formation(GO:0003147) cell migration involved in heart formation(GO:0060974) anterior neural tube closure(GO:0061713) |
| 5.2 | 15.5 | GO:0035732 | nitric oxide storage(GO:0035732) |
| 5.2 | 20.6 | GO:0002188 | translation reinitiation(GO:0002188) |
| 5.1 | 30.3 | GO:0035105 | sterol regulatory element binding protein import into nucleus(GO:0035105) |
| 5.0 | 49.8 | GO:0006621 | protein retention in ER lumen(GO:0006621) |
| 4.9 | 44.3 | GO:0031536 | positive regulation of exit from mitosis(GO:0031536) |
| 4.8 | 19.3 | GO:0032599 | B cell receptor transport within lipid bilayer(GO:0032595) B cell receptor transport into membrane raft(GO:0032597) protein transport out of membrane raft(GO:0032599) chemokine receptor transport out of membrane raft(GO:0032600) negative regulation of transforming growth factor beta3 production(GO:0032913) chemokine receptor transport within lipid bilayer(GO:0033606) |
| 4.8 | 14.4 | GO:0038195 | urokinase plasminogen activator signaling pathway(GO:0038195) |
| 4.7 | 4.7 | GO:1901873 | regulation of post-translational protein modification(GO:1901873) |
| 4.7 | 23.5 | GO:0043126 | regulation of 1-phosphatidylinositol 4-kinase activity(GO:0043126) positive regulation of 1-phosphatidylinositol 4-kinase activity(GO:0043128) |
| 4.6 | 13.9 | GO:0044278 | cell wall disruption in other organism(GO:0044278) |
| 4.5 | 22.3 | GO:0044111 | development involved in symbiotic interaction(GO:0044111) |
| 4.4 | 22.1 | GO:0001971 | negative regulation of activation of membrane attack complex(GO:0001971) |
| 4.4 | 26.2 | GO:0019065 | receptor-mediated endocytosis of virus by host cell(GO:0019065) endocytosis involved in viral entry into host cell(GO:0075509) |
| 4.3 | 13.0 | GO:0014876 | response to injury involved in regulation of muscle adaptation(GO:0014876) |
| 4.3 | 12.9 | GO:0006059 | hexitol metabolic process(GO:0006059) |
| 4.2 | 46.7 | GO:0010756 | positive regulation of plasminogen activation(GO:0010756) |
| 4.2 | 25.1 | GO:0016036 | cellular response to phosphate starvation(GO:0016036) positive regulation of sulfur amino acid metabolic process(GO:0031337) positive regulation of homocysteine metabolic process(GO:0050668) |
| 4.1 | 36.5 | GO:0061302 | smooth muscle cell-matrix adhesion(GO:0061302) |
| 3.9 | 11.7 | GO:0030951 | establishment or maintenance of microtubule cytoskeleton polarity(GO:0030951) |
| 3.7 | 7.4 | GO:0042776 | mitochondrial ATP synthesis coupled proton transport(GO:0042776) |
| 3.6 | 25.5 | GO:0043985 | histone H4-R3 methylation(GO:0043985) |
| 3.6 | 21.8 | GO:0006931 | substrate-dependent cell migration, cell attachment to substrate(GO:0006931) |
| 3.6 | 21.7 | GO:1904274 | tricellular tight junction assembly(GO:1904274) |
| 3.6 | 14.3 | GO:2000259 | positive regulation of complement activation(GO:0045917) positive regulation of protein activation cascade(GO:2000259) |
| 3.6 | 10.7 | GO:0061760 | antifungal innate immune response(GO:0061760) |
| 3.5 | 49.5 | GO:0035826 | rubidium ion transport(GO:0035826) regulation of rubidium ion transport(GO:2000680) |
| 3.5 | 21.0 | GO:0060356 | leucine import(GO:0060356) |
| 3.5 | 10.4 | GO:0070407 | oxidation-dependent protein catabolic process(GO:0070407) |
| 3.5 | 17.3 | GO:0070836 | caveola assembly(GO:0070836) |
| 3.4 | 10.3 | GO:0018211 | protein C-linked glycosylation(GO:0018103) peptidyl-tryptophan modification(GO:0018211) protein C-linked glycosylation via tryptophan(GO:0018317) protein C-linked glycosylation via 2'-alpha-mannosyl-L-tryptophan(GO:0018406) |
| 3.4 | 10.3 | GO:0002086 | diaphragm contraction(GO:0002086) |
| 3.4 | 23.7 | GO:0048050 | post-embryonic eye morphogenesis(GO:0048050) |
| 3.4 | 10.1 | GO:0031550 | positive regulation of brain-derived neurotrophic factor receptor signaling pathway(GO:0031550) |
| 3.3 | 80.4 | GO:0071294 | cellular response to zinc ion(GO:0071294) |
| 3.3 | 13.4 | GO:0030047 | actin modification(GO:0030047) |
| 3.3 | 20.0 | GO:1904044 | response to aldosterone(GO:1904044) |
| 3.3 | 13.3 | GO:0044210 | 'de novo' CTP biosynthetic process(GO:0044210) |
| 3.3 | 13.2 | GO:0046947 | hydroxylysine metabolic process(GO:0046946) hydroxylysine biosynthetic process(GO:0046947) |
| 3.3 | 19.7 | GO:0048549 | positive regulation of pinocytosis(GO:0048549) |
| 3.3 | 9.8 | GO:0006267 | pre-replicative complex assembly involved in nuclear cell cycle DNA replication(GO:0006267) pre-replicative complex assembly(GO:0036388) pre-replicative complex assembly involved in cell cycle DNA replication(GO:1902299) |
| 3.3 | 19.6 | GO:0051552 | flavone metabolic process(GO:0051552) |
| 3.2 | 13.0 | GO:1904715 | negative regulation of chaperone-mediated autophagy(GO:1904715) |
| 3.2 | 22.4 | GO:0035986 | senescence-associated heterochromatin focus assembly(GO:0035986) |
| 3.2 | 3.2 | GO:1903625 | negative regulation of DNA catabolic process(GO:1903625) |
| 3.1 | 18.8 | GO:0019264 | glycine biosynthetic process from serine(GO:0019264) |
| 3.1 | 15.5 | GO:1904579 | response to thapsigargin(GO:1904578) cellular response to thapsigargin(GO:1904579) |
| 3.1 | 21.6 | GO:1904431 | positive regulation of t-circle formation(GO:1904431) |
| 3.0 | 9.0 | GO:0071169 | establishment of protein localization to chromatin(GO:0071169) |
| 3.0 | 83.9 | GO:0031581 | hemidesmosome assembly(GO:0031581) |
| 3.0 | 6.0 | GO:2000254 | regulation of male germ cell proliferation(GO:2000254) |
| 3.0 | 23.6 | GO:0030091 | protein repair(GO:0030091) |
| 2.9 | 11.7 | GO:0009956 | radial pattern formation(GO:0009956) |
| 2.9 | 11.7 | GO:0072526 | pyridine-containing compound catabolic process(GO:0072526) |
| 2.9 | 11.7 | GO:0000912 | assembly of actomyosin apparatus involved in cytokinesis(GO:0000912) actomyosin contractile ring assembly(GO:0000915) actomyosin contractile ring organization(GO:0044837) |
| 2.9 | 8.6 | GO:2000521 | negative regulation of immunological synapse formation(GO:2000521) |
| 2.9 | 11.4 | GO:0010796 | regulation of multivesicular body size(GO:0010796) |
| 2.9 | 31.4 | GO:0046498 | S-adenosylhomocysteine metabolic process(GO:0046498) |
| 2.8 | 14.1 | GO:0042360 | vitamin E metabolic process(GO:0042360) |
| 2.8 | 16.7 | GO:0007296 | vitellogenesis(GO:0007296) |
| 2.7 | 13.7 | GO:0031120 | snRNA pseudouridine synthesis(GO:0031120) |
| 2.7 | 8.1 | GO:0036333 | hepatocyte homeostasis(GO:0036333) response to tetrachloromethane(GO:1904772) |
| 2.7 | 8.1 | GO:1903892 | negative regulation of ATF6-mediated unfolded protein response(GO:1903892) |
| 2.7 | 8.1 | GO:2000360 | negative regulation of binding of sperm to zona pellucida(GO:2000360) |
| 2.7 | 8.0 | GO:0042361 | menaquinone catabolic process(GO:0042361) vitamin K catabolic process(GO:0042377) |
| 2.7 | 10.7 | GO:2000653 | regulation of genetic imprinting(GO:2000653) |
| 2.7 | 8.0 | GO:1990022 | RNA polymerase II complex import to nucleus(GO:0044376) RNA polymerase III complex localization to nucleus(GO:1990022) |
| 2.7 | 10.6 | GO:0042450 | arginine biosynthetic process via ornithine(GO:0042450) |
| 2.7 | 18.6 | GO:0060574 | intestinal epithelial cell maturation(GO:0060574) |
| 2.6 | 7.9 | GO:0019285 | glycine betaine biosynthetic process from choline(GO:0019285) glycine betaine metabolic process(GO:0031455) glycine betaine biosynthetic process(GO:0031456) |
| 2.6 | 15.6 | GO:0010643 | cell communication by chemical coupling(GO:0010643) |
| 2.6 | 12.8 | GO:1900264 | regulation of DNA-directed DNA polymerase activity(GO:1900262) positive regulation of DNA-directed DNA polymerase activity(GO:1900264) |
| 2.5 | 7.6 | GO:0006982 | response to lipid hydroperoxide(GO:0006982) |
| 2.5 | 192.4 | GO:0070125 | mitochondrial translational elongation(GO:0070125) |
| 2.5 | 10.1 | GO:0018106 | peptidyl-histidine phosphorylation(GO:0018106) |
| 2.5 | 7.5 | GO:1900110 | negative regulation of histone H3-K9 dimethylation(GO:1900110) |
| 2.5 | 7.5 | GO:1903976 | negative regulation of glial cell migration(GO:1903976) |
| 2.5 | 14.8 | GO:0070973 | protein localization to endoplasmic reticulum exit site(GO:0070973) |
| 2.5 | 9.9 | GO:1904117 | response to vasopressin(GO:1904116) cellular response to vasopressin(GO:1904117) |
| 2.4 | 9.7 | GO:0061450 | trophoblast cell migration(GO:0061450) regulation of trophoblast cell migration(GO:1901163) |
| 2.4 | 7.2 | GO:0090341 | negative regulation of secretion of lysosomal enzymes(GO:0090341) |
| 2.4 | 9.5 | GO:0035880 | embryonic nail plate morphogenesis(GO:0035880) |
| 2.4 | 7.1 | GO:0072312 | metanephric glomerular epithelium development(GO:0072244) metanephric glomerular visceral epithelial cell differentiation(GO:0072248) metanephric glomerular visceral epithelial cell development(GO:0072249) metanephric glomerular epithelial cell differentiation(GO:0072312) metanephric glomerular epithelial cell development(GO:0072313) |
| 2.4 | 11.8 | GO:2000542 | negative regulation of gastrulation(GO:2000542) |
| 2.3 | 7.0 | GO:0046452 | dihydrofolate metabolic process(GO:0046452) |
| 2.3 | 37.3 | GO:0043248 | proteasome assembly(GO:0043248) |
| 2.3 | 13.9 | GO:0032487 | regulation of Rap protein signal transduction(GO:0032487) |
| 2.3 | 6.9 | GO:0042823 | pyridoxal phosphate metabolic process(GO:0042822) pyridoxal phosphate biosynthetic process(GO:0042823) |
| 2.3 | 13.8 | GO:0052696 | flavonoid glucuronidation(GO:0052696) xenobiotic glucuronidation(GO:0052697) |
| 2.3 | 13.8 | GO:0007079 | mitotic chromosome movement towards spindle pole(GO:0007079) |
| 2.3 | 9.1 | GO:1905040 | vestibulocochlear nerve structural organization(GO:0021649) positive regulation of cytokine activity(GO:0060301) ganglion morphogenesis(GO:0061552) endothelial tip cell fate specification(GO:0097102) VEGF-activated neuropilin signaling pathway involved in axon guidance(GO:1902378) dorsal root ganglion morphogenesis(GO:1904835) otic placode development(GO:1905040) |
| 2.3 | 11.3 | GO:1902626 | assembly of large subunit precursor of preribosome(GO:1902626) |
| 2.3 | 6.8 | GO:0018160 | peptidyl-pyrromethane cofactor linkage(GO:0018160) |
| 2.2 | 27.0 | GO:0006268 | DNA unwinding involved in DNA replication(GO:0006268) |
| 2.2 | 4.4 | GO:0006535 | cysteine biosynthetic process from serine(GO:0006535) |
| 2.2 | 6.6 | GO:0048817 | negative regulation of hair follicle maturation(GO:0048817) |
| 2.2 | 15.5 | GO:0046726 | positive regulation by virus of viral protein levels in host cell(GO:0046726) |
| 2.2 | 28.5 | GO:1900623 | regulation of monocyte aggregation(GO:1900623) positive regulation of monocyte aggregation(GO:1900625) |
| 2.2 | 6.6 | GO:0044240 | multicellular organism lipid catabolic process(GO:0044240) |
| 2.2 | 4.4 | GO:0048319 | axial mesoderm morphogenesis(GO:0048319) |
| 2.2 | 6.5 | GO:0016488 | sesquiterpenoid metabolic process(GO:0006714) sesquiterpenoid catabolic process(GO:0016107) farnesol metabolic process(GO:0016487) farnesol catabolic process(GO:0016488) |
| 2.2 | 8.7 | GO:0048627 | myoblast development(GO:0048627) |
| 2.2 | 4.3 | GO:1903722 | regulation of centriole elongation(GO:1903722) |
| 2.2 | 8.6 | GO:0009051 | pentose-phosphate shunt, oxidative branch(GO:0009051) |
| 2.1 | 8.5 | GO:0046900 | tetrahydrofolylpolyglutamate metabolic process(GO:0046900) |
| 2.1 | 23.1 | GO:0046149 | porphyrin-containing compound catabolic process(GO:0006787) tetrapyrrole catabolic process(GO:0033015) heme catabolic process(GO:0042167) pigment catabolic process(GO:0046149) |
| 2.1 | 33.6 | GO:0006782 | protoporphyrinogen IX biosynthetic process(GO:0006782) |
| 2.1 | 6.3 | GO:0014810 | positive regulation of skeletal muscle contraction by regulation of release of sequestered calcium ion(GO:0014810) |
| 2.1 | 8.4 | GO:0002159 | desmosome assembly(GO:0002159) |
| 2.1 | 6.2 | GO:0060744 | thelarche(GO:0042695) mammary gland branching involved in thelarche(GO:0060744) |
| 2.1 | 10.3 | GO:0043137 | DNA replication, removal of RNA primer(GO:0043137) |
| 2.1 | 8.2 | GO:0060762 | regulation of branching involved in mammary gland duct morphogenesis(GO:0060762) |
| 2.1 | 8.2 | GO:0010986 | positive regulation of lipoprotein particle clearance(GO:0010986) |
| 2.0 | 8.2 | GO:0006526 | arginine biosynthetic process(GO:0006526) |
| 2.0 | 2.0 | GO:1901856 | negative regulation of cellular respiration(GO:1901856) |
| 2.0 | 32.5 | GO:0006228 | UTP biosynthetic process(GO:0006228) |
| 2.0 | 16.1 | GO:0001887 | selenium compound metabolic process(GO:0001887) |
| 2.0 | 2.0 | GO:0034402 | recruitment of 3'-end processing factors to RNA polymerase II holoenzyme complex(GO:0034402) |
| 2.0 | 8.1 | GO:0035750 | protein localization to myelin sheath abaxonal region(GO:0035750) |
| 2.0 | 6.0 | GO:0043490 | malate-aspartate shuttle(GO:0043490) |
| 2.0 | 8.0 | GO:0001519 | peptide amidation(GO:0001519) protein amidation(GO:0018032) peptide modification(GO:0031179) |
| 2.0 | 8.0 | GO:1902283 | negative regulation of primary amine oxidase activity(GO:1902283) |
| 2.0 | 10.0 | GO:0015862 | uridine transport(GO:0015862) |
| 2.0 | 6.0 | GO:0060739 | mesenchymal-epithelial cell signaling involved in prostate gland development(GO:0060739) |
| 2.0 | 11.9 | GO:0015680 | intracellular copper ion transport(GO:0015680) |
| 2.0 | 5.9 | GO:0018171 | peptidyl-cysteine oxidation(GO:0018171) |
| 2.0 | 13.8 | GO:0033211 | adiponectin-activated signaling pathway(GO:0033211) |
| 2.0 | 9.8 | GO:0044209 | AMP salvage(GO:0044209) |
| 2.0 | 5.9 | GO:1901899 | positive regulation of relaxation of cardiac muscle(GO:1901899) |
| 2.0 | 11.7 | GO:0051708 | intracellular transport of viral protein in host cell(GO:0019060) symbiont intracellular protein transport in host(GO:0030581) intracellular protein transport in other organism involved in symbiotic interaction(GO:0051708) |
| 2.0 | 5.9 | GO:0042946 | glucoside transport(GO:0042946) |
| 1.9 | 5.8 | GO:0008215 | spermine metabolic process(GO:0008215) |
| 1.9 | 1.9 | GO:0042374 | phylloquinone metabolic process(GO:0042374) phylloquinone catabolic process(GO:0042376) quinone catabolic process(GO:1901662) |
| 1.9 | 5.8 | GO:1901674 | histone H3-K27 acetylation(GO:0043974) regulation of histone H3-K27 acetylation(GO:1901674) |
| 1.9 | 42.7 | GO:0048385 | regulation of retinoic acid receptor signaling pathway(GO:0048385) |
| 1.9 | 1.9 | GO:0006041 | glucosamine metabolic process(GO:0006041) |
| 1.9 | 5.8 | GO:0061394 | regulation of transcription from RNA polymerase II promoter in response to arsenic-containing substance(GO:0061394) |
| 1.9 | 13.4 | GO:0010724 | regulation of definitive erythrocyte differentiation(GO:0010724) |
| 1.9 | 3.8 | GO:0045715 | negative regulation of low-density lipoprotein particle receptor biosynthetic process(GO:0045715) |
| 1.9 | 7.6 | GO:0071395 | response to jasmonic acid(GO:0009753) cellular response to jasmonic acid stimulus(GO:0071395) |
| 1.9 | 21.0 | GO:0060056 | mammary gland involution(GO:0060056) |
| 1.9 | 9.5 | GO:0022614 | membrane to membrane docking(GO:0022614) |
| 1.9 | 5.7 | GO:0002415 | immunoglobulin transcytosis in epithelial cells mediated by polymeric immunoglobulin receptor(GO:0002415) |
| 1.9 | 13.2 | GO:0035879 | plasma membrane lactate transport(GO:0035879) |
| 1.9 | 3.8 | GO:0060434 | bronchus morphogenesis(GO:0060434) |
| 1.9 | 54.5 | GO:0046597 | negative regulation of viral entry into host cell(GO:0046597) |
| 1.9 | 9.4 | GO:0009189 | deoxyribonucleoside diphosphate biosynthetic process(GO:0009189) |
| 1.9 | 3.7 | GO:0006216 | cytidine catabolic process(GO:0006216) cytidine deamination(GO:0009972) cytidine metabolic process(GO:0046087) |
| 1.9 | 5.6 | GO:0071163 | DNA replication preinitiation complex assembly(GO:0071163) |
| 1.9 | 33.6 | GO:0071803 | positive regulation of podosome assembly(GO:0071803) |
| 1.9 | 5.6 | GO:0070510 | regulation of histone H4-K20 methylation(GO:0070510) positive regulation of histone H4-K20 methylation(GO:0070512) |
| 1.8 | 68.2 | GO:0097284 | hepatocyte apoptotic process(GO:0097284) |
| 1.8 | 7.4 | GO:0035407 | histone H3-T11 phosphorylation(GO:0035407) |
| 1.8 | 5.5 | GO:0007057 | spindle assembly involved in female meiosis I(GO:0007057) |
| 1.8 | 21.9 | GO:0001682 | tRNA 5'-leader removal(GO:0001682) |
| 1.8 | 12.8 | GO:0031126 | snoRNA 3'-end processing(GO:0031126) |
| 1.8 | 5.5 | GO:0014707 | branchiomeric skeletal muscle development(GO:0014707) |
| 1.8 | 9.1 | GO:0009098 | branched-chain amino acid biosynthetic process(GO:0009082) leucine biosynthetic process(GO:0009098) valine biosynthetic process(GO:0009099) |
| 1.8 | 12.7 | GO:1903208 | neuron death in response to hydrogen peroxide(GO:0036476) regulation of hydrogen peroxide-induced neuron death(GO:1903207) negative regulation of hydrogen peroxide-induced neuron death(GO:1903208) |
| 1.8 | 21.4 | GO:0019388 | galactose catabolic process(GO:0019388) |
| 1.8 | 5.3 | GO:1901842 | negative regulation of high voltage-gated calcium channel activity(GO:1901842) |
| 1.8 | 7.1 | GO:1903377 | negative regulation of oxidative stress-induced neuron intrinsic apoptotic signaling pathway(GO:1903377) |
| 1.8 | 8.8 | GO:0045337 | geranyl diphosphate metabolic process(GO:0033383) geranyl diphosphate biosynthetic process(GO:0033384) farnesyl diphosphate biosynthetic process(GO:0045337) |
| 1.8 | 7.0 | GO:0045218 | zonula adherens maintenance(GO:0045218) |
| 1.8 | 7.0 | GO:0090235 | regulation of metaphase plate congression(GO:0090235) |
| 1.7 | 5.2 | GO:0003104 | positive regulation of glomerular filtration(GO:0003104) |
| 1.7 | 7.0 | GO:0003285 | septum secundum development(GO:0003285) atrial septum secundum morphogenesis(GO:0003290) |
| 1.7 | 22.5 | GO:1900029 | positive regulation of ruffle assembly(GO:1900029) |
| 1.7 | 5.2 | GO:0070901 | mitochondrial tRNA methylation(GO:0070901) |
| 1.7 | 1.7 | GO:0021824 | cerebral cortex tangential migration using cell-axon interactions(GO:0021824) gonadotrophin-releasing hormone neuronal migration to the hypothalamus(GO:0021828) hypothalamic tangential migration using cell-axon interactions(GO:0021856) facioacoustic ganglion development(GO:1903375) |
| 1.7 | 15.3 | GO:2000124 | regulation of endocannabinoid signaling pathway(GO:2000124) |
| 1.7 | 11.8 | GO:0002084 | protein depalmitoylation(GO:0002084) |
| 1.7 | 3.4 | GO:0051798 | positive regulation of hair follicle development(GO:0051798) |
| 1.7 | 5.0 | GO:1905000 | regulation of membrane repolarization during atrial cardiac muscle cell action potential(GO:1905000) |
| 1.7 | 35.1 | GO:0051764 | actin crosslink formation(GO:0051764) |
| 1.7 | 14.9 | GO:0033088 | negative regulation of immature T cell proliferation in thymus(GO:0033088) |
| 1.6 | 13.2 | GO:0006689 | ganglioside catabolic process(GO:0006689) |
| 1.6 | 11.5 | GO:0090166 | Golgi disassembly(GO:0090166) |
| 1.6 | 36.0 | GO:0046697 | decidualization(GO:0046697) |
| 1.6 | 1.6 | GO:0045643 | regulation of eosinophil differentiation(GO:0045643) positive regulation of eosinophil differentiation(GO:0045645) |
| 1.6 | 3.3 | GO:0018879 | biphenyl metabolic process(GO:0018879) |
| 1.6 | 4.9 | GO:0006421 | asparaginyl-tRNA aminoacylation(GO:0006421) |
| 1.6 | 4.9 | GO:0006106 | fumarate metabolic process(GO:0006106) |
| 1.6 | 4.9 | GO:2000661 | positive regulation of interleukin-1-mediated signaling pathway(GO:2000661) |
| 1.6 | 1.6 | GO:0051794 | catagen(GO:0042637) regulation of catagen(GO:0051794) |
| 1.6 | 12.9 | GO:1902661 | negative regulation of transcription during mitosis(GO:0007068) negative regulation of transcription from RNA polymerase II promoter during mitosis(GO:0007070) positive regulation of glucose mediated signaling pathway(GO:1902661) |
| 1.6 | 3.2 | GO:0010751 | negative regulation of nitric oxide mediated signal transduction(GO:0010751) |
| 1.6 | 6.4 | GO:0036114 | medium-chain fatty-acyl-CoA catabolic process(GO:0036114) long-chain fatty-acyl-CoA catabolic process(GO:0036116) palmitic acid metabolic process(GO:1900533) palmitic acid biosynthetic process(GO:1900535) |
| 1.6 | 9.6 | GO:0042780 | tRNA 3'-end processing(GO:0042780) |
| 1.6 | 6.4 | GO:0009438 | methylglyoxal metabolic process(GO:0009438) |
| 1.6 | 1.6 | GO:0060995 | cell-cell signaling involved in kidney development(GO:0060995) Wnt signaling pathway involved in kidney development(GO:0061289) canonical Wnt signaling pathway involved in metanephric kidney development(GO:0061290) cell-cell signaling involved in metanephros development(GO:0072204) |
| 1.6 | 3.2 | GO:0034201 | response to oleic acid(GO:0034201) |
| 1.6 | 6.4 | GO:0035900 | response to isolation stress(GO:0035900) |
| 1.6 | 11.1 | GO:0032218 | riboflavin transport(GO:0032218) |
| 1.6 | 3.2 | GO:2001268 | negative regulation of cysteine-type endopeptidase activity involved in apoptotic signaling pathway(GO:2001268) |
| 1.6 | 7.9 | GO:0003404 | optic vesicle morphogenesis(GO:0003404) |
| 1.6 | 31.3 | GO:0032968 | positive regulation of transcription elongation from RNA polymerase II promoter(GO:0032968) |
| 1.6 | 1.6 | GO:1901420 | negative regulation of response to alcohol(GO:1901420) |
| 1.6 | 1.6 | GO:0097534 | lymphoid lineage cell migration(GO:0097534) lymphoid lineage cell migration into thymus(GO:0097535) |
| 1.6 | 3.1 | GO:0002329 | pre-B cell differentiation(GO:0002329) pre-B cell allelic exclusion(GO:0002331) |
| 1.6 | 7.8 | GO:0009635 | response to herbicide(GO:0009635) |
| 1.6 | 3.1 | GO:0006065 | UDP-glucuronate biosynthetic process(GO:0006065) |
| 1.5 | 23.1 | GO:0000022 | mitotic spindle elongation(GO:0000022) |
| 1.5 | 7.7 | GO:0070131 | positive regulation of mitochondrial translation(GO:0070131) |
| 1.5 | 10.7 | GO:0006880 | intracellular sequestering of iron ion(GO:0006880) sequestering of iron ion(GO:0097577) |
| 1.5 | 3.1 | GO:1905244 | regulation of modification of synaptic structure(GO:1905244) |
| 1.5 | 3.1 | GO:0097252 | negative regulation of helicase activity(GO:0051097) oligodendrocyte apoptotic process(GO:0097252) |
| 1.5 | 18.3 | GO:0090435 | protein localization to nuclear envelope(GO:0090435) |
| 1.5 | 18.2 | GO:0007076 | mitotic chromosome condensation(GO:0007076) |
| 1.5 | 1.5 | GO:0009404 | toxin metabolic process(GO:0009404) |
| 1.5 | 36.4 | GO:0032802 | low-density lipoprotein particle receptor catabolic process(GO:0032802) |
| 1.5 | 4.5 | GO:2000234 | positive regulation of ribosome biogenesis(GO:0090070) positive regulation of rRNA processing(GO:2000234) |
| 1.5 | 12.1 | GO:0075525 | viral translational termination-reinitiation(GO:0075525) |
| 1.5 | 1.5 | GO:0016080 | synaptic vesicle targeting(GO:0016080) |
| 1.5 | 1.5 | GO:0051414 | response to cortisol(GO:0051414) |
| 1.5 | 4.5 | GO:0042369 | vitamin D catabolic process(GO:0042369) |
| 1.5 | 24.0 | GO:0045899 | positive regulation of RNA polymerase II transcriptional preinitiation complex assembly(GO:0045899) |
| 1.5 | 16.5 | GO:0042262 | DNA protection(GO:0042262) |
| 1.5 | 16.4 | GO:0000052 | citrulline metabolic process(GO:0000052) |
| 1.5 | 4.5 | GO:1904352 | positive regulation of protein catabolic process in the vacuole(GO:1904352) |
| 1.5 | 4.5 | GO:1902990 | mitotic telomere maintenance via semi-conservative replication(GO:1902990) |
| 1.5 | 13.3 | GO:0090500 | endocardial cushion to mesenchymal transition(GO:0090500) |
| 1.5 | 7.4 | GO:0010637 | negative regulation of mitochondrial fusion(GO:0010637) |
| 1.5 | 2.9 | GO:1904751 | positive regulation of protein localization to nucleolus(GO:1904751) |
| 1.5 | 5.8 | GO:0019418 | sulfide oxidation(GO:0019418) sulfide oxidation, using sulfide:quinone oxidoreductase(GO:0070221) |
| 1.5 | 7.3 | GO:0014886 | transition between slow and fast fiber(GO:0014886) |
| 1.4 | 17.3 | GO:0048251 | elastic fiber assembly(GO:0048251) |
| 1.4 | 8.6 | GO:0032916 | transforming growth factor beta3 production(GO:0032907) regulation of transforming growth factor beta3 production(GO:0032910) positive regulation of transforming growth factor beta3 production(GO:0032916) negative regulation of lung blood pressure(GO:0061767) |
| 1.4 | 4.3 | GO:0001189 | RNA polymerase I transcriptional preinitiation complex assembly(GO:0001188) RNA polymerase I transcriptional preinitiation complex assembly at the promoter for the nuclear large rRNA transcript(GO:0001189) |
| 1.4 | 1.4 | GO:0032650 | regulation of interleukin-1 alpha production(GO:0032650) |
| 1.4 | 4.3 | GO:1903721 | regulation of I-kappaB phosphorylation(GO:1903719) positive regulation of I-kappaB phosphorylation(GO:1903721) |
| 1.4 | 7.0 | GO:0003164 | His-Purkinje system development(GO:0003164) |
| 1.4 | 1.4 | GO:0072197 | ureter urothelium development(GO:0072190) ureter morphogenesis(GO:0072197) |
| 1.4 | 5.6 | GO:1990928 | response to amino acid starvation(GO:1990928) |
| 1.4 | 18.0 | GO:0035372 | protein localization to microtubule(GO:0035372) |
| 1.4 | 11.1 | GO:0072307 | metanephric nephron tubule epithelial cell differentiation(GO:0072257) regulation of metanephric nephron tubule epithelial cell differentiation(GO:0072307) |
| 1.4 | 6.9 | GO:2000860 | positive regulation of mineralocorticoid secretion(GO:2000857) positive regulation of aldosterone secretion(GO:2000860) |
| 1.4 | 12.4 | GO:0061004 | pattern specification involved in kidney development(GO:0061004) renal system pattern specification(GO:0072048) |
| 1.4 | 101.8 | GO:0010257 | NADH dehydrogenase complex assembly(GO:0010257) mitochondrial respiratory chain complex I assembly(GO:0032981) mitochondrial respiratory chain complex I biogenesis(GO:0097031) |
| 1.4 | 11.0 | GO:0060426 | lung vasculature development(GO:0060426) |
| 1.4 | 5.5 | GO:0072719 | cellular response to cisplatin(GO:0072719) |
| 1.4 | 4.1 | GO:1905204 | regulation of connective tissue replacement involved in inflammatory response wound healing(GO:1904596) negative regulation of connective tissue replacement involved in inflammatory response wound healing(GO:1904597) regulation of advanced glycation end-product receptor activity(GO:1904603) negative regulation of advanced glycation end-product receptor activity(GO:1904604) negative regulation of connective tissue replacement(GO:1905204) |
| 1.4 | 24.4 | GO:0019511 | peptidyl-proline hydroxylation(GO:0019511) |
| 1.4 | 6.8 | GO:0036072 | intramembranous ossification(GO:0001957) direct ossification(GO:0036072) |
| 1.4 | 9.5 | GO:0098502 | DNA dephosphorylation(GO:0098502) |
| 1.3 | 5.4 | GO:0061073 | ciliary body morphogenesis(GO:0061073) |
| 1.3 | 5.4 | GO:0033591 | response to L-ascorbic acid(GO:0033591) |
| 1.3 | 4.0 | GO:0016114 | terpenoid biosynthetic process(GO:0016114) |
| 1.3 | 9.4 | GO:0097084 | vascular smooth muscle cell development(GO:0097084) |
| 1.3 | 4.0 | GO:2000048 | negative regulation of cell-cell adhesion mediated by cadherin(GO:2000048) |
| 1.3 | 4.0 | GO:0007518 | myoblast fate determination(GO:0007518) |
| 1.3 | 4.0 | GO:1903595 | positive regulation of histamine secretion by mast cell(GO:1903595) |
| 1.3 | 18.7 | GO:0034356 | NAD biosynthesis via nicotinamide riboside salvage pathway(GO:0034356) |
| 1.3 | 2.7 | GO:0046086 | adenosine biosynthetic process(GO:0046086) |
| 1.3 | 12.0 | GO:0071578 | zinc II ion transmembrane import(GO:0071578) |
| 1.3 | 1.3 | GO:1903422 | negative regulation of synaptic vesicle recycling(GO:1903422) |
| 1.3 | 7.9 | GO:2000188 | regulation of cholesterol homeostasis(GO:2000188) |
| 1.3 | 2.6 | GO:0097435 | fibril organization(GO:0097435) |
| 1.3 | 9.2 | GO:0030579 | ubiquitin-dependent SMAD protein catabolic process(GO:0030579) |
| 1.3 | 3.9 | GO:0035519 | protein K29-linked ubiquitination(GO:0035519) |
| 1.3 | 10.4 | GO:0016128 | phytosteroid metabolic process(GO:0016128) phytosteroid biosynthetic process(GO:0016129) |
| 1.3 | 5.2 | GO:0021759 | globus pallidus development(GO:0021759) |
| 1.3 | 3.9 | GO:0098734 | macromolecule depalmitoylation(GO:0098734) |
| 1.3 | 6.4 | GO:1903265 | positive regulation of tumor necrosis factor-mediated signaling pathway(GO:1903265) |
| 1.3 | 2.6 | GO:2001027 | negative regulation of endothelial cell chemotaxis(GO:2001027) |
| 1.3 | 3.8 | GO:1901804 | beta-glucoside metabolic process(GO:1901804) beta-glucoside catabolic process(GO:1901805) positive regulation of neuronal action potential(GO:1904457) |
| 1.3 | 6.4 | GO:0046185 | aldehyde catabolic process(GO:0046185) |
| 1.3 | 3.8 | GO:0035803 | egg coat formation(GO:0035803) |
| 1.3 | 7.6 | GO:0048739 | cardiac muscle fiber development(GO:0048739) |
| 1.3 | 3.8 | GO:0006566 | threonine metabolic process(GO:0006566) |
| 1.3 | 11.3 | GO:0042178 | xenobiotic catabolic process(GO:0042178) |
| 1.2 | 2.5 | GO:0045013 | carbon catabolite repression of transcription(GO:0045013) negative regulation of transcription by glucose(GO:0045014) |
| 1.2 | 3.7 | GO:2000504 | positive regulation of blood vessel remodeling(GO:2000504) |
| 1.2 | 5.0 | GO:1900138 | negative regulation of phospholipase A2 activity(GO:1900138) |
| 1.2 | 21.2 | GO:0032060 | bleb assembly(GO:0032060) |
| 1.2 | 1.2 | GO:0014834 | skeletal muscle satellite cell maintenance involved in skeletal muscle regeneration(GO:0014834) |
| 1.2 | 2.5 | GO:0018312 | peptidyl-serine ADP-ribosylation(GO:0018312) |
| 1.2 | 18.6 | GO:1904851 | positive regulation of establishment of protein localization to telomere(GO:1904851) |
| 1.2 | 1.2 | GO:0032707 | negative regulation of interleukin-23 production(GO:0032707) |
| 1.2 | 2.5 | GO:0009180 | ADP biosynthetic process(GO:0006172) purine nucleoside diphosphate biosynthetic process(GO:0009136) purine ribonucleoside diphosphate biosynthetic process(GO:0009180) ribonucleoside diphosphate biosynthetic process(GO:0009188) |
| 1.2 | 9.8 | GO:2000210 | positive regulation of anoikis(GO:2000210) |
| 1.2 | 4.9 | GO:0036496 | regulation of translational initiation by eIF2 alpha dephosphorylation(GO:0036496) |
| 1.2 | 1.2 | GO:0090400 | stress-induced premature senescence(GO:0090400) |
| 1.2 | 4.9 | GO:0000961 | negative regulation of mitochondrial RNA catabolic process(GO:0000961) |
| 1.2 | 2.4 | GO:0032808 | lacrimal gland development(GO:0032808) |
| 1.2 | 9.6 | GO:0045959 | regulation of complement activation, classical pathway(GO:0030450) negative regulation of complement activation, classical pathway(GO:0045959) |
| 1.2 | 22.8 | GO:0032780 | negative regulation of ATPase activity(GO:0032780) |
| 1.2 | 4.8 | GO:0099640 | axo-dendritic protein transport(GO:0099640) |
| 1.2 | 3.6 | GO:0046586 | regulation of calcium-dependent cell-cell adhesion(GO:0046586) |
| 1.2 | 1.2 | GO:1903923 | protein processing in phagocytic vesicle(GO:1900756) regulation of protein processing in phagocytic vesicle(GO:1903921) positive regulation of protein processing in phagocytic vesicle(GO:1903923) |
| 1.2 | 3.6 | GO:0048280 | vesicle fusion with Golgi apparatus(GO:0048280) |
| 1.2 | 2.4 | GO:0010940 | positive regulation of necrotic cell death(GO:0010940) |
| 1.2 | 4.7 | GO:0090131 | mesenchyme migration(GO:0090131) |
| 1.2 | 3.5 | GO:0038018 | Wnt receptor catabolic process(GO:0038018) |
| 1.2 | 1.2 | GO:0052564 | response to immune response of other organism involved in symbiotic interaction(GO:0052564) response to host immune response(GO:0052572) |
| 1.2 | 2.4 | GO:0000733 | DNA strand renaturation(GO:0000733) |
| 1.2 | 3.5 | GO:0070314 | G1 to G0 transition(GO:0070314) |
| 1.2 | 3.5 | GO:0035752 | lysosomal lumen pH elevation(GO:0035752) |
| 1.2 | 12.8 | GO:0060700 | regulation of ribonuclease activity(GO:0060700) |
| 1.2 | 12.8 | GO:0048007 | antigen processing and presentation of lipid antigen via MHC class Ib(GO:0048003) antigen processing and presentation, exogenous lipid antigen via MHC class Ib(GO:0048007) |
| 1.2 | 16.2 | GO:0001778 | plasma membrane repair(GO:0001778) |
| 1.2 | 12.8 | GO:2000781 | positive regulation of double-strand break repair(GO:2000781) |
| 1.2 | 16.2 | GO:0007175 | negative regulation of epidermal growth factor-activated receptor activity(GO:0007175) |
| 1.2 | 10.4 | GO:0033629 | negative regulation of cell adhesion mediated by integrin(GO:0033629) |
| 1.1 | 2.3 | GO:0039702 | viral budding via host ESCRT complex(GO:0039702) |
| 1.1 | 10.3 | GO:0033262 | regulation of nuclear cell cycle DNA replication(GO:0033262) |
| 1.1 | 3.4 | GO:1901253 | negative regulation of intracellular transport of viral material(GO:1901253) |
| 1.1 | 9.1 | GO:0034625 | fatty acid elongation, saturated fatty acid(GO:0019367) fatty acid elongation, unsaturated fatty acid(GO:0019368) fatty acid elongation, monounsaturated fatty acid(GO:0034625) fatty acid elongation, polyunsaturated fatty acid(GO:0034626) |
| 1.1 | 3.4 | GO:0000050 | urea cycle(GO:0000050) |
| 1.1 | 4.5 | GO:0032929 | negative regulation of superoxide anion generation(GO:0032929) |
| 1.1 | 9.1 | GO:0045905 | translational frameshifting(GO:0006452) positive regulation of translational termination(GO:0045905) |
| 1.1 | 9.1 | GO:0055129 | proline biosynthetic process(GO:0006561) L-proline biosynthetic process(GO:0055129) |
| 1.1 | 11.3 | GO:0009414 | response to water deprivation(GO:0009414) |
| 1.1 | 7.9 | GO:0032534 | regulation of microvillus assembly(GO:0032534) |
| 1.1 | 4.5 | GO:0060528 | secretory columnal luminar epithelial cell differentiation involved in prostate glandular acinus development(GO:0060528) |
| 1.1 | 2.3 | GO:2000562 | negative regulation of CD4-positive, alpha-beta T cell proliferation(GO:2000562) |
| 1.1 | 1.1 | GO:0034349 | glial cell apoptotic process(GO:0034349) regulation of glial cell apoptotic process(GO:0034350) negative regulation of glial cell apoptotic process(GO:0034351) |
| 1.1 | 16.9 | GO:0007084 | mitotic nuclear envelope reassembly(GO:0007084) |
| 1.1 | 3.4 | GO:0019747 | regulation of isoprenoid metabolic process(GO:0019747) |
| 1.1 | 2.2 | GO:0071373 | cellular response to luteinizing hormone stimulus(GO:0071373) |
| 1.1 | 6.7 | GO:0030497 | fatty acid elongation(GO:0030497) very long-chain fatty acid biosynthetic process(GO:0042761) |
| 1.1 | 2.2 | GO:0072718 | response to cisplatin(GO:0072718) |
| 1.1 | 4.4 | GO:0030948 | negative regulation of vascular endothelial growth factor receptor signaling pathway(GO:0030948) |
| 1.1 | 7.7 | GO:0040016 | embryonic cleavage(GO:0040016) |
| 1.1 | 3.3 | GO:0043465 | fermentation(GO:0006113) regulation of fermentation(GO:0043465) |
| 1.1 | 9.9 | GO:0075522 | IRES-dependent viral translational initiation(GO:0075522) |
| 1.1 | 2.2 | GO:0048743 | positive regulation of skeletal muscle fiber development(GO:0048743) |
| 1.1 | 3.3 | GO:0001868 | regulation of complement activation, lectin pathway(GO:0001868) negative regulation of complement activation, lectin pathway(GO:0001869) |
| 1.1 | 8.6 | GO:0000466 | maturation of 5.8S rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA)(GO:0000466) |
| 1.1 | 18.4 | GO:0030388 | fructose 1,6-bisphosphate metabolic process(GO:0030388) |
| 1.1 | 7.5 | GO:0006307 | DNA dealkylation involved in DNA repair(GO:0006307) |
| 1.1 | 2.1 | GO:2000381 | negative regulation of mesoderm development(GO:2000381) |
| 1.1 | 4.3 | GO:0042415 | norepinephrine metabolic process(GO:0042415) |
| 1.1 | 8.5 | GO:0045039 | protein import into mitochondrial inner membrane(GO:0045039) |
| 1.1 | 1.1 | GO:0001757 | somite specification(GO:0001757) |
| 1.1 | 4.2 | GO:1902544 | regulation of DNA N-glycosylase activity(GO:1902544) |
| 1.1 | 21.1 | GO:0006851 | mitochondrial calcium ion transport(GO:0006851) |
| 1.1 | 13.7 | GO:0006002 | fructose 6-phosphate metabolic process(GO:0006002) |
| 1.1 | 8.4 | GO:0097039 | protein linear polyubiquitination(GO:0097039) |
| 1.0 | 18.8 | GO:0003215 | cardiac right ventricle morphogenesis(GO:0003215) |
| 1.0 | 11.5 | GO:0051988 | regulation of attachment of spindle microtubules to kinetochore(GO:0051988) |
| 1.0 | 2.1 | GO:2000811 | negative regulation of anoikis(GO:2000811) |
| 1.0 | 5.2 | GO:2000645 | negative regulation of receptor catabolic process(GO:2000645) |
| 1.0 | 9.3 | GO:0006189 | 'de novo' IMP biosynthetic process(GO:0006189) |
| 1.0 | 4.1 | GO:0021539 | subthalamus development(GO:0021539) |
| 1.0 | 25.7 | GO:0015949 | nucleobase-containing small molecule interconversion(GO:0015949) |
| 1.0 | 2.0 | GO:0048254 | snoRNA localization(GO:0048254) |
| 1.0 | 5.1 | GO:2001295 | malonyl-CoA biosynthetic process(GO:2001295) |
| 1.0 | 17.3 | GO:0003334 | keratinocyte development(GO:0003334) |
| 1.0 | 5.1 | GO:0019348 | dolichol metabolic process(GO:0019348) |
| 1.0 | 6.1 | GO:0050689 | negative regulation of defense response to virus by host(GO:0050689) |
| 1.0 | 4.0 | GO:0090191 | negative regulation of branching involved in ureteric bud morphogenesis(GO:0090191) |
| 1.0 | 3.0 | GO:0033512 | L-lysine catabolic process to acetyl-CoA via saccharopine(GO:0033512) |
| 1.0 | 43.1 | GO:0006370 | 7-methylguanosine mRNA capping(GO:0006370) |
| 1.0 | 5.0 | GO:0090270 | fibroblast growth factor production(GO:0090269) regulation of fibroblast growth factor production(GO:0090270) |
| 1.0 | 4.0 | GO:0044571 | [2Fe-2S] cluster assembly(GO:0044571) |
| 1.0 | 1.0 | GO:0060316 | positive regulation of ryanodine-sensitive calcium-release channel activity(GO:0060316) |
| 1.0 | 10.0 | GO:0000212 | meiotic spindle organization(GO:0000212) |
| 1.0 | 1.0 | GO:0036118 | hyaluranon cable assembly(GO:0036118) regulation of hyaluranon cable assembly(GO:1900104) positive regulation of hyaluranon cable assembly(GO:1900106) |
| 1.0 | 14.9 | GO:0043162 | ubiquitin-dependent protein catabolic process via the multivesicular body sorting pathway(GO:0043162) |
| 1.0 | 22.8 | GO:0032201 | telomere maintenance via semi-conservative replication(GO:0032201) |
| 1.0 | 18.8 | GO:0006123 | mitochondrial electron transport, cytochrome c to oxygen(GO:0006123) |
| 1.0 | 4.9 | GO:0097461 | ferric iron import into cell(GO:0097461) ferric iron import across plasma membrane(GO:0098706) |
| 1.0 | 3.0 | GO:0060166 | olfactory pit development(GO:0060166) |
| 1.0 | 2.9 | GO:0031639 | plasminogen activation(GO:0031639) |
| 1.0 | 11.8 | GO:0051964 | negative regulation of synapse assembly(GO:0051964) |
| 1.0 | 1.0 | GO:0006565 | L-serine catabolic process(GO:0006565) |
| 1.0 | 1.0 | GO:0006447 | regulation of translational initiation by iron(GO:0006447) |
| 1.0 | 1.0 | GO:0071284 | cellular response to lead ion(GO:0071284) |
| 1.0 | 36.0 | GO:0000387 | spliceosomal snRNP assembly(GO:0000387) |
| 1.0 | 1.0 | GO:0006545 | glycine biosynthetic process(GO:0006545) |
| 1.0 | 2.9 | GO:0044854 | plasma membrane raft assembly(GO:0044854) plasma membrane raft organization(GO:0044857) |
| 1.0 | 1.0 | GO:1900109 | regulation of histone H3-K9 dimethylation(GO:1900109) |
| 1.0 | 95.6 | GO:0070268 | cornification(GO:0070268) |
| 1.0 | 13.5 | GO:0007220 | Notch receptor processing(GO:0007220) |
| 1.0 | 1.0 | GO:0051799 | negative regulation of hair follicle development(GO:0051799) |
| 1.0 | 4.8 | GO:0061042 | vascular wound healing(GO:0061042) |
| 1.0 | 2.9 | GO:0070365 | hepatocyte differentiation(GO:0070365) |
| 1.0 | 4.8 | GO:0086048 | membrane depolarization during bundle of His cell action potential(GO:0086048) |
| 0.9 | 1.9 | GO:1901993 | meiotic cell cycle phase transition(GO:0044771) regulation of meiotic cell cycle phase transition(GO:1901993) negative regulation of meiotic cell cycle phase transition(GO:1901994) |
| 0.9 | 12.3 | GO:0032786 | positive regulation of DNA-templated transcription, elongation(GO:0032786) |
| 0.9 | 6.6 | GO:0006990 | positive regulation of transcription from RNA polymerase II promoter involved in unfolded protein response(GO:0006990) |
| 0.9 | 4.7 | GO:1904885 | beta-catenin destruction complex assembly(GO:1904885) |
| 0.9 | 2.8 | GO:0002183 | cytoplasmic translational initiation(GO:0002183) |
| 0.9 | 2.8 | GO:1903644 | regulation of chaperone-mediated protein folding(GO:1903644) |
| 0.9 | 0.9 | GO:0046601 | positive regulation of centriole replication(GO:0046601) |
| 0.9 | 1.9 | GO:0098903 | regulation of membrane repolarization during action potential(GO:0098903) |
| 0.9 | 1.9 | GO:1901876 | regulation of calcium ion binding(GO:1901876) negative regulation of calcium ion binding(GO:1901877) |
| 0.9 | 4.6 | GO:0016139 | glycoside catabolic process(GO:0016139) |
| 0.9 | 3.7 | GO:0046166 | glyceraldehyde-3-phosphate biosynthetic process(GO:0046166) |
| 0.9 | 3.7 | GO:0031468 | nuclear envelope reassembly(GO:0031468) |
| 0.9 | 4.6 | GO:0038165 | oncostatin-M-mediated signaling pathway(GO:0038165) |
| 0.9 | 0.9 | GO:0043418 | homocysteine catabolic process(GO:0043418) |
| 0.9 | 3.7 | GO:0090096 | metanephric cap development(GO:0072185) metanephric cap morphogenesis(GO:0072186) metanephric cap mesenchymal cell proliferation involved in metanephros development(GO:0090094) regulation of metanephric cap mesenchymal cell proliferation(GO:0090095) positive regulation of metanephric cap mesenchymal cell proliferation(GO:0090096) |
| 0.9 | 2.8 | GO:1990641 | response to iron ion starvation(GO:1990641) |
| 0.9 | 2.7 | GO:0048205 | COPI-coated vesicle budding(GO:0035964) Golgi transport vesicle coating(GO:0048200) COPI coating of Golgi vesicle(GO:0048205) |
| 0.9 | 5.4 | GO:0000727 | double-strand break repair via break-induced replication(GO:0000727) |
| 0.9 | 2.7 | GO:0051177 | meiotic sister chromatid cohesion(GO:0051177) |
| 0.9 | 9.9 | GO:0071550 | death-inducing signaling complex assembly(GO:0071550) |
| 0.9 | 2.7 | GO:0030327 | prenylated protein catabolic process(GO:0030327) |
| 0.9 | 2.7 | GO:0045903 | positive regulation of translational fidelity(GO:0045903) |
| 0.9 | 7.1 | GO:0042407 | cristae formation(GO:0042407) |
| 0.9 | 4.5 | GO:0006015 | 5-phosphoribose 1-diphosphate biosynthetic process(GO:0006015) 5-phosphoribose 1-diphosphate metabolic process(GO:0046391) |
| 0.9 | 10.7 | GO:0030150 | protein import into mitochondrial matrix(GO:0030150) |
| 0.9 | 1.8 | GO:0051832 | evasion or tolerance of host defenses by virus(GO:0019049) avoidance of host defenses(GO:0044413) evasion or tolerance of host defenses(GO:0044415) avoidance of defenses of other organism involved in symbiotic interaction(GO:0051832) evasion or tolerance of defenses of other organism involved in symbiotic interaction(GO:0051834) |
| 0.9 | 7.1 | GO:0006572 | tyrosine catabolic process(GO:0006572) |
| 0.9 | 5.3 | GO:0051918 | negative regulation of fibrinolysis(GO:0051918) |
| 0.9 | 0.9 | GO:0010835 | regulation of protein ADP-ribosylation(GO:0010835) |
| 0.9 | 6.2 | GO:0002318 | myeloid progenitor cell differentiation(GO:0002318) |
| 0.9 | 1.8 | GO:0019853 | L-ascorbic acid biosynthetic process(GO:0019853) |
| 0.9 | 2.6 | GO:0045082 | positive regulation of interleukin-10 biosynthetic process(GO:0045082) |
| 0.9 | 67.8 | GO:0000079 | regulation of cyclin-dependent protein serine/threonine kinase activity(GO:0000079) |
| 0.9 | 6.2 | GO:0006116 | NADH oxidation(GO:0006116) |
| 0.9 | 3.5 | GO:1903974 | positive regulation of odontogenesis of dentin-containing tooth(GO:0042488) mammary gland fat development(GO:0060611) positive regulation of macrophage colony-stimulating factor signaling pathway(GO:1902228) positive regulation of response to macrophage colony-stimulating factor(GO:1903971) positive regulation of cellular response to macrophage colony-stimulating factor stimulus(GO:1903974) microglial cell migration(GO:1904124) regulation of microglial cell migration(GO:1904139) positive regulation of microglial cell migration(GO:1904141) |
| 0.9 | 4.4 | GO:0097647 | calcitonin family receptor signaling pathway(GO:0097646) amylin receptor signaling pathway(GO:0097647) |
| 0.9 | 27.1 | GO:0016338 | calcium-independent cell-cell adhesion via plasma membrane cell-adhesion molecules(GO:0016338) |
| 0.9 | 4.4 | GO:0042986 | positive regulation of amyloid precursor protein biosynthetic process(GO:0042986) |
| 0.9 | 2.6 | GO:0003408 | optic cup formation involved in camera-type eye development(GO:0003408) |
| 0.9 | 7.0 | GO:0060315 | negative regulation of ryanodine-sensitive calcium-release channel activity(GO:0060315) |
| 0.9 | 7.8 | GO:0070208 | protein heterotrimerization(GO:0070208) |
| 0.9 | 7.8 | GO:0034723 | DNA replication-dependent nucleosome assembly(GO:0006335) DNA replication-dependent nucleosome organization(GO:0034723) |
| 0.9 | 0.9 | GO:0061009 | common bile duct development(GO:0061009) |
| 0.9 | 3.5 | GO:0044533 | induction of programmed cell death(GO:0012502) positive regulation of apoptotic process in other organism(GO:0044533) positive regulation by symbiont of host programmed cell death(GO:0052042) positive regulation by organism of programmed cell death in other organism involved in symbiotic interaction(GO:0052330) positive regulation by organism of apoptotic process in other organism involved in symbiotic interaction(GO:0052501) |
| 0.9 | 1.7 | GO:0034435 | steroid esterification(GO:0034433) sterol esterification(GO:0034434) cholesterol esterification(GO:0034435) |
| 0.9 | 6.9 | GO:0042373 | vitamin K metabolic process(GO:0042373) |
| 0.9 | 14.6 | GO:0006957 | complement activation, alternative pathway(GO:0006957) |
| 0.9 | 4.3 | GO:0015742 | alpha-ketoglutarate transport(GO:0015742) |
| 0.9 | 2.6 | GO:0061357 | positive regulation of Wnt protein secretion(GO:0061357) |
| 0.9 | 11.2 | GO:0006388 | tRNA splicing, via endonucleolytic cleavage and ligation(GO:0006388) |
| 0.9 | 7.7 | GO:0045717 | negative regulation of fatty acid biosynthetic process(GO:0045717) |
| 0.9 | 2.6 | GO:0000472 | endonucleolytic cleavage to generate mature 5'-end of SSU-rRNA from (SSU-rRNA, 5.8S rRNA, LSU-rRNA)(GO:0000472) rRNA 5'-end processing(GO:0000967) ncRNA 5'-end processing(GO:0034471) |
| 0.9 | 1.7 | GO:2000296 | negative regulation of hydrogen peroxide catabolic process(GO:2000296) |
| 0.8 | 8.5 | GO:0034134 | toll-like receptor 2 signaling pathway(GO:0034134) |
| 0.8 | 3.4 | GO:0008588 | release of cytoplasmic sequestered NF-kappaB(GO:0008588) |
| 0.8 | 10.9 | GO:0000028 | ribosomal small subunit assembly(GO:0000028) |
| 0.8 | 5.0 | GO:0097396 | response to interleukin-17(GO:0097396) cellular response to interleukin-17(GO:0097398) |
| 0.8 | 2.5 | GO:1902412 | regulation of mitotic cytokinesis(GO:1902412) |
| 0.8 | 8.3 | GO:0008216 | spermidine metabolic process(GO:0008216) |
| 0.8 | 26.6 | GO:2000816 | negative regulation of mitotic sister chromatid separation(GO:2000816) |
| 0.8 | 9.1 | GO:0038089 | positive regulation of cell migration by vascular endothelial growth factor signaling pathway(GO:0038089) |
| 0.8 | 3.3 | GO:0071727 | toll-like receptor TLR1:TLR2 signaling pathway(GO:0038123) response to triacyl bacterial lipopeptide(GO:0071725) cellular response to triacyl bacterial lipopeptide(GO:0071727) |
| 0.8 | 23.0 | GO:0043567 | regulation of insulin-like growth factor receptor signaling pathway(GO:0043567) |
| 0.8 | 2.5 | GO:1901389 | regulation of transforming growth factor beta activation(GO:1901388) negative regulation of transforming growth factor beta activation(GO:1901389) |
| 0.8 | 4.9 | GO:0006021 | inositol biosynthetic process(GO:0006021) |
| 0.8 | 1.6 | GO:0006627 | protein processing involved in protein targeting to mitochondrion(GO:0006627) |
| 0.8 | 1.6 | GO:0070272 | proton-transporting ATP synthase complex assembly(GO:0043461) proton-transporting ATP synthase complex biogenesis(GO:0070272) |
| 0.8 | 2.5 | GO:0070370 | heat acclimation(GO:0010286) cellular heat acclimation(GO:0070370) |
| 0.8 | 1.6 | GO:0070885 | negative regulation of calcineurin-NFAT signaling cascade(GO:0070885) |
| 0.8 | 1.6 | GO:1904378 | maintenance of unfolded protein(GO:0036506) maintenance of unfolded protein involved in ERAD pathway(GO:1904378) |
| 0.8 | 3.3 | GO:0018008 | N-terminal peptidyl-glycine N-myristoylation(GO:0018008) peptidyl-glycine modification(GO:0018201) |
| 0.8 | 29.3 | GO:0000462 | maturation of SSU-rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA)(GO:0000462) |
| 0.8 | 4.9 | GO:0071847 | TNFSF11-mediated signaling pathway(GO:0071847) |
| 0.8 | 2.4 | GO:0015888 | thiamine transport(GO:0015888) thiamine transmembrane transport(GO:0071934) |
| 0.8 | 1.6 | GO:0032911 | negative regulation of transforming growth factor beta1 production(GO:0032911) |
| 0.8 | 3.2 | GO:2000344 | positive regulation of acrosome reaction(GO:2000344) |
| 0.8 | 38.8 | GO:0007077 | mitotic nuclear envelope disassembly(GO:0007077) |
| 0.8 | 4.0 | GO:0033590 | response to cobalamin(GO:0033590) |
| 0.8 | 3.2 | GO:0042796 | snRNA transcription from RNA polymerase III promoter(GO:0042796) |
| 0.8 | 2.4 | GO:0000710 | meiotic mismatch repair(GO:0000710) |
| 0.8 | 4.8 | GO:0071503 | response to heparin(GO:0071503) cellular response to heparin(GO:0071504) |
| 0.8 | 6.4 | GO:2000587 | negative regulation of platelet-derived growth factor receptor-beta signaling pathway(GO:2000587) |
| 0.8 | 2.4 | GO:0009298 | GDP-mannose biosynthetic process(GO:0009298) |
| 0.8 | 0.8 | GO:0046110 | purine nucleobase catabolic process(GO:0006145) xanthine metabolic process(GO:0046110) |
| 0.8 | 5.5 | GO:0032020 | ISG15-protein conjugation(GO:0032020) |
| 0.8 | 2.4 | GO:0070476 | RNA (guanine-N7)-methylation(GO:0036265) rRNA (guanine-N7)-methylation(GO:0070476) |
| 0.8 | 3.2 | GO:0090362 | positive regulation of platelet-derived growth factor production(GO:0090362) |
| 0.8 | 2.4 | GO:0030961 | peptidyl-arginine hydroxylation(GO:0030961) |
| 0.8 | 3.1 | GO:0046654 | tetrahydrofolate biosynthetic process(GO:0046654) |
| 0.8 | 1.6 | GO:0009111 | vitamin catabolic process(GO:0009111) |
| 0.8 | 1.6 | GO:0090116 | C-5 methylation of cytosine(GO:0090116) |
| 0.8 | 3.1 | GO:0002265 | astrocyte activation involved in immune response(GO:0002265) smooth endoplasmic reticulum calcium ion homeostasis(GO:0051563) |
| 0.8 | 0.8 | GO:0051792 | medium-chain fatty acid biosynthetic process(GO:0051792) |
| 0.8 | 2.3 | GO:0061624 | fructose catabolic process(GO:0006001) fructose catabolic process to hydroxyacetone phosphate and glyceraldehyde-3-phosphate(GO:0061624) |
| 0.8 | 2.3 | GO:2000105 | positive regulation of DNA-dependent DNA replication(GO:2000105) |
| 0.8 | 2.3 | GO:0003064 | regulation of heart rate by hormone(GO:0003064) |
| 0.8 | 7.0 | GO:0031936 | negative regulation of chromatin silencing(GO:0031936) |
| 0.8 | 1.5 | GO:2000722 | regulation of cardiac vascular smooth muscle cell differentiation(GO:2000722) |
| 0.8 | 0.8 | GO:0048633 | positive regulation of skeletal muscle tissue growth(GO:0048633) |
| 0.8 | 0.8 | GO:0071947 | protein deubiquitination involved in ubiquitin-dependent protein catabolic process(GO:0071947) |
| 0.8 | 2.3 | GO:1902462 | transforming growth factor beta activation(GO:0036363) regulation of mesenchymal stem cell proliferation(GO:1902460) positive regulation of mesenchymal stem cell proliferation(GO:1902462) |
| 0.8 | 1.5 | GO:0022007 | neural plate elongation(GO:0014022) convergent extension involved in neural plate elongation(GO:0022007) |
| 0.8 | 2.3 | GO:0002541 | activation of plasma proteins involved in acute inflammatory response(GO:0002541) |
| 0.8 | 2.3 | GO:0033132 | negative regulation of glucokinase activity(GO:0033132) negative regulation of hexokinase activity(GO:1903300) |
| 0.8 | 0.8 | GO:0090009 | primitive streak formation(GO:0090009) |
| 0.8 | 6.1 | GO:2000628 | regulation of miRNA metabolic process(GO:2000628) |
| 0.8 | 0.8 | GO:0010944 | negative regulation of transcription by competitive promoter binding(GO:0010944) |
| 0.8 | 2.3 | GO:0032815 | negative regulation of natural killer cell activation(GO:0032815) |
| 0.8 | 12.8 | GO:0070389 | chaperone cofactor-dependent protein refolding(GO:0070389) |
| 0.8 | 3.8 | GO:0070966 | nuclear-transcribed mRNA catabolic process, no-go decay(GO:0070966) |
| 0.8 | 5.3 | GO:2000042 | negative regulation of double-strand break repair via homologous recombination(GO:2000042) |
| 0.7 | 0.7 | GO:0045144 | meiotic sister chromatid segregation(GO:0045144) |
| 0.7 | 7.5 | GO:1903003 | positive regulation of protein deubiquitination(GO:1903003) |
| 0.7 | 34.9 | GO:0000413 | protein peptidyl-prolyl isomerization(GO:0000413) peptidyl-proline modification(GO:0018208) |
| 0.7 | 0.7 | GO:1901421 | positive regulation of response to alcohol(GO:1901421) |
| 0.7 | 3.7 | GO:0032429 | regulation of phospholipase A2 activity(GO:0032429) |
| 0.7 | 2.2 | GO:0051970 | negative regulation of transmission of nerve impulse(GO:0051970) |
| 0.7 | 2.9 | GO:0038194 | thyroid-stimulating hormone signaling pathway(GO:0038194) cellular response to glycoprotein(GO:1904588) cellular response to thyrotropin-releasing hormone(GO:1905229) |
| 0.7 | 19.8 | GO:0009235 | cobalamin metabolic process(GO:0009235) |
| 0.7 | 2.9 | GO:0018197 | peptidyl-aspartic acid modification(GO:0018197) peptidyl-aspartic acid hydroxylation(GO:0042264) |
| 0.7 | 2.2 | GO:1990426 | homologous recombination-dependent replication fork processing(GO:1990426) |
| 0.7 | 5.1 | GO:0021891 | olfactory bulb interneuron development(GO:0021891) |
| 0.7 | 4.4 | GO:0090481 | pyrimidine nucleotide-sugar transmembrane transport(GO:0090481) |
| 0.7 | 4.4 | GO:0043353 | enucleate erythrocyte differentiation(GO:0043353) |
| 0.7 | 3.6 | GO:1901350 | cell-cell signaling involved in cell-cell junction organization(GO:1901350) |
| 0.7 | 50.0 | GO:0006521 | regulation of cellular amino acid metabolic process(GO:0006521) |
| 0.7 | 2.2 | GO:0036071 | N-glycan fucosylation(GO:0036071) |
| 0.7 | 3.6 | GO:0034244 | negative regulation of transcription elongation from RNA polymerase II promoter(GO:0034244) |
| 0.7 | 2.9 | GO:1903173 | phytol metabolic process(GO:0033306) fatty alcohol metabolic process(GO:1903173) |
| 0.7 | 7.2 | GO:0010839 | negative regulation of keratinocyte proliferation(GO:0010839) |
| 0.7 | 36.1 | GO:0043486 | histone exchange(GO:0043486) |
| 0.7 | 4.3 | GO:0043102 | amino acid salvage(GO:0043102) L-methionine salvage(GO:0071267) |
| 0.7 | 1.4 | GO:1902568 | positive regulation of eosinophil degranulation(GO:0043311) positive regulation of eosinophil activation(GO:1902568) |
| 0.7 | 0.7 | GO:0055099 | response to high density lipoprotein particle(GO:0055099) |
| 0.7 | 0.7 | GO:0038016 | insulin receptor internalization(GO:0038016) |
| 0.7 | 0.7 | GO:0003273 | cell migration involved in endocardial cushion formation(GO:0003273) |
| 0.7 | 4.2 | GO:0042866 | pyruvate biosynthetic process(GO:0042866) |
| 0.7 | 0.7 | GO:0071926 | endocannabinoid signaling pathway(GO:0071926) |
| 0.7 | 63.0 | GO:0006903 | vesicle targeting(GO:0006903) |
| 0.7 | 7.0 | GO:0045716 | regulation of low-density lipoprotein particle receptor biosynthetic process(GO:0045714) positive regulation of low-density lipoprotein particle receptor biosynthetic process(GO:0045716) |
| 0.7 | 12.6 | GO:0007080 | mitotic metaphase plate congression(GO:0007080) |
| 0.7 | 1.4 | GO:0035166 | post-embryonic hemopoiesis(GO:0035166) |
| 0.7 | 1.4 | GO:0002386 | immune response in mucosal-associated lymphoid tissue(GO:0002386) |
| 0.7 | 10.4 | GO:0042730 | fibrinolysis(GO:0042730) |
| 0.7 | 1.4 | GO:0002176 | male germ cell proliferation(GO:0002176) germ cell proliferation(GO:0036093) |
| 0.7 | 36.7 | GO:0030049 | muscle filament sliding(GO:0030049) actin-myosin filament sliding(GO:0033275) |
| 0.7 | 2.1 | GO:0015722 | canalicular bile acid transport(GO:0015722) |
| 0.7 | 2.1 | GO:1902498 | regulation of protein autoubiquitination(GO:1902498) |
| 0.7 | 1.4 | GO:0046271 | phenylpropanoid catabolic process(GO:0046271) |
| 0.7 | 12.4 | GO:0017004 | cytochrome complex assembly(GO:0017004) |
| 0.7 | 2.1 | GO:0071971 | extracellular exosome assembly(GO:0071971) |
| 0.7 | 3.4 | GO:0061146 | Peyer's patch morphogenesis(GO:0061146) |
| 0.7 | 2.7 | GO:0045743 | positive regulation of fibroblast growth factor receptor signaling pathway(GO:0045743) |
| 0.7 | 12.3 | GO:0072697 | protein localization to cell cortex(GO:0072697) |
| 0.7 | 7.5 | GO:0009162 | deoxyribonucleoside monophosphate metabolic process(GO:0009162) |
| 0.7 | 4.8 | GO:0090656 | t-circle formation(GO:0090656) |
| 0.7 | 2.0 | GO:0072675 | macrophage fusion(GO:0034238) regulation of macrophage fusion(GO:0034239) positive regulation of macrophage fusion(GO:0034241) multinuclear osteoclast differentiation(GO:0072674) osteoclast fusion(GO:0072675) |
| 0.7 | 4.7 | GO:1903142 | positive regulation of endothelial cell development(GO:1901552) positive regulation of establishment of endothelial barrier(GO:1903142) |
| 0.7 | 2.0 | GO:0007096 | regulation of exit from mitosis(GO:0007096) |
| 0.7 | 8.1 | GO:0034384 | high-density lipoprotein particle clearance(GO:0034384) |
| 0.7 | 4.7 | GO:0007023 | post-chaperonin tubulin folding pathway(GO:0007023) |
| 0.7 | 6.1 | GO:2000767 | positive regulation of cytoplasmic translation(GO:2000767) |
| 0.7 | 0.7 | GO:0000478 | endonucleolytic cleavage involved in rRNA processing(GO:0000478) |
| 0.7 | 2.0 | GO:0006271 | DNA strand elongation involved in DNA replication(GO:0006271) |
| 0.7 | 2.0 | GO:1904814 | regulation of protein localization to chromosome, telomeric region(GO:1904814) positive regulation of protein localization to chromosome, telomeric region(GO:1904816) |
| 0.7 | 4.7 | GO:0001886 | endothelial cell morphogenesis(GO:0001886) |
| 0.7 | 4.0 | GO:0019255 | glucose 1-phosphate metabolic process(GO:0019255) |
| 0.7 | 2.0 | GO:0010965 | regulation of mitotic sister chromatid separation(GO:0010965) |
| 0.7 | 0.7 | GO:0070837 | dehydroascorbic acid transport(GO:0070837) |
| 0.7 | 10.7 | GO:0060216 | definitive hemopoiesis(GO:0060216) |
| 0.7 | 5.3 | GO:2000507 | positive regulation of energy homeostasis(GO:2000507) |
| 0.7 | 0.7 | GO:1904925 | positive regulation of macromitophagy(GO:1901526) positive regulation of mitophagy in response to mitochondrial depolarization(GO:1904925) |
| 0.7 | 3.3 | GO:1903421 | regulation of synaptic vesicle recycling(GO:1903421) |
| 0.7 | 2.0 | GO:0006409 | tRNA export from nucleus(GO:0006409) tRNA transport(GO:0051031) tRNA-containing ribonucleoprotein complex export from nucleus(GO:0071431) |
| 0.7 | 2.0 | GO:0010520 | meiotic gene conversion(GO:0006311) regulation of reciprocal meiotic recombination(GO:0010520) |
| 0.7 | 2.0 | GO:0045607 | regulation of auditory receptor cell differentiation(GO:0045607) regulation of mechanoreceptor differentiation(GO:0045631) regulation of inner ear receptor cell differentiation(GO:2000980) |
| 0.6 | 1.9 | GO:0033184 | positive regulation of histone ubiquitination(GO:0033184) |
| 0.6 | 7.8 | GO:0010529 | regulation of transposition(GO:0010528) negative regulation of transposition(GO:0010529) |
| 0.6 | 1.9 | GO:0060448 | dichotomous subdivision of terminal units involved in lung branching(GO:0060448) |
| 0.6 | 3.2 | GO:0090136 | epithelial cell-cell adhesion(GO:0090136) |
| 0.6 | 3.2 | GO:0060850 | regulation of transcription involved in cell fate commitment(GO:0060850) |
| 0.6 | 0.6 | GO:0033087 | negative regulation of immature T cell proliferation(GO:0033087) |
| 0.6 | 1.9 | GO:0035425 | autocrine signaling(GO:0035425) |
| 0.6 | 4.4 | GO:0000012 | single strand break repair(GO:0000012) |
| 0.6 | 0.6 | GO:0035759 | mesangial cell-matrix adhesion(GO:0035759) |
| 0.6 | 6.3 | GO:0046951 | ketone body biosynthetic process(GO:0046951) |
| 0.6 | 6.3 | GO:0030043 | actin filament fragmentation(GO:0030043) |
| 0.6 | 17.6 | GO:0031648 | protein destabilization(GO:0031648) |
| 0.6 | 6.9 | GO:0010837 | regulation of keratinocyte proliferation(GO:0010837) |
| 0.6 | 0.6 | GO:0044848 | biological phase(GO:0044848) |
| 0.6 | 10.0 | GO:0060347 | heart trabecula formation(GO:0060347) |
| 0.6 | 4.4 | GO:0015866 | ADP transport(GO:0015866) |
| 0.6 | 2.5 | GO:0021523 | somatic motor neuron differentiation(GO:0021523) |
| 0.6 | 1.9 | GO:0006711 | estrogen catabolic process(GO:0006711) |
| 0.6 | 1.2 | GO:0060982 | coronary artery morphogenesis(GO:0060982) |
| 0.6 | 5.6 | GO:0060712 | spongiotrophoblast layer development(GO:0060712) |
| 0.6 | 12.3 | GO:0042744 | hydrogen peroxide catabolic process(GO:0042744) |
| 0.6 | 3.7 | GO:0030949 | positive regulation of vascular endothelial growth factor receptor signaling pathway(GO:0030949) |
| 0.6 | 1.8 | GO:0060838 | lymphatic endothelial cell fate commitment(GO:0060838) |
| 0.6 | 7.4 | GO:0000038 | very long-chain fatty acid metabolic process(GO:0000038) |
| 0.6 | 8.6 | GO:0070934 | CRD-mediated mRNA stabilization(GO:0070934) |
| 0.6 | 15.9 | GO:0007216 | G-protein coupled glutamate receptor signaling pathway(GO:0007216) |
| 0.6 | 0.6 | GO:0070842 | aggresome assembly(GO:0070842) |
| 0.6 | 10.9 | GO:0006465 | signal peptide processing(GO:0006465) |
| 0.6 | 1.2 | GO:0002840 | T cell mediated immune response to tumor cell(GO:0002424) regulation of T cell mediated immune response to tumor cell(GO:0002840) |
| 0.6 | 6.6 | GO:0036158 | outer dynein arm assembly(GO:0036158) |
| 0.6 | 1.8 | GO:0036245 | cellular response to menadione(GO:0036245) |
| 0.6 | 2.4 | GO:0046121 | deoxyribonucleoside catabolic process(GO:0046121) |
| 0.6 | 6.0 | GO:0034498 | early endosome to Golgi transport(GO:0034498) |
| 0.6 | 0.6 | GO:2000152 | regulation of ubiquitin-specific protease activity(GO:2000152) |
| 0.6 | 10.2 | GO:0042304 | regulation of fatty acid biosynthetic process(GO:0042304) |
| 0.6 | 3.0 | GO:0051045 | negative regulation of membrane protein ectodomain proteolysis(GO:0051045) |
| 0.6 | 7.2 | GO:0021842 | directional guidance of interneurons involved in migration from the subpallium to the cortex(GO:0021840) chemorepulsion involved in interneuron migration from the subpallium to the cortex(GO:0021842) |
| 0.6 | 1.2 | GO:0097212 | lysosomal membrane organization(GO:0097212) regulation of late endosome to lysosome transport(GO:1902822) |
| 0.6 | 4.1 | GO:0021612 | facial nerve structural organization(GO:0021612) |
| 0.6 | 16.0 | GO:0022904 | respiratory electron transport chain(GO:0022904) |
| 0.6 | 1.8 | GO:0003284 | septum primum development(GO:0003284) |
| 0.6 | 1.2 | GO:0061056 | sclerotome development(GO:0061056) |
| 0.6 | 6.5 | GO:1901687 | glutathione derivative metabolic process(GO:1901685) glutathione derivative biosynthetic process(GO:1901687) |
| 0.6 | 10.6 | GO:0006270 | DNA replication initiation(GO:0006270) |
| 0.6 | 4.1 | GO:0042797 | 5S class rRNA transcription from RNA polymerase III type 1 promoter(GO:0042791) tRNA transcription from RNA polymerase III promoter(GO:0042797) |
| 0.6 | 1.7 | GO:0019287 | isopentenyl diphosphate biosynthetic process, mevalonate pathway(GO:0019287) |
| 0.6 | 41.8 | GO:0042273 | ribosomal large subunit biogenesis(GO:0042273) |
| 0.6 | 1.7 | GO:0044805 | late nucleophagy(GO:0044805) |
| 0.6 | 2.3 | GO:0034227 | tRNA thio-modification(GO:0034227) |
| 0.6 | 1.7 | GO:0045062 | extrathymic T cell selection(GO:0045062) |
| 0.6 | 4.0 | GO:0002051 | osteoblast fate commitment(GO:0002051) |
| 0.6 | 3.5 | GO:0045603 | positive regulation of endothelial cell differentiation(GO:0045603) |
| 0.6 | 5.8 | GO:0048227 | plasma membrane to endosome transport(GO:0048227) |
| 0.6 | 4.0 | GO:0009249 | protein lipoylation(GO:0009249) |
| 0.6 | 2.3 | GO:0036101 | leukotriene catabolic process(GO:0036100) leukotriene B4 catabolic process(GO:0036101) leukotriene B4 metabolic process(GO:0036102) icosanoid catabolic process(GO:1901523) fatty acid derivative catabolic process(GO:1901569) |
| 0.6 | 4.0 | GO:0046459 | short-chain fatty acid metabolic process(GO:0046459) |
| 0.6 | 2.3 | GO:0016554 | cytidine to uridine editing(GO:0016554) |
| 0.6 | 10.8 | GO:0010888 | negative regulation of lipid storage(GO:0010888) |
| 0.6 | 0.6 | GO:0010916 | regulation of very-low-density lipoprotein particle clearance(GO:0010915) negative regulation of very-low-density lipoprotein particle clearance(GO:0010916) |
| 0.6 | 3.4 | GO:0035063 | nuclear speck organization(GO:0035063) |
| 0.6 | 1.7 | GO:0045080 | positive regulation of chemokine biosynthetic process(GO:0045080) |
| 0.6 | 1.7 | GO:0006391 | transcription initiation from mitochondrial promoter(GO:0006391) |
| 0.6 | 2.3 | GO:0060729 | intestinal epithelial structure maintenance(GO:0060729) |
| 0.6 | 0.6 | GO:0060353 | regulation of cell adhesion molecule production(GO:0060353) |
| 0.6 | 4.5 | GO:0061484 | hematopoietic stem cell homeostasis(GO:0061484) |
| 0.6 | 7.9 | GO:0036109 | alpha-linolenic acid metabolic process(GO:0036109) |
| 0.6 | 15.2 | GO:0032435 | negative regulation of proteasomal ubiquitin-dependent protein catabolic process(GO:0032435) |
| 0.6 | 3.4 | GO:0035583 | sequestering of TGFbeta in extracellular matrix(GO:0035583) |
| 0.6 | 5.6 | GO:0060236 | regulation of mitotic spindle organization(GO:0060236) |
| 0.6 | 2.8 | GO:0046146 | tetrahydrobiopterin biosynthetic process(GO:0006729) tetrahydrobiopterin metabolic process(GO:0046146) |
| 0.6 | 2.8 | GO:0038166 | angiotensin-activated signaling pathway(GO:0038166) |
| 0.6 | 6.7 | GO:0019852 | L-ascorbic acid metabolic process(GO:0019852) |
| 0.6 | 5.0 | GO:0008635 | activation of cysteine-type endopeptidase activity involved in apoptotic process by cytochrome c(GO:0008635) |
| 0.6 | 2.2 | GO:2000393 | negative regulation of lamellipodium morphogenesis(GO:2000393) |
| 0.6 | 1.1 | GO:0090244 | Wnt signaling pathway involved in somitogenesis(GO:0090244) regulation of Wnt signaling pathway involved in dorsal/ventral axis specification(GO:2000053) |
| 0.6 | 0.6 | GO:0060535 | trachea cartilage morphogenesis(GO:0060535) |
| 0.6 | 2.8 | GO:0007198 | adenylate cyclase-inhibiting serotonin receptor signaling pathway(GO:0007198) |
| 0.5 | 3.8 | GO:0032836 | glomerular basement membrane development(GO:0032836) |
| 0.5 | 0.5 | GO:0010939 | regulation of necrotic cell death(GO:0010939) |
| 0.5 | 2.2 | GO:0097089 | methyl-branched fatty acid metabolic process(GO:0097089) |
| 0.5 | 8.2 | GO:1902236 | negative regulation of endoplasmic reticulum stress-induced intrinsic apoptotic signaling pathway(GO:1902236) |
| 0.5 | 3.8 | GO:0046618 | drug export(GO:0046618) |
| 0.5 | 2.7 | GO:0034036 | purine ribonucleoside bisphosphate biosynthetic process(GO:0034036) 3'-phosphoadenosine 5'-phosphosulfate biosynthetic process(GO:0050428) |
| 0.5 | 0.5 | GO:0048865 | stem cell fate commitment(GO:0048865) |
| 0.5 | 2.7 | GO:0006346 | methylation-dependent chromatin silencing(GO:0006346) |
| 0.5 | 1.1 | GO:0001561 | fatty acid alpha-oxidation(GO:0001561) |
| 0.5 | 1.1 | GO:0021896 | forebrain astrocyte differentiation(GO:0021896) forebrain astrocyte development(GO:0021897) |
| 0.5 | 3.2 | GO:0007549 | dosage compensation(GO:0007549) dosage compensation by inactivation of X chromosome(GO:0009048) |
| 0.5 | 0.5 | GO:0072137 | condensed mesenchymal cell proliferation(GO:0072137) |
| 0.5 | 1.1 | GO:2000855 | mineralocorticoid secretion(GO:0035931) aldosterone secretion(GO:0035932) regulation of mineralocorticoid secretion(GO:2000855) regulation of aldosterone secretion(GO:2000858) |
| 0.5 | 1.1 | GO:0001994 | norepinephrine-epinephrine vasoconstriction involved in regulation of systemic arterial blood pressure(GO:0001994) |
| 0.5 | 1.1 | GO:0003174 | mitral valve development(GO:0003174) |
| 0.5 | 6.4 | GO:0070886 | positive regulation of calcineurin-NFAT signaling cascade(GO:0070886) |
| 0.5 | 0.5 | GO:1902896 | terminal web assembly(GO:1902896) |
| 0.5 | 1.6 | GO:0046521 | sphingoid catabolic process(GO:0046521) |
| 0.5 | 2.1 | GO:0009440 | cyanate metabolic process(GO:0009439) cyanate catabolic process(GO:0009440) |
| 0.5 | 1.6 | GO:0038155 | interleukin-23-mediated signaling pathway(GO:0038155) |
| 0.5 | 8.4 | GO:0046341 | CDP-diacylglycerol metabolic process(GO:0046341) |
| 0.5 | 6.8 | GO:0000338 | protein deneddylation(GO:0000338) |
| 0.5 | 3.6 | GO:1900119 | positive regulation of execution phase of apoptosis(GO:1900119) |
| 0.5 | 4.2 | GO:0007185 | transmembrane receptor protein tyrosine phosphatase signaling pathway(GO:0007185) |
| 0.5 | 4.7 | GO:0090190 | positive regulation of branching involved in ureteric bud morphogenesis(GO:0090190) |
| 0.5 | 2.6 | GO:0019323 | pentose catabolic process(GO:0019323) |
| 0.5 | 1.0 | GO:2000279 | negative regulation of DNA biosynthetic process(GO:2000279) |
| 0.5 | 0.5 | GO:0032831 | regulation of CD4-positive, CD25-positive, alpha-beta regulatory T cell differentiation(GO:0032829) positive regulation of CD4-positive, CD25-positive, alpha-beta regulatory T cell differentiation(GO:0032831) positive regulation of immature T cell proliferation(GO:0033091) |
| 0.5 | 1.0 | GO:0035995 | detection of muscle stretch(GO:0035995) |
| 0.5 | 2.5 | GO:0051694 | pointed-end actin filament capping(GO:0051694) |
| 0.5 | 2.0 | GO:0007386 | compartment pattern specification(GO:0007386) |
| 0.5 | 3.1 | GO:0071680 | response to indole-3-methanol(GO:0071680) cellular response to indole-3-methanol(GO:0071681) |
| 0.5 | 1.0 | GO:2000272 | negative regulation of receptor activity(GO:2000272) |
| 0.5 | 6.1 | GO:0031268 | pseudopodium organization(GO:0031268) |
| 0.5 | 2.0 | GO:0006651 | diacylglycerol biosynthetic process(GO:0006651) |
| 0.5 | 2.0 | GO:0000183 | chromatin silencing at rDNA(GO:0000183) |
| 0.5 | 6.1 | GO:2000194 | regulation of female gonad development(GO:2000194) |
| 0.5 | 1.5 | GO:1904849 | positive regulation of cell chemotaxis to fibroblast growth factor(GO:1904849) positive regulation of endothelial cell chemotaxis to fibroblast growth factor(GO:2000546) |
| 0.5 | 2.0 | GO:0070816 | phosphorylation of RNA polymerase II C-terminal domain(GO:0070816) |
| 0.5 | 11.6 | GO:0002089 | lens morphogenesis in camera-type eye(GO:0002089) |
| 0.5 | 1.0 | GO:0042747 | circadian sleep/wake cycle, REM sleep(GO:0042747) |
| 0.5 | 4.5 | GO:2000252 | negative regulation of feeding behavior(GO:2000252) |
| 0.5 | 5.0 | GO:0021520 | spinal cord motor neuron cell fate specification(GO:0021520) |
| 0.5 | 0.5 | GO:0010587 | miRNA catabolic process(GO:0010587) |
| 0.5 | 4.0 | GO:0030473 | cell motility involved in cerebral cortex radial glia guided migration(GO:0021814) modulation of microtubule cytoskeleton involved in cerebral cortex radial glia guided migration(GO:0021815) nucleokinesis involved in cell motility in cerebral cortex radial glia guided migration(GO:0021817) nuclear migration along microtubule(GO:0030473) |
| 0.5 | 2.0 | GO:1904627 | response to phorbol 13-acetate 12-myristate(GO:1904627) cellular response to phorbol 13-acetate 12-myristate(GO:1904628) |
| 0.5 | 6.3 | GO:0097502 | mannosylation(GO:0097502) |
| 0.5 | 1.9 | GO:0006710 | androgen catabolic process(GO:0006710) |
| 0.5 | 1.5 | GO:0044539 | long-chain fatty acid import(GO:0044539) |
| 0.5 | 0.5 | GO:0090206 | negative regulation of cholesterol biosynthetic process(GO:0045541) negative regulation of cholesterol metabolic process(GO:0090206) |
| 0.5 | 0.5 | GO:0050957 | equilibrioception(GO:0050957) |
| 0.5 | 2.4 | GO:0016255 | attachment of GPI anchor to protein(GO:0016255) |
| 0.5 | 1.0 | GO:0002752 | cell surface pattern recognition receptor signaling pathway(GO:0002752) |
| 0.5 | 2.9 | GO:0001765 | membrane raft assembly(GO:0001765) |
| 0.5 | 1.4 | GO:0048250 | mitochondrial iron ion transport(GO:0048250) |
| 0.5 | 5.7 | GO:0045116 | protein neddylation(GO:0045116) |
| 0.5 | 2.4 | GO:0015793 | glycerol transport(GO:0015793) |
| 0.5 | 0.9 | GO:0086021 | SA node cell to atrial cardiac muscle cell communication by electrical coupling(GO:0086021) AV node cell to bundle of His cell communication by electrical coupling(GO:0086053) |
| 0.5 | 8.5 | GO:0071549 | cellular response to dexamethasone stimulus(GO:0071549) |
| 0.5 | 2.8 | GO:0044387 | negative regulation of protein kinase activity by regulation of protein phosphorylation(GO:0044387) |
| 0.5 | 0.9 | GO:0000460 | maturation of 5.8S rRNA(GO:0000460) |
| 0.5 | 4.2 | GO:0061732 | mitochondrial acetyl-CoA biosynthetic process from pyruvate(GO:0061732) |
| 0.5 | 1.4 | GO:0042938 | dipeptide transport(GO:0042938) |
| 0.5 | 1.9 | GO:1903899 | positive regulation of IRE1-mediated unfolded protein response(GO:1903896) positive regulation of PERK-mediated unfolded protein response(GO:1903899) |
| 0.5 | 1.4 | GO:0003099 | positive regulation of the force of heart contraction by chemical signal(GO:0003099) |
| 0.5 | 2.8 | GO:1903026 | negative regulation of RNA polymerase II regulatory region sequence-specific DNA binding(GO:1903026) |
| 0.5 | 3.2 | GO:0000389 | mRNA 3'-splice site recognition(GO:0000389) |
| 0.5 | 1.8 | GO:0001692 | histamine metabolic process(GO:0001692) |
| 0.5 | 1.4 | GO:1904398 | positive regulation of neuromuscular junction development(GO:1904398) |
| 0.5 | 17.8 | GO:0034314 | Arp2/3 complex-mediated actin nucleation(GO:0034314) |
| 0.5 | 2.7 | GO:0008218 | bioluminescence(GO:0008218) |
| 0.5 | 5.5 | GO:0010832 | negative regulation of myotube differentiation(GO:0010832) |
| 0.5 | 1.4 | GO:0035791 | platelet-derived growth factor receptor-beta signaling pathway(GO:0035791) |
| 0.5 | 0.5 | GO:0043045 | DNA methylation involved in embryo development(GO:0043045) changes to DNA methylation involved in embryo development(GO:1901538) |
| 0.5 | 1.4 | GO:0019046 | release from viral latency(GO:0019046) |
| 0.5 | 6.8 | GO:0007171 | activation of transmembrane receptor protein tyrosine kinase activity(GO:0007171) |
| 0.5 | 2.7 | GO:0000160 | phosphorelay signal transduction system(GO:0000160) |
| 0.5 | 0.5 | GO:0036022 | limb joint morphogenesis(GO:0036022) embryonic skeletal limb joint morphogenesis(GO:0036023) |
| 0.5 | 0.9 | GO:0046532 | regulation of photoreceptor cell differentiation(GO:0046532) |
| 0.4 | 3.1 | GO:0071688 | striated muscle myosin thick filament assembly(GO:0071688) |
| 0.4 | 10.8 | GO:0035329 | hippo signaling(GO:0035329) |
| 0.4 | 2.7 | GO:0048569 | post-embryonic organ development(GO:0048569) |
| 0.4 | 2.2 | GO:0001992 | regulation of systemic arterial blood pressure by vasopressin(GO:0001992) |
| 0.4 | 6.6 | GO:0044241 | lipid digestion(GO:0044241) |
| 0.4 | 5.3 | GO:0001522 | pseudouridine synthesis(GO:0001522) |
| 0.4 | 0.9 | GO:0001842 | neural fold formation(GO:0001842) |
| 0.4 | 3.1 | GO:0048625 | myoblast fate commitment(GO:0048625) |
| 0.4 | 2.6 | GO:0003266 | regulation of secondary heart field cardioblast proliferation(GO:0003266) |
| 0.4 | 4.0 | GO:0070986 | left/right axis specification(GO:0070986) |
| 0.4 | 0.9 | GO:0097112 | gamma-aminobutyric acid receptor clustering(GO:0097112) |
| 0.4 | 4.8 | GO:0030050 | vesicle transport along actin filament(GO:0030050) |
| 0.4 | 1.3 | GO:0060715 | syncytiotrophoblast cell differentiation involved in labyrinthine layer development(GO:0060715) |
| 0.4 | 1.3 | GO:0097210 | response to gonadotropin-releasing hormone(GO:0097210) cellular response to gonadotropin-releasing hormone(GO:0097211) |
| 0.4 | 28.7 | GO:0030574 | collagen catabolic process(GO:0030574) |
| 0.4 | 1.3 | GO:0033076 | isoquinoline alkaloid metabolic process(GO:0033076) |
| 0.4 | 16.0 | GO:0070979 | protein K11-linked ubiquitination(GO:0070979) |
| 0.4 | 0.4 | GO:0043587 | tongue morphogenesis(GO:0043587) |
| 0.4 | 0.9 | GO:0072396 | response to cell cycle checkpoint signaling(GO:0072396) response to DNA integrity checkpoint signaling(GO:0072402) response to DNA damage checkpoint signaling(GO:0072423) |
| 0.4 | 1.3 | GO:0007501 | mesodermal cell fate specification(GO:0007501) |
| 0.4 | 13.3 | GO:0001570 | vasculogenesis(GO:0001570) |
| 0.4 | 1.3 | GO:0009624 | response to nematode(GO:0009624) |
| 0.4 | 0.9 | GO:0070933 | histone H4 deacetylation(GO:0070933) |
| 0.4 | 1.7 | GO:0031427 | response to methotrexate(GO:0031427) |
| 0.4 | 0.4 | GO:1901979 | regulation of inward rectifier potassium channel activity(GO:1901979) |
| 0.4 | 3.4 | GO:0033689 | negative regulation of osteoblast proliferation(GO:0033689) |
| 0.4 | 2.5 | GO:0001705 | ectoderm formation(GO:0001705) ectodermal cell fate commitment(GO:0001712) |
| 0.4 | 5.4 | GO:1901750 | leukotriene D4 metabolic process(GO:1901748) leukotriene D4 biosynthetic process(GO:1901750) |
| 0.4 | 3.8 | GO:0001867 | complement activation, lectin pathway(GO:0001867) |
| 0.4 | 1.2 | GO:0090027 | sequestering of BMP in extracellular matrix(GO:0035582) negative regulation of monocyte chemotaxis(GO:0090027) |
| 0.4 | 1.2 | GO:0010992 | ubiquitin homeostasis(GO:0010992) |
| 0.4 | 3.3 | GO:0050819 | negative regulation of coagulation(GO:0050819) |
| 0.4 | 0.4 | GO:0010726 | positive regulation of hydrogen peroxide metabolic process(GO:0010726) |
| 0.4 | 0.4 | GO:0090669 | telomerase RNA stabilization(GO:0090669) |
| 0.4 | 0.4 | GO:1904640 | response to methionine(GO:1904640) |
| 0.4 | 0.8 | GO:1904526 | regulation of microtubule binding(GO:1904526) |
| 0.4 | 3.7 | GO:0015693 | magnesium ion transport(GO:0015693) |
| 0.4 | 0.4 | GO:1902617 | response to fluoride(GO:1902617) |
| 0.4 | 0.4 | GO:0010898 | positive regulation of triglyceride catabolic process(GO:0010898) |
| 0.4 | 4.1 | GO:0007021 | tubulin complex assembly(GO:0007021) |
| 0.4 | 0.8 | GO:0080184 | response to phenylpropanoid(GO:0080184) |
| 0.4 | 4.0 | GO:0009954 | proximal/distal pattern formation(GO:0009954) |
| 0.4 | 0.4 | GO:0044828 | negative regulation by host of viral genome replication(GO:0044828) |
| 0.4 | 12.5 | GO:0032467 | positive regulation of cytokinesis(GO:0032467) |
| 0.4 | 1.6 | GO:1903385 | regulation of homophilic cell adhesion(GO:1903385) |
| 0.4 | 39.7 | GO:0009410 | response to xenobiotic stimulus(GO:0009410) |
| 0.4 | 1.2 | GO:0072178 | nephric duct development(GO:0072176) mesonephric duct development(GO:0072177) nephric duct morphogenesis(GO:0072178) mesonephric duct morphogenesis(GO:0072180) |
| 0.4 | 2.4 | GO:0001893 | maternal placenta development(GO:0001893) |
| 0.4 | 7.9 | GO:0006084 | acetyl-CoA metabolic process(GO:0006084) |
| 0.4 | 1.2 | GO:0038193 | thromboxane A2 signaling pathway(GO:0038193) |
| 0.4 | 3.2 | GO:0034379 | very-low-density lipoprotein particle assembly(GO:0034379) |
| 0.4 | 3.2 | GO:0042753 | positive regulation of circadian rhythm(GO:0042753) |
| 0.4 | 0.4 | GO:1990253 | cellular response to leucine starvation(GO:1990253) |
| 0.4 | 1.2 | GO:0030573 | bile acid catabolic process(GO:0030573) |
| 0.4 | 1.6 | GO:0070307 | lens fiber cell development(GO:0070307) |
| 0.4 | 2.0 | GO:1901093 | regulation of protein tetramerization(GO:1901090) negative regulation of protein tetramerization(GO:1901091) regulation of protein homotetramerization(GO:1901093) negative regulation of protein homotetramerization(GO:1901094) |
| 0.4 | 1.2 | GO:0060398 | regulation of growth hormone receptor signaling pathway(GO:0060398) |
| 0.4 | 0.4 | GO:0010700 | negative regulation of norepinephrine secretion(GO:0010700) |
| 0.4 | 1.2 | GO:0061536 | glycine secretion(GO:0061536) glycine secretion, neurotransmission(GO:0061537) |
| 0.4 | 1.9 | GO:1901202 | negative regulation of extracellular matrix assembly(GO:1901202) |
| 0.4 | 2.3 | GO:0042249 | establishment of planar polarity of embryonic epithelium(GO:0042249) |
| 0.4 | 6.5 | GO:0003322 | pancreatic A cell development(GO:0003322) |
| 0.4 | 2.3 | GO:0033564 | anterior/posterior axon guidance(GO:0033564) |
| 0.4 | 4.6 | GO:0070911 | global genome nucleotide-excision repair(GO:0070911) |
| 0.4 | 1.9 | GO:0006590 | thyroid hormone generation(GO:0006590) |
| 0.4 | 4.2 | GO:0018206 | peptidyl-methionine modification(GO:0018206) |
| 0.4 | 1.1 | GO:0071963 | establishment or maintenance of cell polarity regulating cell shape(GO:0071963) |
| 0.4 | 0.8 | GO:0015853 | adenine transport(GO:0015853) |
| 0.4 | 1.1 | GO:0071460 | cellular response to cell-matrix adhesion(GO:0071460) |
| 0.4 | 0.8 | GO:0086100 | endothelin receptor signaling pathway(GO:0086100) |
| 0.4 | 2.6 | GO:0035860 | glial cell-derived neurotrophic factor receptor signaling pathway(GO:0035860) |
| 0.4 | 0.4 | GO:1900154 | regulation of bone trabecula formation(GO:1900154) negative regulation of bone trabecula formation(GO:1900155) |
| 0.4 | 12.3 | GO:0043252 | sodium-independent organic anion transport(GO:0043252) |
| 0.4 | 1.1 | GO:0048880 | sensory system development(GO:0048880) |
| 0.4 | 5.2 | GO:0010991 | negative regulation of SMAD protein complex assembly(GO:0010991) |
| 0.4 | 3.7 | GO:0042474 | middle ear morphogenesis(GO:0042474) |
| 0.4 | 3.0 | GO:0032057 | negative regulation of translation in response to stress(GO:0032055) negative regulation of translational initiation in response to stress(GO:0032057) |
| 0.4 | 4.4 | GO:0030325 | adrenal gland development(GO:0030325) |
| 0.4 | 3.7 | GO:0002566 | somatic diversification of immune receptors via somatic mutation(GO:0002566) |
| 0.4 | 2.9 | GO:0050872 | white fat cell differentiation(GO:0050872) |
| 0.4 | 5.9 | GO:1901663 | ubiquinone biosynthetic process(GO:0006744) quinone biosynthetic process(GO:1901663) |
| 0.4 | 0.4 | GO:0033484 | nitric oxide homeostasis(GO:0033484) |
| 0.4 | 0.4 | GO:0048861 | leukemia inhibitory factor signaling pathway(GO:0048861) |
| 0.4 | 0.7 | GO:0050720 | interleukin-1 beta biosynthetic process(GO:0050720) |
| 0.4 | 11.7 | GO:0000188 | inactivation of MAPK activity(GO:0000188) |
| 0.4 | 3.3 | GO:2000427 | positive regulation of apoptotic cell clearance(GO:2000427) |
| 0.4 | 1.5 | GO:0051660 | establishment of centrosome localization(GO:0051660) |
| 0.4 | 0.7 | GO:0045085 | negative regulation of interleukin-2 biosynthetic process(GO:0045085) |
| 0.4 | 0.7 | GO:0021785 | branchiomotor neuron axon guidance(GO:0021785) |
| 0.4 | 0.7 | GO:1904467 | regulation of tumor necrosis factor secretion(GO:1904467) positive regulation of tumor necrosis factor secretion(GO:1904469) tumor necrosis factor secretion(GO:1990774) |
| 0.4 | 8.9 | GO:0042438 | melanin biosynthetic process(GO:0042438) |
| 0.4 | 2.1 | GO:0048853 | forebrain morphogenesis(GO:0048853) |
| 0.4 | 3.6 | GO:0071313 | cellular response to caffeine(GO:0071313) |
| 0.4 | 0.4 | GO:0005988 | lactose metabolic process(GO:0005988) lactose biosynthetic process(GO:0005989) |
| 0.4 | 3.9 | GO:2001288 | positive regulation of caveolin-mediated endocytosis(GO:2001288) |
| 0.4 | 0.7 | GO:2001028 | positive regulation of endothelial cell chemotaxis(GO:2001028) |
| 0.4 | 0.4 | GO:0038129 | ERBB3 signaling pathway(GO:0038129) |
| 0.4 | 2.8 | GO:0046628 | positive regulation of insulin receptor signaling pathway(GO:0046628) |
| 0.4 | 0.4 | GO:0070662 | mast cell proliferation(GO:0070662) |
| 0.3 | 13.3 | GO:0034308 | primary alcohol metabolic process(GO:0034308) |
| 0.3 | 0.7 | GO:0042414 | epinephrine metabolic process(GO:0042414) epinephrine biosynthetic process(GO:0042418) |
| 0.3 | 4.8 | GO:0006704 | glucocorticoid biosynthetic process(GO:0006704) |
| 0.3 | 0.3 | GO:0019673 | GDP-mannose metabolic process(GO:0019673) |
| 0.3 | 1.7 | GO:0060244 | negative regulation of cell proliferation involved in contact inhibition(GO:0060244) |
| 0.3 | 0.7 | GO:1904504 | regulation of lipophagy(GO:1904502) positive regulation of lipophagy(GO:1904504) |
| 0.3 | 0.7 | GO:0014805 | smooth muscle adaptation(GO:0014805) smooth muscle hyperplasia(GO:0014806) |
| 0.3 | 2.0 | GO:0060670 | branching involved in labyrinthine layer morphogenesis(GO:0060670) |
| 0.3 | 1.4 | GO:0051572 | negative regulation of histone H3-K4 methylation(GO:0051572) |
| 0.3 | 6.1 | GO:0002076 | osteoblast development(GO:0002076) |
| 0.3 | 1.0 | GO:0070345 | negative regulation of fat cell proliferation(GO:0070345) |
| 0.3 | 5.7 | GO:0007052 | mitotic spindle organization(GO:0007052) |
| 0.3 | 0.3 | GO:2001023 | regulation of response to drug(GO:2001023) |
| 0.3 | 2.0 | GO:0001866 | NK T cell proliferation(GO:0001866) |
| 0.3 | 1.7 | GO:0007571 | age-dependent response to oxidative stress(GO:0001306) age-dependent response to reactive oxygen species(GO:0001315) regulation of systemic arterial blood pressure by acetylcholine(GO:0003068) vasodilation by acetylcholine involved in regulation of systemic arterial blood pressure(GO:0003069) regulation of systemic arterial blood pressure by neurotransmitter(GO:0003070) age-dependent general metabolic decline(GO:0007571) |
| 0.3 | 0.7 | GO:0006524 | alanine metabolic process(GO:0006522) alanine catabolic process(GO:0006524) pyruvate family amino acid metabolic process(GO:0009078) pyruvate family amino acid catabolic process(GO:0009080) |
| 0.3 | 0.7 | GO:0060672 | epithelial cell differentiation involved in embryonic placenta development(GO:0060671) epithelial cell morphogenesis involved in placental branching(GO:0060672) |
| 0.3 | 1.3 | GO:2000825 | positive regulation of androgen receptor activity(GO:2000825) |
| 0.3 | 1.6 | GO:0043584 | nose development(GO:0043584) |
| 0.3 | 0.6 | GO:0071105 | response to interleukin-11(GO:0071105) |
| 0.3 | 1.0 | GO:0038001 | paracrine signaling(GO:0038001) tertiary branching involved in mammary gland duct morphogenesis(GO:0060748) |
| 0.3 | 3.2 | GO:0006108 | malate metabolic process(GO:0006108) |
| 0.3 | 0.3 | GO:0021979 | hypothalamus cell differentiation(GO:0021979) |
| 0.3 | 1.0 | GO:0060012 | synaptic transmission, glycinergic(GO:0060012) |
| 0.3 | 1.3 | GO:2000346 | negative regulation of hepatocyte proliferation(GO:2000346) |
| 0.3 | 1.6 | GO:0022900 | electron transport chain(GO:0022900) |
| 0.3 | 9.4 | GO:0098915 | membrane repolarization during ventricular cardiac muscle cell action potential(GO:0098915) |
| 0.3 | 2.8 | GO:0010667 | negative regulation of cardiac muscle cell apoptotic process(GO:0010667) |
| 0.3 | 0.6 | GO:1990262 | regulation of anti-Mullerian hormone signaling pathway(GO:1902612) negative regulation of anti-Mullerian hormone signaling pathway(GO:1902613) anti-Mullerian hormone signaling pathway(GO:1990262) |
| 0.3 | 2.5 | GO:0048026 | positive regulation of mRNA splicing, via spliceosome(GO:0048026) |
| 0.3 | 0.3 | GO:0060800 | regulation of cell differentiation involved in embryonic placenta development(GO:0060800) |
| 0.3 | 1.2 | GO:1901594 | detection of temperature stimulus involved in thermoception(GO:0050960) negative regulation of establishment of blood-brain barrier(GO:0090212) response to capsazepine(GO:1901594) |
| 0.3 | 3.6 | GO:0060445 | branching involved in salivary gland morphogenesis(GO:0060445) |
| 0.3 | 1.8 | GO:1904261 | regulation of basement membrane assembly involved in embryonic body morphogenesis(GO:1904259) positive regulation of basement membrane assembly involved in embryonic body morphogenesis(GO:1904261) basement membrane assembly involved in embryonic body morphogenesis(GO:2001197) |
| 0.3 | 2.7 | GO:0006682 | galactosylceramide biosynthetic process(GO:0006682) galactolipid biosynthetic process(GO:0019375) |
| 0.3 | 3.3 | GO:0034975 | protein folding in endoplasmic reticulum(GO:0034975) |
| 0.3 | 0.9 | GO:0014724 | regulation of twitch skeletal muscle contraction(GO:0014724) |
| 0.3 | 1.2 | GO:0032641 | lymphotoxin A production(GO:0032641) lymphotoxin A biosynthetic process(GO:0042109) |
| 0.3 | 0.3 | GO:0043605 | cellular amide catabolic process(GO:0043605) |
| 0.3 | 0.6 | GO:1902202 | regulation of hepatocyte growth factor receptor signaling pathway(GO:1902202) |
| 0.3 | 1.5 | GO:0046688 | response to copper ion(GO:0046688) |
| 0.3 | 3.0 | GO:0003298 | physiological muscle hypertrophy(GO:0003298) physiological cardiac muscle hypertrophy(GO:0003301) cell growth involved in cardiac muscle cell development(GO:0061049) |
| 0.3 | 0.9 | GO:0097384 | cellular lipid biosynthetic process(GO:0097384) |
| 0.3 | 2.7 | GO:0071712 | ER-associated misfolded protein catabolic process(GO:0071712) |
| 0.3 | 1.8 | GO:0043616 | keratinocyte proliferation(GO:0043616) |
| 0.3 | 6.8 | GO:0043044 | ATP-dependent chromatin remodeling(GO:0043044) |
| 0.3 | 2.0 | GO:0006700 | C21-steroid hormone biosynthetic process(GO:0006700) |
| 0.3 | 4.6 | GO:0031424 | keratinization(GO:0031424) |
| 0.3 | 2.0 | GO:0071372 | cellular response to follicle-stimulating hormone stimulus(GO:0071372) |
| 0.3 | 0.6 | GO:0040031 | snRNA modification(GO:0040031) |
| 0.3 | 0.6 | GO:0019919 | peptidyl-arginine methylation, to asymmetrical-dimethyl arginine(GO:0019919) |
| 0.3 | 0.3 | GO:0060579 | ventral spinal cord interneuron fate commitment(GO:0060579) cell fate commitment involved in pattern specification(GO:0060581) |
| 0.3 | 0.8 | GO:0007039 | protein catabolic process in the vacuole(GO:0007039) |
| 0.3 | 3.6 | GO:0051180 | vitamin transport(GO:0051180) |
| 0.3 | 1.4 | GO:0043455 | regulation of secondary metabolic process(GO:0043455) |
| 0.3 | 1.7 | GO:0071467 | cellular response to pH(GO:0071467) |
| 0.3 | 7.5 | GO:0006506 | GPI anchor metabolic process(GO:0006505) GPI anchor biosynthetic process(GO:0006506) |
| 0.3 | 0.6 | GO:0048484 | enteric nervous system development(GO:0048484) |
| 0.3 | 0.8 | GO:0019732 | antifungal humoral response(GO:0019732) |
| 0.3 | 1.1 | GO:1904706 | negative regulation of vascular smooth muscle cell proliferation(GO:1904706) |
| 0.3 | 1.4 | GO:0050915 | sensory perception of sour taste(GO:0050915) |
| 0.3 | 0.5 | GO:0006776 | vitamin A metabolic process(GO:0006776) |
| 0.3 | 0.8 | GO:0050686 | negative regulation of mRNA processing(GO:0050686) |
| 0.3 | 0.5 | GO:0035815 | positive regulation of renal sodium excretion(GO:0035815) |
| 0.3 | 2.4 | GO:0002011 | morphogenesis of an epithelial sheet(GO:0002011) |
| 0.3 | 1.3 | GO:0035413 | positive regulation of catenin import into nucleus(GO:0035413) |
| 0.3 | 1.1 | GO:0048630 | skeletal muscle tissue growth(GO:0048630) |
| 0.3 | 2.7 | GO:0006703 | estrogen biosynthetic process(GO:0006703) |
| 0.3 | 0.8 | GO:0002760 | positive regulation of antimicrobial peptide production(GO:0002225) positive regulation of antimicrobial humoral response(GO:0002760) regulation of antimicrobial peptide production(GO:0002784) regulation of antibacterial peptide production(GO:0002786) positive regulation of antibacterial peptide production(GO:0002803) |
| 0.3 | 0.8 | GO:1903542 | epidermal growth factor catabolic process(GO:0007174) negative regulation of exosomal secretion(GO:1903542) |
| 0.3 | 1.1 | GO:0007042 | lysosomal lumen acidification(GO:0007042) |
| 0.3 | 1.1 | GO:0035965 | cardiolipin acyl-chain remodeling(GO:0035965) |
| 0.3 | 2.7 | GO:0061635 | regulation of protein complex stability(GO:0061635) |
| 0.3 | 2.4 | GO:0051095 | regulation of helicase activity(GO:0051095) positive regulation of helicase activity(GO:0051096) |
| 0.3 | 0.8 | GO:0008354 | germ cell migration(GO:0008354) |
| 0.3 | 1.8 | GO:0048012 | hepatocyte growth factor receptor signaling pathway(GO:0048012) |
| 0.3 | 0.8 | GO:0010166 | wax biosynthetic process(GO:0010025) wax metabolic process(GO:0010166) |
| 0.3 | 0.8 | GO:0034553 | respiratory chain complex II assembly(GO:0034552) mitochondrial respiratory chain complex II assembly(GO:0034553) mitochondrial respiratory chain complex II biogenesis(GO:0097032) |
| 0.3 | 9.2 | GO:0048565 | digestive tract development(GO:0048565) |
| 0.3 | 1.3 | GO:0006432 | phenylalanyl-tRNA aminoacylation(GO:0006432) |
| 0.3 | 2.1 | GO:0001967 | suckling behavior(GO:0001967) |
| 0.3 | 2.1 | GO:1902455 | negative regulation of stem cell population maintenance(GO:1902455) |
| 0.3 | 13.0 | GO:0045454 | cell redox homeostasis(GO:0045454) |
| 0.3 | 0.8 | GO:0009651 | response to salt stress(GO:0009651) |
| 0.3 | 0.8 | GO:0035426 | extracellular matrix-cell signaling(GO:0035426) |
| 0.3 | 4.3 | GO:0007176 | regulation of epidermal growth factor-activated receptor activity(GO:0007176) |
| 0.3 | 0.8 | GO:0051387 | negative regulation of neurotrophin TRK receptor signaling pathway(GO:0051387) |
| 0.3 | 1.5 | GO:0010739 | positive regulation of protein kinase A signaling(GO:0010739) |
| 0.3 | 1.0 | GO:2000483 | negative regulation of interleukin-8 secretion(GO:2000483) |
| 0.3 | 1.0 | GO:0000451 | rRNA 2'-O-methylation(GO:0000451) |
| 0.3 | 0.5 | GO:0051546 | keratinocyte migration(GO:0051546) |
| 0.3 | 3.0 | GO:0030033 | microvillus assembly(GO:0030033) |
| 0.3 | 1.0 | GO:0045627 | positive regulation of T-helper 1 cell differentiation(GO:0045627) |
| 0.2 | 2.0 | GO:0045793 | positive regulation of cell size(GO:0045793) |
| 0.2 | 5.4 | GO:0006749 | glutathione metabolic process(GO:0006749) |
| 0.2 | 2.7 | GO:0010815 | bradykinin catabolic process(GO:0010815) |
| 0.2 | 0.5 | GO:0051036 | regulation of endosome size(GO:0051036) |
| 0.2 | 0.7 | GO:0038163 | thrombopoietin-mediated signaling pathway(GO:0038163) |
| 0.2 | 0.2 | GO:1902866 | regulation of neural retina development(GO:0061074) regulation of retina development in camera-type eye(GO:1902866) |
| 0.2 | 1.0 | GO:0051001 | negative regulation of nitric-oxide synthase activity(GO:0051001) |
| 0.2 | 0.7 | GO:2001226 | negative regulation of chloride transport(GO:2001226) |
| 0.2 | 1.9 | GO:0003148 | outflow tract septum morphogenesis(GO:0003148) |
| 0.2 | 0.5 | GO:1903764 | regulation of potassium ion export(GO:1902302) regulation of potassium ion export across plasma membrane(GO:1903764) |
| 0.2 | 1.4 | GO:0098967 | exocytic insertion of neurotransmitter receptor to plasma membrane(GO:0098881) exocytic insertion of neurotransmitter receptor to postsynaptic membrane(GO:0098967) |
| 0.2 | 1.6 | GO:0051103 | DNA ligation involved in DNA repair(GO:0051103) |
| 0.2 | 2.5 | GO:0060510 | trigeminal sensory nucleus development(GO:0021730) principal sensory nucleus of trigeminal nerve development(GO:0021740) Type II pneumocyte differentiation(GO:0060510) negative regulation of epithelial cell proliferation involved in lung morphogenesis(GO:2000795) |
| 0.2 | 0.2 | GO:0051284 | negative regulation of release of sequestered calcium ion into cytosol(GO:0051280) positive regulation of sequestering of calcium ion(GO:0051284) |
| 0.2 | 2.5 | GO:0006610 | ribosomal protein import into nucleus(GO:0006610) |
| 0.2 | 0.7 | GO:0035881 | amacrine cell differentiation(GO:0035881) |
| 0.2 | 2.0 | GO:0007217 | tachykinin receptor signaling pathway(GO:0007217) |
| 0.2 | 0.9 | GO:0010138 | pyrimidine ribonucleotide salvage(GO:0010138) pyrimidine nucleotide salvage(GO:0032262) UMP salvage(GO:0044206) |
| 0.2 | 6.3 | GO:0031100 | organ regeneration(GO:0031100) |
| 0.2 | 0.7 | GO:0034138 | toll-like receptor 3 signaling pathway(GO:0034138) |
| 0.2 | 0.9 | GO:0070199 | establishment of protein localization to chromosome(GO:0070199) |
| 0.2 | 1.1 | GO:0036438 | maintenance of lens transparency(GO:0036438) |
| 0.2 | 2.5 | GO:0002385 | mucosal immune response(GO:0002385) |
| 0.2 | 1.1 | GO:0031953 | negative regulation of protein autophosphorylation(GO:0031953) |
| 0.2 | 2.9 | GO:0001502 | cartilage condensation(GO:0001502) |
| 0.2 | 1.8 | GO:2000786 | positive regulation of autophagosome assembly(GO:2000786) |
| 0.2 | 0.4 | GO:0046349 | amino sugar biosynthetic process(GO:0046349) |
| 0.2 | 0.4 | GO:0051005 | negative regulation of lipoprotein lipase activity(GO:0051005) |
| 0.2 | 1.3 | GO:0035457 | cellular response to interferon-alpha(GO:0035457) |
| 0.2 | 3.4 | GO:0060325 | face morphogenesis(GO:0060325) |
| 0.2 | 1.3 | GO:1902741 | interferon-alpha secretion(GO:0072642) regulation of interferon-alpha secretion(GO:1902739) positive regulation of interferon-alpha secretion(GO:1902741) |
| 0.2 | 3.4 | GO:0001523 | retinoid metabolic process(GO:0001523) |
| 0.2 | 0.9 | GO:0033504 | floor plate development(GO:0033504) |
| 0.2 | 1.5 | GO:0097500 | receptor localization to nonmotile primary cilium(GO:0097500) |
| 0.2 | 4.7 | GO:0051123 | RNA polymerase II transcriptional preinitiation complex assembly(GO:0051123) |
| 0.2 | 1.7 | GO:0006975 | DNA damage induced protein phosphorylation(GO:0006975) |
| 0.2 | 6.9 | GO:0031016 | pancreas development(GO:0031016) |
| 0.2 | 0.8 | GO:0031507 | heterochromatin assembly(GO:0031507) |
| 0.2 | 10.6 | GO:1902653 | cholesterol biosynthetic process(GO:0006695) secondary alcohol biosynthetic process(GO:1902653) |
| 0.2 | 0.6 | GO:1900424 | regulation of defense response to bacterium(GO:1900424) |
| 0.2 | 0.2 | GO:0007183 | SMAD protein complex assembly(GO:0007183) |
| 0.2 | 2.3 | GO:1902884 | positive regulation of response to oxidative stress(GO:1902884) |
| 0.2 | 2.3 | GO:0006907 | pinocytosis(GO:0006907) |
| 0.2 | 1.8 | GO:0045987 | positive regulation of smooth muscle contraction(GO:0045987) |
| 0.2 | 0.4 | GO:0036518 | chemorepulsion of dopaminergic neuron axon(GO:0036518) chemorepulsion of axon(GO:0061643) |
| 0.2 | 1.0 | GO:1903588 | negative regulation of blood vessel endothelial cell proliferation involved in sprouting angiogenesis(GO:1903588) |
| 0.2 | 1.4 | GO:0051451 | myoblast migration(GO:0051451) |
| 0.2 | 0.6 | GO:0046116 | queuosine biosynthetic process(GO:0008616) queuosine metabolic process(GO:0046116) |
| 0.2 | 1.0 | GO:0007621 | negative regulation of female receptivity(GO:0007621) |
| 0.2 | 0.6 | GO:0014813 | skeletal muscle satellite cell commitment(GO:0014813) |
| 0.2 | 1.0 | GO:0060575 | intestinal epithelial cell differentiation(GO:0060575) |
| 0.2 | 0.6 | GO:0010885 | regulation of cholesterol storage(GO:0010885) |
| 0.2 | 0.6 | GO:0043586 | tongue development(GO:0043586) |
| 0.2 | 0.4 | GO:0090080 | positive regulation of MAPKKK cascade by fibroblast growth factor receptor signaling pathway(GO:0090080) |
| 0.2 | 1.0 | GO:0006290 | pyrimidine dimer repair(GO:0006290) |
| 0.2 | 0.4 | GO:0034165 | positive regulation of toll-like receptor 9 signaling pathway(GO:0034165) |
| 0.2 | 0.6 | GO:0070897 | DNA-templated transcriptional preinitiation complex assembly(GO:0070897) |
| 0.2 | 4.6 | GO:0045682 | regulation of epidermis development(GO:0045682) |
| 0.2 | 3.6 | GO:0006491 | N-glycan processing(GO:0006491) |
| 0.2 | 2.3 | GO:0042340 | keratan sulfate catabolic process(GO:0042340) |
| 0.2 | 0.9 | GO:1903012 | positive regulation of bone development(GO:1903012) |
| 0.2 | 0.4 | GO:0072114 | regulation of kidney size(GO:0035564) regulation of pronephros size(GO:0035565) pronephros morphogenesis(GO:0072114) |
| 0.2 | 1.3 | GO:1903671 | negative regulation of sprouting angiogenesis(GO:1903671) |
| 0.2 | 0.7 | GO:2000647 | negative regulation of stem cell proliferation(GO:2000647) |
| 0.2 | 0.6 | GO:1900060 | negative regulation of sphingolipid biosynthetic process(GO:0090155) negative regulation of ceramide biosynthetic process(GO:1900060) |
| 0.2 | 0.4 | GO:0086042 | cardiac muscle cell-cardiac muscle cell adhesion(GO:0086042) |
| 0.2 | 0.6 | GO:0071529 | cementum mineralization(GO:0071529) |
| 0.2 | 4.2 | GO:0032008 | positive regulation of TOR signaling(GO:0032008) |
| 0.2 | 3.1 | GO:0035635 | entry of bacterium into host cell(GO:0035635) |
| 0.2 | 0.2 | GO:0090168 | Golgi reassembly(GO:0090168) |
| 0.2 | 4.6 | GO:0071470 | cellular response to osmotic stress(GO:0071470) |
| 0.2 | 0.2 | GO:2001026 | regulation of endothelial cell chemotaxis(GO:2001026) |
| 0.2 | 1.4 | GO:0048286 | lung alveolus development(GO:0048286) |
| 0.2 | 3.2 | GO:0006418 | tRNA aminoacylation for protein translation(GO:0006418) |
| 0.2 | 0.7 | GO:0086043 | bundle of His cell to Purkinje myocyte signaling(GO:0086028) bundle of His cell action potential(GO:0086043) |
| 0.2 | 2.1 | GO:0000185 | activation of MAPKKK activity(GO:0000185) |
| 0.2 | 0.5 | GO:0000414 | regulation of histone H3-K36 methylation(GO:0000414) |
| 0.2 | 2.1 | GO:0006379 | mRNA cleavage(GO:0006379) |
| 0.2 | 0.5 | GO:0090675 | intermicrovillar adhesion(GO:0090675) |
| 0.2 | 0.3 | GO:0055118 | negative regulation of cardiac muscle contraction(GO:0055118) |
| 0.2 | 0.5 | GO:0051490 | negative regulation of filopodium assembly(GO:0051490) |
| 0.2 | 4.1 | GO:0055092 | cholesterol homeostasis(GO:0042632) sterol homeostasis(GO:0055092) |
| 0.2 | 7.1 | GO:0050909 | sensory perception of taste(GO:0050909) |
| 0.2 | 0.2 | GO:0034729 | histone H3-K79 methylation(GO:0034729) |
| 0.2 | 0.5 | GO:0006663 | platelet activating factor biosynthetic process(GO:0006663) |
| 0.2 | 4.9 | GO:0051496 | positive regulation of stress fiber assembly(GO:0051496) |
| 0.2 | 0.2 | GO:0014005 | microglia differentiation(GO:0014004) microglia development(GO:0014005) |
| 0.2 | 0.8 | GO:0006177 | GMP biosynthetic process(GO:0006177) |
| 0.2 | 0.5 | GO:0010936 | negative regulation of macrophage cytokine production(GO:0010936) |
| 0.2 | 2.1 | GO:1901621 | negative regulation of smoothened signaling pathway involved in dorsal/ventral neural tube patterning(GO:1901621) |
| 0.2 | 3.9 | GO:0043171 | peptide catabolic process(GO:0043171) |
| 0.2 | 0.5 | GO:0000019 | regulation of mitotic recombination(GO:0000019) |
| 0.2 | 0.5 | GO:0046831 | regulation of RNA export from nucleus(GO:0046831) |
| 0.2 | 2.1 | GO:0045746 | negative regulation of Notch signaling pathway(GO:0045746) |
| 0.2 | 0.6 | GO:2000739 | regulation of mesenchymal stem cell differentiation(GO:2000739) |
| 0.2 | 0.3 | GO:2000270 | negative regulation of fibroblast apoptotic process(GO:2000270) |
| 0.2 | 0.8 | GO:0052695 | cellular glucuronidation(GO:0052695) |
| 0.2 | 0.3 | GO:0060369 | positive regulation of Fc receptor mediated stimulatory signaling pathway(GO:0060369) |
| 0.2 | 0.9 | GO:0071711 | basement membrane organization(GO:0071711) |
| 0.2 | 0.3 | GO:2001045 | closure of optic fissure(GO:0061386) negative regulation of integrin-mediated signaling pathway(GO:2001045) |
| 0.2 | 1.5 | GO:0046135 | pyrimidine nucleoside catabolic process(GO:0046135) |
| 0.2 | 0.6 | GO:0006119 | oxidative phosphorylation(GO:0006119) |
| 0.2 | 0.9 | GO:0071243 | cellular response to arsenic-containing substance(GO:0071243) |
| 0.1 | 0.1 | GO:0019373 | epoxygenase P450 pathway(GO:0019373) |
| 0.1 | 1.0 | GO:0050434 | positive regulation of viral transcription(GO:0050434) |
| 0.1 | 0.9 | GO:0070286 | axonemal dynein complex assembly(GO:0070286) |
| 0.1 | 0.4 | GO:0015732 | prostaglandin transport(GO:0015732) |
| 0.1 | 0.9 | GO:0046325 | negative regulation of glucose import(GO:0046325) |
| 0.1 | 0.3 | GO:0030186 | melatonin metabolic process(GO:0030186) melatonin biosynthetic process(GO:0030187) |
| 0.1 | 7.9 | GO:0008543 | fibroblast growth factor receptor signaling pathway(GO:0008543) |
| 0.1 | 1.0 | GO:0015705 | iodide transport(GO:0015705) |
| 0.1 | 3.2 | GO:0048025 | negative regulation of mRNA splicing, via spliceosome(GO:0048025) |
| 0.1 | 1.7 | GO:0051683 | establishment of Golgi localization(GO:0051683) |
| 0.1 | 0.3 | GO:1902573 | positive regulation of serine-type endopeptidase activity(GO:1900005) positive regulation of serine-type peptidase activity(GO:1902573) |
| 0.1 | 2.2 | GO:0008156 | negative regulation of DNA replication(GO:0008156) |
| 0.1 | 1.2 | GO:0018344 | protein geranylgeranylation(GO:0018344) |
| 0.1 | 0.5 | GO:0008628 | hormone-mediated apoptotic signaling pathway(GO:0008628) |
| 0.1 | 2.5 | GO:0010039 | response to iron ion(GO:0010039) |
| 0.1 | 0.7 | GO:0017144 | drug metabolic process(GO:0017144) |
| 0.1 | 3.9 | GO:0016339 | calcium-dependent cell-cell adhesion via plasma membrane cell adhesion molecules(GO:0016339) |
| 0.1 | 3.1 | GO:0098754 | detoxification(GO:0098754) |
| 0.1 | 0.1 | GO:0031548 | regulation of brain-derived neurotrophic factor receptor signaling pathway(GO:0031548) |
| 0.1 | 4.4 | GO:0032392 | DNA geometric change(GO:0032392) |
| 0.1 | 3.4 | GO:0043928 | exonucleolytic nuclear-transcribed mRNA catabolic process involved in deadenylation-dependent decay(GO:0043928) |
| 0.1 | 0.4 | GO:0035048 | splicing factor protein import into nucleus(GO:0035048) |
| 0.1 | 0.3 | GO:0071224 | positive regulation of antigen processing and presentation of peptide or polysaccharide antigen via MHC class II(GO:0002582) positive regulation of antigen processing and presentation of peptide antigen(GO:0002585) positive regulation of antigen processing and presentation of peptide antigen via MHC class II(GO:0002588) positive regulation of chemokine-mediated signaling pathway(GO:0070101) cellular response to peptidoglycan(GO:0071224) |
| 0.1 | 2.1 | GO:0019800 | peptide cross-linking via chondroitin 4-sulfate glycosaminoglycan(GO:0019800) |
| 0.1 | 0.1 | GO:0016101 | diterpenoid metabolic process(GO:0016101) |
| 0.1 | 0.5 | GO:0019321 | pentose metabolic process(GO:0019321) |
| 0.1 | 1.0 | GO:0035095 | behavioral response to nicotine(GO:0035095) |
| 0.1 | 0.6 | GO:0051725 | protein de-ADP-ribosylation(GO:0051725) |
| 0.1 | 0.2 | GO:0070171 | negative regulation of tooth mineralization(GO:0070171) |
| 0.1 | 0.4 | GO:0033260 | nuclear DNA replication(GO:0033260) |
| 0.1 | 2.7 | GO:0006261 | DNA-dependent DNA replication(GO:0006261) |
| 0.1 | 0.5 | GO:0090050 | positive regulation of cell migration involved in sprouting angiogenesis(GO:0090050) |
| 0.1 | 0.6 | GO:0006613 | cotranslational protein targeting to membrane(GO:0006613) |
| 0.1 | 11.2 | GO:0043488 | regulation of mRNA stability(GO:0043488) |
| 0.1 | 0.4 | GO:0030199 | collagen fibril organization(GO:0030199) |
| 0.1 | 0.6 | GO:0007468 | regulation of rhodopsin gene expression(GO:0007468) |
| 0.1 | 1.7 | GO:0044259 | multicellular organismal macromolecule metabolic process(GO:0044259) |
| 0.1 | 0.3 | GO:0018125 | peptidyl-cysteine methylation(GO:0018125) |
| 0.1 | 1.1 | GO:0007213 | G-protein coupled acetylcholine receptor signaling pathway(GO:0007213) |
| 0.1 | 10.8 | GO:0045047 | protein targeting to ER(GO:0045047) |
| 0.1 | 0.7 | GO:0007256 | activation of JNKK activity(GO:0007256) |
| 0.1 | 0.8 | GO:0015760 | hexose phosphate transport(GO:0015712) glucose-6-phosphate transport(GO:0015760) |
| 0.1 | 0.6 | GO:0045948 | positive regulation of translational initiation(GO:0045948) |
| 0.1 | 1.4 | GO:0009226 | nucleotide-sugar biosynthetic process(GO:0009226) |
| 0.1 | 0.3 | GO:0030952 | establishment or maintenance of cytoskeleton polarity(GO:0030952) |
| 0.1 | 0.1 | GO:0060298 | positive regulation of sarcomere organization(GO:0060298) |
| 0.1 | 0.3 | GO:0071104 | response to interleukin-9(GO:0071104) |
| 0.1 | 0.9 | GO:0033234 | negative regulation of protein sumoylation(GO:0033234) |
| 0.1 | 0.1 | GO:0097267 | omega-hydroxylase P450 pathway(GO:0097267) |
| 0.1 | 0.1 | GO:0072014 | proximal tubule development(GO:0072014) |
| 0.1 | 0.1 | GO:0035745 | T-helper 2 cell cytokine production(GO:0035745) |
| 0.1 | 2.1 | GO:0009083 | branched-chain amino acid catabolic process(GO:0009083) |
| 0.1 | 0.1 | GO:0050968 | detection of chemical stimulus involved in sensory perception of pain(GO:0050968) |
| 0.1 | 0.4 | GO:0048262 | determination of dorsal/ventral asymmetry(GO:0048262) |
| 0.1 | 2.2 | GO:0006656 | phosphatidylcholine biosynthetic process(GO:0006656) |
| 0.1 | 0.3 | GO:0043039 | amino acid activation(GO:0043038) tRNA aminoacylation(GO:0043039) |
| 0.1 | 0.2 | GO:1901029 | negative regulation of mitochondrial outer membrane permeabilization involved in apoptotic signaling pathway(GO:1901029) |
| 0.1 | 0.5 | GO:0051026 | chiasma assembly(GO:0051026) |
| 0.1 | 0.4 | GO:0007598 | blood coagulation, extrinsic pathway(GO:0007598) |
| 0.1 | 4.8 | GO:0006369 | termination of RNA polymerase II transcription(GO:0006369) |
| 0.1 | 0.6 | GO:0038172 | interleukin-33-mediated signaling pathway(GO:0038172) |
| 0.1 | 0.5 | GO:0003281 | ventricular septum development(GO:0003281) |
| 0.1 | 1.6 | GO:0000070 | mitotic sister chromatid segregation(GO:0000070) |
| 0.1 | 0.8 | GO:0021517 | ventral spinal cord development(GO:0021517) |
| 0.1 | 0.8 | GO:0034465 | response to carbon monoxide(GO:0034465) |
| 0.1 | 0.4 | GO:0098711 | iron ion import into cell(GO:0097459) iron ion import across plasma membrane(GO:0098711) |
| 0.1 | 0.2 | GO:0000393 | spliceosomal conformational changes to generate catalytic conformation(GO:0000393) |
| 0.1 | 0.1 | GO:0032227 | negative regulation of synaptic transmission, dopaminergic(GO:0032227) |
| 0.1 | 0.7 | GO:2000641 | regulation of early endosome to late endosome transport(GO:2000641) |
| 0.1 | 0.3 | GO:0071316 | cellular response to nicotine(GO:0071316) |
| 0.1 | 4.8 | GO:0031638 | zymogen activation(GO:0031638) |
| 0.1 | 0.3 | GO:0002070 | epithelial cell maturation(GO:0002070) |
| 0.1 | 0.3 | GO:0051902 | negative regulation of mitochondrial depolarization(GO:0051902) negative regulation of membrane depolarization(GO:1904180) |
| 0.1 | 1.0 | GO:0030728 | ovulation(GO:0030728) |
| 0.1 | 0.9 | GO:0034629 | cellular protein complex localization(GO:0034629) |
| 0.1 | 0.8 | GO:0030322 | stabilization of membrane potential(GO:0030322) |
| 0.1 | 1.1 | GO:0042398 | cellular modified amino acid biosynthetic process(GO:0042398) |
| 0.1 | 0.8 | GO:0060749 | mammary gland alveolus development(GO:0060749) mammary gland lobule development(GO:0061377) |
| 0.1 | 0.2 | GO:0014722 | regulation of skeletal muscle contraction by calcium ion signaling(GO:0014722) |
| 0.1 | 0.5 | GO:0043152 | induction of bacterial agglutination(GO:0043152) |
| 0.1 | 0.3 | GO:0034334 | adherens junction maintenance(GO:0034334) |
| 0.1 | 0.1 | GO:1904354 | negative regulation of telomere capping(GO:1904354) |
| 0.1 | 0.2 | GO:0033688 | regulation of osteoblast proliferation(GO:0033688) |
| 0.1 | 1.0 | GO:0071577 | zinc II ion transmembrane transport(GO:0071577) |
| 0.1 | 0.1 | GO:0060372 | regulation of atrial cardiac muscle cell membrane repolarization(GO:0060372) |
| 0.1 | 0.9 | GO:0035589 | G-protein coupled purinergic nucleotide receptor signaling pathway(GO:0035589) |
| 0.1 | 0.9 | GO:0043403 | skeletal muscle tissue regeneration(GO:0043403) |
| 0.1 | 0.1 | GO:0097490 | sympathetic neuron projection extension(GO:0097490) sympathetic neuron projection guidance(GO:0097491) |
| 0.1 | 0.2 | GO:1902231 | positive regulation of intrinsic apoptotic signaling pathway in response to DNA damage(GO:1902231) |
| 0.1 | 0.4 | GO:0007379 | segment specification(GO:0007379) |
| 0.1 | 0.2 | GO:0006102 | isocitrate metabolic process(GO:0006102) |
| 0.1 | 0.6 | GO:0006768 | biotin metabolic process(GO:0006768) |
| 0.1 | 0.1 | GO:0042483 | negative regulation of odontogenesis(GO:0042483) |
| 0.1 | 0.1 | GO:0032528 | microvillus organization(GO:0032528) |
| 0.1 | 0.1 | GO:0001951 | intestinal D-glucose absorption(GO:0001951) |
| 0.1 | 0.3 | GO:0072386 | plus-end-directed organelle transport along microtubule(GO:0072386) |
| 0.1 | 0.1 | GO:0051344 | negative regulation of cyclic-nucleotide phosphodiesterase activity(GO:0051344) |
| 0.1 | 3.1 | GO:0051225 | spindle assembly(GO:0051225) |
| 0.1 | 0.2 | GO:0032276 | regulation of gonadotropin secretion(GO:0032276) |
| 0.1 | 0.2 | GO:0001833 | inner cell mass cell proliferation(GO:0001833) |
| 0.1 | 0.7 | GO:0033141 | positive regulation of peptidyl-serine phosphorylation of STAT protein(GO:0033141) |
| 0.1 | 0.3 | GO:1904995 | negative regulation of leukocyte tethering or rolling(GO:1903237) negative regulation of leukocyte adhesion to vascular endothelial cell(GO:1904995) |
| 0.1 | 0.4 | GO:0098814 | spontaneous neurotransmitter secretion(GO:0061669) spontaneous synaptic transmission(GO:0098814) |
| 0.0 | 0.4 | GO:0001675 | acrosome assembly(GO:0001675) |
| 0.0 | 1.0 | GO:0022030 | cerebral cortex radial glia guided migration(GO:0021801) telencephalon glial cell migration(GO:0022030) |
| 0.0 | 0.5 | GO:0046007 | negative regulation of activated T cell proliferation(GO:0046007) |
| 0.0 | 0.1 | GO:0002874 | regulation of chronic inflammatory response to antigenic stimulus(GO:0002874) positive regulation of chronic inflammatory response to antigenic stimulus(GO:0002876) |
| 0.0 | 0.1 | GO:0015746 | tricarboxylic acid transport(GO:0006842) citrate transport(GO:0015746) |
| 0.0 | 0.0 | GO:0071502 | cellular response to temperature stimulus(GO:0071502) |
| 0.0 | 0.3 | GO:0014823 | response to activity(GO:0014823) |
| 0.0 | 0.1 | GO:0043129 | surfactant homeostasis(GO:0043129) |
| 0.0 | 0.2 | GO:0006098 | pentose-phosphate shunt(GO:0006098) glyceraldehyde-3-phosphate metabolic process(GO:0019682) |
| 0.0 | 0.2 | GO:0051389 | inactivation of MAPKK activity(GO:0051389) |
| 0.0 | 0.2 | GO:0002943 | tRNA dihydrouridine synthesis(GO:0002943) |
| 0.0 | 0.4 | GO:0045742 | positive regulation of epidermal growth factor receptor signaling pathway(GO:0045742) |
| 0.0 | 0.6 | GO:0015937 | coenzyme A biosynthetic process(GO:0015937) |
| 0.0 | 0.3 | GO:0044245 | polysaccharide digestion(GO:0044245) |
| 0.0 | 0.1 | GO:0010727 | negative regulation of hydrogen peroxide metabolic process(GO:0010727) |
| 0.0 | 0.2 | GO:1902237 | positive regulation of endoplasmic reticulum stress-induced intrinsic apoptotic signaling pathway(GO:1902237) |
| 0.0 | 0.2 | GO:0006049 | UDP-N-acetylglucosamine catabolic process(GO:0006049) |
| 0.0 | 0.4 | GO:0015721 | bile acid and bile salt transport(GO:0015721) |
| 0.0 | 0.3 | GO:0046599 | regulation of centriole replication(GO:0046599) |
| 0.0 | 0.3 | GO:0003321 | positive regulation of blood pressure by epinephrine-norepinephrine(GO:0003321) |
| 0.0 | 0.2 | GO:1905123 | regulation of glucosylceramidase activity(GO:1905123) |
| 0.0 | 1.9 | GO:1902807 | negative regulation of cell cycle G1/S phase transition(GO:1902807) negative regulation of G1/S transition of mitotic cell cycle(GO:2000134) |
| 0.0 | 0.1 | GO:0042420 | dopamine catabolic process(GO:0042420) |
| 0.0 | 0.0 | GO:0019805 | quinolinate biosynthetic process(GO:0019805) |
| 0.0 | 0.1 | GO:0035897 | proteolysis in other organism(GO:0035897) |
| 0.0 | 0.2 | GO:0006685 | sphingomyelin catabolic process(GO:0006685) |
| 0.0 | 0.8 | GO:0007588 | excretion(GO:0007588) |
| 0.0 | 0.0 | GO:0032224 | positive regulation of synaptic transmission, cholinergic(GO:0032224) |
| 0.0 | 0.0 | GO:0007352 | zygotic specification of dorsal/ventral axis(GO:0007352) |
| 0.0 | 0.1 | GO:0072734 | response to staurosporine(GO:0072733) cellular response to staurosporine(GO:0072734) |
| 0.0 | 0.2 | GO:0001707 | mesoderm formation(GO:0001707) |
| 0.0 | 0.0 | GO:0033189 | response to vitamin A(GO:0033189) |
| 0.0 | 0.0 | GO:0090467 | L-arginine import(GO:0043091) arginine import(GO:0090467) L-arginine transport(GO:1902023) |
| 0.0 | 0.1 | GO:0043631 | mRNA polyadenylation(GO:0006378) RNA polyadenylation(GO:0043631) |
| 0.0 | 0.1 | GO:0006828 | manganese ion transport(GO:0006828) |
Gene overrepresentation in cellular component category:
| Log-likelihood per target | Total log-likelihood | Term | Description |
|---|---|---|---|
| 11.6 | 46.4 | GO:0097125 | cyclin B1-CDK1 complex(GO:0097125) |
| 6.3 | 31.5 | GO:0097149 | centralspindlin complex(GO:0097149) |
| 5.6 | 44.5 | GO:0000015 | phosphopyruvate hydratase complex(GO:0000015) |
| 5.0 | 19.9 | GO:0005602 | complement component C1 complex(GO:0005602) |
| 4.7 | 23.5 | GO:0070557 | PCNA-p21 complex(GO:0070557) |
| 4.3 | 52.1 | GO:0097487 | multivesicular body, internal vesicle(GO:0097487) |
| 4.3 | 8.6 | GO:0070435 | Shc-EGFR complex(GO:0070435) |
| 4.2 | 8.5 | GO:0043260 | laminin-11 complex(GO:0043260) |
| 4.1 | 28.9 | GO:0005610 | laminin-5 complex(GO:0005610) |
| 4.1 | 57.1 | GO:0005862 | muscle thin filament tropomyosin(GO:0005862) |
| 4.0 | 23.8 | GO:0009368 | endopeptidase Clp complex(GO:0009368) |
| 4.0 | 11.9 | GO:0031262 | Ndc80 complex(GO:0031262) |
| 3.9 | 15.5 | GO:0097057 | TRAF2-GSTP1 complex(GO:0097057) |
| 3.6 | 21.7 | GO:1990357 | terminal web(GO:1990357) |
| 3.6 | 57.6 | GO:0034709 | methylosome(GO:0034709) |
| 3.5 | 10.4 | GO:0045323 | interleukin-1 receptor complex(GO:0045323) |
| 3.4 | 3.4 | GO:0043259 | laminin-10 complex(GO:0043259) |
| 3.3 | 9.8 | GO:0036387 | nuclear pre-replicative complex(GO:0005656) pre-replicative complex(GO:0036387) |
| 3.2 | 22.4 | GO:0035985 | senescence-associated heterochromatin focus(GO:0035985) |
| 3.2 | 66.5 | GO:0005861 | troponin complex(GO:0005861) |
| 3.1 | 75.2 | GO:0031362 | anchored component of external side of plasma membrane(GO:0031362) |
| 3.0 | 21.1 | GO:0005956 | protein kinase CK2 complex(GO:0005956) |
| 3.0 | 33.2 | GO:0005638 | lamin filament(GO:0005638) |
| 3.0 | 3.0 | GO:0034665 | integrin alpha1-beta1 complex(GO:0034665) |
| 3.0 | 11.9 | GO:0008537 | proteasome activator complex(GO:0008537) |
| 2.9 | 8.8 | GO:0044393 | microspike(GO:0044393) |
| 2.9 | 115.4 | GO:0000315 | organellar large ribosomal subunit(GO:0000315) mitochondrial large ribosomal subunit(GO:0005762) |
| 2.9 | 34.5 | GO:0008290 | F-actin capping protein complex(GO:0008290) |
| 2.9 | 14.3 | GO:0045283 | mitochondrial respiratory chain complex II, succinate dehydrogenase complex (ubiquinone)(GO:0005749) succinate dehydrogenase complex (ubiquinone)(GO:0045257) respiratory chain complex II(GO:0045273) succinate dehydrogenase complex(GO:0045281) fumarate reductase complex(GO:0045283) |
| 2.8 | 22.6 | GO:0070522 | ERCC4-ERCC1 complex(GO:0070522) |
| 2.8 | 44.7 | GO:0030663 | COPI-coated vesicle membrane(GO:0030663) |
| 2.7 | 8.1 | GO:0002081 | outer acrosomal membrane(GO:0002081) |
| 2.6 | 26.3 | GO:0031595 | nuclear proteasome complex(GO:0031595) |
| 2.6 | 17.9 | GO:0031298 | replication fork protection complex(GO:0031298) |
| 2.6 | 25.6 | GO:0008541 | proteasome regulatory particle, lid subcomplex(GO:0008541) |
| 2.5 | 17.2 | GO:0044354 | pinosome(GO:0044352) macropinosome(GO:0044354) |
| 2.4 | 4.8 | GO:0000942 | condensed nuclear chromosome outer kinetochore(GO:0000942) |
| 2.4 | 7.1 | GO:0034515 | proteasome storage granule(GO:0034515) |
| 2.4 | 9.5 | GO:0036502 | Derlin-1-VIMP complex(GO:0036502) |
| 2.4 | 7.1 | GO:0071001 | U4/U6 snRNP(GO:0071001) |
| 2.4 | 25.9 | GO:0070449 | elongin complex(GO:0070449) |
| 2.3 | 23.5 | GO:0097255 | R2TP complex(GO:0097255) |
| 2.3 | 9.3 | GO:0001405 | presequence translocase-associated import motor(GO:0001405) |
| 2.3 | 18.4 | GO:0016012 | sarcoglycan complex(GO:0016012) |
| 2.3 | 6.8 | GO:0044611 | nuclear pore inner ring(GO:0044611) |
| 2.2 | 20.1 | GO:0032133 | chromosome passenger complex(GO:0032133) |
| 2.2 | 8.9 | GO:1990423 | RZZ complex(GO:1990423) |
| 2.2 | 2.2 | GO:0005797 | Golgi medial cisterna(GO:0005797) |
| 2.2 | 99.7 | GO:0045095 | keratin filament(GO:0045095) |
| 2.2 | 8.8 | GO:0005971 | ribonucleoside-diphosphate reductase complex(GO:0005971) |
| 2.2 | 6.6 | GO:0036284 | tubulobulbar complex(GO:0036284) |
| 2.2 | 58.8 | GO:0005763 | organellar small ribosomal subunit(GO:0000314) mitochondrial small ribosomal subunit(GO:0005763) |
| 2.2 | 6.5 | GO:1990622 | CHOP-ATF3 complex(GO:1990622) |
| 2.2 | 10.9 | GO:0043625 | delta DNA polymerase complex(GO:0043625) |
| 2.1 | 12.8 | GO:0031390 | Ctf18 RFC-like complex(GO:0031390) |
| 2.1 | 8.5 | GO:0031510 | SUMO activating enzyme complex(GO:0031510) |
| 2.1 | 12.7 | GO:0005761 | organellar ribosome(GO:0000313) mitochondrial ribosome(GO:0005761) |
| 2.1 | 4.2 | GO:0031209 | SCAR complex(GO:0031209) |
| 2.1 | 22.6 | GO:0035692 | macrophage migration inhibitory factor receptor complex(GO:0035692) |
| 2.0 | 51.2 | GO:0042627 | chylomicron(GO:0042627) |
| 2.0 | 6.1 | GO:0005588 | collagen type V trimer(GO:0005588) |
| 2.0 | 26.3 | GO:0034098 | VCP-NPL4-UFD1 AAA ATPase complex(GO:0034098) |
| 2.0 | 20.2 | GO:0070552 | BRISC complex(GO:0070552) |
| 2.0 | 6.0 | GO:0097441 | basilar dendrite(GO:0097441) |
| 2.0 | 13.9 | GO:0000940 | condensed chromosome outer kinetochore(GO:0000940) |
| 2.0 | 11.9 | GO:0005784 | Sec61 translocon complex(GO:0005784) translocon complex(GO:0071256) |
| 2.0 | 25.7 | GO:0042555 | MCM complex(GO:0042555) |
| 2.0 | 13.7 | GO:0031429 | box H/ACA snoRNP complex(GO:0031429) box H/ACA RNP complex(GO:0072588) box H/ACA scaRNP complex(GO:0072589) box H/ACA telomerase RNP complex(GO:0090661) |
| 1.9 | 19.4 | GO:0071541 | eukaryotic translation initiation factor 3 complex, eIF3m(GO:0071541) |
| 1.9 | 3.8 | GO:0034680 | integrin alpha10-beta1 complex(GO:0034680) |
| 1.9 | 37.4 | GO:0001527 | microfibril(GO:0001527) fibril(GO:0043205) |
| 1.9 | 24.2 | GO:0030677 | ribonuclease P complex(GO:0030677) |
| 1.9 | 3.7 | GO:1990730 | VCP-NSFL1C complex(GO:1990730) |
| 1.8 | 5.5 | GO:0033185 | dolichol-phosphate-mannose synthase complex(GO:0033185) |
| 1.8 | 23.8 | GO:0005915 | zonula adherens(GO:0005915) |
| 1.8 | 21.9 | GO:0030056 | hemidesmosome(GO:0030056) |
| 1.8 | 3.6 | GO:0043203 | axon hillock(GO:0043203) |
| 1.8 | 18.0 | GO:0033018 | sarcoplasmic reticulum lumen(GO:0033018) |
| 1.8 | 5.3 | GO:0097135 | cyclin E2-CDK2 complex(GO:0097135) |
| 1.8 | 21.2 | GO:0036454 | insulin-like growth factor binding protein complex(GO:0016942) growth factor complex(GO:0036454) |
| 1.7 | 19.2 | GO:0032593 | insulin-responsive compartment(GO:0032593) |
| 1.7 | 38.3 | GO:0036020 | endolysosome membrane(GO:0036020) |
| 1.7 | 15.3 | GO:0070765 | gamma-secretase complex(GO:0070765) |
| 1.7 | 6.8 | GO:0008540 | proteasome regulatory particle, base subcomplex(GO:0008540) |
| 1.7 | 47.1 | GO:0016327 | apicolateral plasma membrane(GO:0016327) |
| 1.7 | 26.7 | GO:0005736 | DNA-directed RNA polymerase I complex(GO:0005736) |
| 1.7 | 5.0 | GO:1990723 | cytoplasmic periphery of the nuclear pore complex(GO:1990723) |
| 1.7 | 13.3 | GO:0000796 | condensin complex(GO:0000796) |
| 1.7 | 29.9 | GO:0031089 | platelet dense granule lumen(GO:0031089) |
| 1.7 | 5.0 | GO:0035867 | alphav-beta3 integrin-IGF-1-IGF1R complex(GO:0035867) |
| 1.6 | 8.1 | GO:0014802 | terminal cisterna(GO:0014802) |
| 1.6 | 20.7 | GO:0005751 | mitochondrial respiratory chain complex IV(GO:0005751) |
| 1.6 | 6.4 | GO:0017059 | serine C-palmitoyltransferase complex(GO:0017059) endoplasmic reticulum palmitoyltransferase complex(GO:0031211) |
| 1.6 | 1.6 | GO:0034666 | integrin alpha2-beta1 complex(GO:0034666) |
| 1.5 | 23.2 | GO:0000812 | Swr1 complex(GO:0000812) |
| 1.5 | 16.9 | GO:0045275 | mitochondrial respiratory chain complex III(GO:0005750) respiratory chain complex III(GO:0045275) |
| 1.5 | 1.5 | GO:0034750 | Scrib-APC-beta-catenin complex(GO:0034750) |
| 1.5 | 4.5 | GO:0098837 | postsynaptic recycling endosome(GO:0098837) |
| 1.5 | 22.4 | GO:0034663 | endoplasmic reticulum chaperone complex(GO:0034663) |
| 1.5 | 5.9 | GO:0071159 | NF-kappaB complex(GO:0071159) |
| 1.5 | 13.2 | GO:0097452 | GAIT complex(GO:0097452) |
| 1.4 | 17.4 | GO:0008250 | oligosaccharyltransferase complex(GO:0008250) |
| 1.4 | 27.1 | GO:0000177 | cytoplasmic exosome (RNase complex)(GO:0000177) |
| 1.4 | 22.9 | GO:0031080 | nuclear pore outer ring(GO:0031080) |
| 1.4 | 12.8 | GO:1990630 | IRE1-RACK1-PP2A complex(GO:1990630) |
| 1.4 | 4.3 | GO:0071148 | TEAD-1-YAP complex(GO:0071148) |
| 1.4 | 5.6 | GO:1990393 | 3M complex(GO:1990393) |
| 1.4 | 28.1 | GO:0002080 | acrosomal membrane(GO:0002080) |
| 1.4 | 12.6 | GO:0001739 | sex chromatin(GO:0001739) |
| 1.4 | 5.6 | GO:0071986 | Ragulator complex(GO:0071986) |
| 1.4 | 8.4 | GO:0071797 | LUBAC complex(GO:0071797) |
| 1.4 | 12.5 | GO:0042719 | mitochondrial intermembrane space protein transporter complex(GO:0042719) |
| 1.4 | 11.1 | GO:0098575 | lumenal side of lysosomal membrane(GO:0098575) |
| 1.4 | 9.7 | GO:0016600 | flotillin complex(GO:0016600) |
| 1.4 | 10.9 | GO:0097443 | sorting endosome(GO:0097443) |
| 1.4 | 6.8 | GO:0031523 | Myb complex(GO:0031523) |
| 1.4 | 2.7 | GO:0005899 | insulin receptor complex(GO:0005899) |
| 1.4 | 16.3 | GO:0002199 | zona pellucida receptor complex(GO:0002199) |
| 1.3 | 40.4 | GO:0031143 | pseudopodium(GO:0031143) |
| 1.3 | 9.2 | GO:0071953 | elastic fiber(GO:0071953) |
| 1.3 | 18.0 | GO:0070938 | contractile ring(GO:0070938) |
| 1.3 | 5.1 | GO:0071595 | Nem1-Spo7 phosphatase complex(GO:0071595) |
| 1.3 | 8.8 | GO:1990726 | Lsm1-7-Pat1 complex(GO:1990726) |
| 1.3 | 1.3 | GO:0005863 | striated muscle myosin thick filament(GO:0005863) |
| 1.3 | 6.3 | GO:0000214 | tRNA-intron endonuclease complex(GO:0000214) |
| 1.3 | 47.6 | GO:0042629 | mast cell granule(GO:0042629) |
| 1.3 | 33.8 | GO:0005680 | anaphase-promoting complex(GO:0005680) |
| 1.2 | 5.0 | GO:0000438 | core TFIIH complex portion of holo TFIIH complex(GO:0000438) |
| 1.2 | 7.5 | GO:0061617 | MICOS complex(GO:0061617) |
| 1.2 | 9.8 | GO:0005851 | eukaryotic translation initiation factor 2B complex(GO:0005851) |
| 1.2 | 74.9 | GO:0030964 | mitochondrial respiratory chain complex I(GO:0005747) NADH dehydrogenase complex(GO:0030964) respiratory chain complex I(GO:0045271) |
| 1.2 | 10.9 | GO:0005787 | signal peptidase complex(GO:0005787) |
| 1.2 | 6.0 | GO:0032044 | DSIF complex(GO:0032044) |
| 1.2 | 14.2 | GO:0045120 | pronucleus(GO:0045120) |
| 1.2 | 31.3 | GO:0031528 | microvillus membrane(GO:0031528) |
| 1.1 | 2.3 | GO:0071062 | alphav-beta3 integrin-vitronectin complex(GO:0071062) |
| 1.1 | 5.7 | GO:0001651 | dense fibrillar component(GO:0001651) |
| 1.1 | 2.2 | GO:0034366 | spherical high-density lipoprotein particle(GO:0034366) |
| 1.1 | 5.6 | GO:0031436 | BRCA1-BARD1 complex(GO:0031436) |
| 1.1 | 5.3 | GO:0045160 | myosin I complex(GO:0045160) |
| 1.1 | 1.1 | GO:0005742 | mitochondrial outer membrane translocase complex(GO:0005742) |
| 1.0 | 9.4 | GO:0034385 | very-low-density lipoprotein particle(GO:0034361) triglyceride-rich lipoprotein particle(GO:0034385) |
| 1.0 | 34.3 | GO:0005790 | smooth endoplasmic reticulum(GO:0005790) |
| 1.0 | 5.2 | GO:0036021 | endolysosome lumen(GO:0036021) |
| 1.0 | 6.2 | GO:0017101 | aminoacyl-tRNA synthetase multienzyme complex(GO:0017101) |
| 1.0 | 2.1 | GO:0071598 | neuronal ribonucleoprotein granule(GO:0071598) |
| 1.0 | 9.1 | GO:0042382 | paraspeckles(GO:0042382) |
| 1.0 | 118.9 | GO:0005604 | basement membrane(GO:0005604) |
| 1.0 | 5.1 | GO:0005658 | alpha DNA polymerase:primase complex(GO:0005658) |
| 1.0 | 3.0 | GO:0030289 | protein phosphatase 4 complex(GO:0030289) |
| 1.0 | 12.0 | GO:0034364 | high-density lipoprotein particle(GO:0034364) |
| 1.0 | 6.9 | GO:0016272 | prefoldin complex(GO:0016272) |
| 1.0 | 42.5 | GO:0008180 | COP9 signalosome(GO:0008180) |
| 1.0 | 72.0 | GO:0097517 | stress fiber(GO:0001725) contractile actin filament bundle(GO:0097517) |
| 1.0 | 4.8 | GO:0032449 | CBM complex(GO:0032449) |
| 1.0 | 1.0 | GO:0000439 | core TFIIH complex(GO:0000439) |
| 1.0 | 13.3 | GO:0019774 | proteasome core complex, beta-subunit complex(GO:0019774) |
| 0.9 | 18.0 | GO:0035371 | microtubule plus-end(GO:0035371) |
| 0.9 | 14.0 | GO:0071438 | invadopodium membrane(GO:0071438) |
| 0.9 | 8.4 | GO:0000506 | glycosylphosphatidylinositol-N-acetylglucosaminyltransferase (GPI-GnT) complex(GO:0000506) |
| 0.9 | 10.2 | GO:0033588 | Elongator holoenzyme complex(GO:0033588) |
| 0.9 | 20.9 | GO:0031305 | intrinsic component of mitochondrial inner membrane(GO:0031304) integral component of mitochondrial inner membrane(GO:0031305) |
| 0.9 | 4.5 | GO:0000408 | EKC/KEOPS complex(GO:0000408) |
| 0.9 | 10.8 | GO:0097136 | Bcl-2 family protein complex(GO:0097136) |
| 0.9 | 18.6 | GO:0046930 | pore complex(GO:0046930) |
| 0.9 | 7.9 | GO:0019907 | cyclin-dependent protein kinase activating kinase holoenzyme complex(GO:0019907) |
| 0.9 | 4.4 | GO:0032301 | MutSalpha complex(GO:0032301) |
| 0.9 | 2.6 | GO:0005674 | transcription factor TFIIF complex(GO:0005674) |
| 0.9 | 2.6 | GO:0005850 | eukaryotic translation initiation factor 2 complex(GO:0005850) |
| 0.9 | 3.5 | GO:0033186 | CAF-1 complex(GO:0033186) |
| 0.9 | 18.3 | GO:0030867 | rough endoplasmic reticulum membrane(GO:0030867) |
| 0.9 | 3.4 | GO:0005846 | nuclear cap binding complex(GO:0005846) |
| 0.9 | 6.9 | GO:0005688 | U6 snRNP(GO:0005688) |
| 0.9 | 14.6 | GO:0005885 | Arp2/3 protein complex(GO:0005885) |
| 0.9 | 23.1 | GO:0070971 | endoplasmic reticulum exit site(GO:0070971) |
| 0.9 | 2.6 | GO:0033565 | ESCRT-0 complex(GO:0033565) |
| 0.8 | 10.1 | GO:0019773 | proteasome core complex, alpha-subunit complex(GO:0019773) |
| 0.8 | 5.9 | GO:0032021 | NELF complex(GO:0032021) |
| 0.8 | 2.5 | GO:0071821 | FANCM-MHF complex(GO:0071821) |
| 0.8 | 60.4 | GO:0031672 | A band(GO:0031672) |
| 0.8 | 4.1 | GO:0005947 | mitochondrial alpha-ketoglutarate dehydrogenase complex(GO:0005947) |
| 0.8 | 3.3 | GO:0042765 | GPI-anchor transamidase complex(GO:0042765) |
| 0.8 | 0.8 | GO:0005732 | small nucleolar ribonucleoprotein complex(GO:0005732) |
| 0.8 | 1.6 | GO:0071817 | MMXD complex(GO:0071817) |
| 0.8 | 8.0 | GO:1990023 | mitotic spindle midzone(GO:1990023) |
| 0.8 | 7.1 | GO:0051233 | spindle midzone(GO:0051233) |
| 0.8 | 49.0 | GO:0045171 | intercellular bridge(GO:0045171) |
| 0.8 | 3.2 | GO:0005960 | glycine cleavage complex(GO:0005960) |
| 0.8 | 2.3 | GO:0070195 | growth hormone receptor complex(GO:0070195) |
| 0.8 | 75.9 | GO:0005913 | cell-cell adherens junction(GO:0005913) |
| 0.8 | 3.1 | GO:0097059 | CNTFR-CLCF1 complex(GO:0097059) |
| 0.8 | 2.3 | GO:0072669 | tRNA-splicing ligase complex(GO:0072669) |
| 0.8 | 2.3 | GO:0072563 | endothelial microparticle(GO:0072563) |
| 0.8 | 12.2 | GO:0097470 | ribbon synapse(GO:0097470) |
| 0.7 | 12.7 | GO:0032433 | filopodium tip(GO:0032433) |
| 0.7 | 3.7 | GO:0042643 | actomyosin, actin portion(GO:0042643) |
| 0.7 | 4.4 | GO:1990752 | microtubule end(GO:1990752) |
| 0.7 | 2.2 | GO:0033593 | BRCA2-MAGE-D1 complex(GO:0033593) |
| 0.7 | 28.2 | GO:0000502 | proteasome complex(GO:0000502) |
| 0.7 | 2.9 | GO:0031905 | early endosome lumen(GO:0031905) |
| 0.7 | 1.4 | GO:0071942 | XPC complex(GO:0071942) |
| 0.7 | 5.7 | GO:1903440 | calcitonin family receptor complex(GO:1903439) amylin receptor complex(GO:1903440) |
| 0.7 | 2.8 | GO:0005968 | Rab-protein geranylgeranyltransferase complex(GO:0005968) |
| 0.7 | 16.2 | GO:0005921 | gap junction(GO:0005921) |
| 0.7 | 4.9 | GO:0030127 | COPII vesicle coat(GO:0030127) |
| 0.7 | 2.0 | GO:0016589 | NURF complex(GO:0016589) |
| 0.7 | 27.0 | GO:0009295 | nucleoid(GO:0009295) mitochondrial nucleoid(GO:0042645) |
| 0.7 | 8.1 | GO:0097486 | multivesicular body lumen(GO:0097486) |
| 0.7 | 15.4 | GO:0030057 | desmosome(GO:0030057) |
| 0.7 | 2.6 | GO:0008043 | intracellular ferritin complex(GO:0008043) ferritin complex(GO:0070288) |
| 0.7 | 2.0 | GO:0005600 | collagen type XIII trimer(GO:0005600) transmembrane collagen trimer(GO:0030936) |
| 0.7 | 2.6 | GO:0043541 | UDP-N-acetylglucosamine transferase complex(GO:0043541) |
| 0.6 | 3.9 | GO:0030688 | preribosome, small subunit precursor(GO:0030688) |
| 0.6 | 9.6 | GO:0042622 | photoreceptor outer segment membrane(GO:0042622) |
| 0.6 | 5.8 | GO:0071144 | SMAD2-SMAD3 protein complex(GO:0071144) |
| 0.6 | 5.7 | GO:0072546 | ER membrane protein complex(GO:0072546) |
| 0.6 | 44.2 | GO:0015935 | small ribosomal subunit(GO:0015935) |
| 0.6 | 78.0 | GO:0005793 | endoplasmic reticulum-Golgi intermediate compartment(GO:0005793) |
| 0.6 | 44.5 | GO:1904724 | tertiary granule lumen(GO:1904724) |
| 0.6 | 4.9 | GO:0098643 | fibrillar collagen trimer(GO:0005583) banded collagen fibril(GO:0098643) |
| 0.6 | 18.9 | GO:0030687 | preribosome, large subunit precursor(GO:0030687) |
| 0.6 | 2.4 | GO:0033257 | Bcl3/NF-kappaB2 complex(GO:0033257) |
| 0.6 | 1.2 | GO:0016222 | procollagen-proline 4-dioxygenase complex(GO:0016222) |
| 0.6 | 7.9 | GO:0005852 | eukaryotic translation initiation factor 3 complex(GO:0005852) |
| 0.6 | 5.4 | GO:0031233 | intrinsic component of external side of plasma membrane(GO:0031233) |
| 0.6 | 2.4 | GO:0071920 | cleavage body(GO:0071920) |
| 0.6 | 6.6 | GO:0030130 | clathrin coat of trans-Golgi network vesicle(GO:0030130) |
| 0.6 | 1.2 | GO:0031428 | box C/D snoRNP complex(GO:0031428) |
| 0.6 | 6.5 | GO:0031465 | Cul4B-RING E3 ubiquitin ligase complex(GO:0031465) |
| 0.6 | 3.0 | GO:0032806 | carboxy-terminal domain protein kinase complex(GO:0032806) |
| 0.6 | 4.1 | GO:0000127 | transcription factor TFIIIC complex(GO:0000127) |
| 0.6 | 4.1 | GO:0034719 | SMN-Sm protein complex(GO:0034719) |
| 0.6 | 1.7 | GO:0000939 | condensed chromosome inner kinetochore(GO:0000939) |
| 0.6 | 2.9 | GO:1902560 | GMP reductase complex(GO:1902560) |
| 0.6 | 19.0 | GO:0032154 | cleavage furrow(GO:0032154) cell surface furrow(GO:0097610) |
| 0.6 | 5.1 | GO:0035749 | myelin sheath adaxonal region(GO:0035749) |
| 0.6 | 1.7 | GO:0005958 | DNA-dependent protein kinase-DNA ligase 4 complex(GO:0005958) |
| 0.6 | 19.2 | GO:0071564 | npBAF complex(GO:0071564) |
| 0.6 | 210.3 | GO:0005759 | mitochondrial matrix(GO:0005759) |
| 0.6 | 2.8 | GO:0034388 | Pwp2p-containing subcomplex of 90S preribosome(GO:0034388) |
| 0.6 | 0.6 | GO:0045179 | apical cortex(GO:0045179) |
| 0.5 | 27.4 | GO:0016459 | myosin complex(GO:0016459) |
| 0.5 | 1.6 | GO:0033597 | mitotic checkpoint complex(GO:0033597) bub1-bub3 complex(GO:1990298) |
| 0.5 | 6.0 | GO:0030686 | 90S preribosome(GO:0030686) |
| 0.5 | 15.7 | GO:0031092 | platelet alpha granule membrane(GO:0031092) |
| 0.5 | 5.4 | GO:0031616 | spindle pole centrosome(GO:0031616) |
| 0.5 | 9.1 | GO:0005665 | DNA-directed RNA polymerase II, core complex(GO:0005665) |
| 0.5 | 1.1 | GO:0097208 | alveolar lamellar body(GO:0097208) |
| 0.5 | 59.6 | GO:0042470 | melanosome(GO:0042470) pigment granule(GO:0048770) |
| 0.5 | 1.6 | GO:0072536 | interleukin-23 receptor complex(GO:0072536) |
| 0.5 | 3.1 | GO:0071141 | SMAD protein complex(GO:0071141) |
| 0.5 | 17.1 | GO:0035580 | specific granule lumen(GO:0035580) |
| 0.5 | 19.5 | GO:0045178 | basal part of cell(GO:0045178) |
| 0.5 | 21.1 | GO:0000307 | cyclin-dependent protein kinase holoenzyme complex(GO:0000307) |
| 0.5 | 2.5 | GO:0008274 | gamma-tubulin large complex(GO:0000931) gamma-tubulin ring complex(GO:0008274) |
| 0.5 | 6.6 | GO:0005689 | U12-type spliceosomal complex(GO:0005689) |
| 0.5 | 2.0 | GO:0089701 | U2AF(GO:0089701) |
| 0.5 | 230.3 | GO:0005925 | focal adhesion(GO:0005925) |
| 0.5 | 1.5 | GO:0036513 | Derlin-1 retrotranslocation complex(GO:0036513) |
| 0.5 | 1.5 | GO:0016938 | kinesin I complex(GO:0016938) |
| 0.5 | 26.1 | GO:0044391 | ribosomal subunit(GO:0044391) |
| 0.5 | 26.0 | GO:0031526 | brush border membrane(GO:0031526) |
| 0.5 | 2.9 | GO:0033093 | Weibel-Palade body(GO:0033093) |
| 0.5 | 3.3 | GO:0008282 | ATP-sensitive potassium channel complex(GO:0008282) |
| 0.5 | 3.8 | GO:0005827 | polar microtubule(GO:0005827) |
| 0.5 | 3.3 | GO:0030905 | retromer, tubulation complex(GO:0030905) |
| 0.5 | 2.3 | GO:0032299 | ribonuclease H2 complex(GO:0032299) |
| 0.4 | 8.0 | GO:0005902 | microvillus(GO:0005902) |
| 0.4 | 0.4 | GO:0042588 | zymogen granule(GO:0042588) |
| 0.4 | 3.1 | GO:0070369 | beta-catenin-TCF7L2 complex(GO:0070369) |
| 0.4 | 2.6 | GO:0097431 | mitotic spindle pole(GO:0097431) |
| 0.4 | 3.1 | GO:1990909 | Wnt signalosome(GO:1990909) |
| 0.4 | 3.9 | GO:0043240 | Fanconi anaemia nuclear complex(GO:0043240) |
| 0.4 | 1.7 | GO:0005889 | hydrogen:potassium-exchanging ATPase complex(GO:0005889) |
| 0.4 | 5.7 | GO:0098647 | collagen type VI trimer(GO:0005589) collagen beaded filament(GO:0098647) |
| 0.4 | 1.7 | GO:0070876 | SOSS complex(GO:0070876) |
| 0.4 | 3.4 | GO:0031931 | TORC1 complex(GO:0031931) |
| 0.4 | 6.8 | GO:0046658 | anchored component of plasma membrane(GO:0046658) |
| 0.4 | 3.4 | GO:0005686 | U2 snRNP(GO:0005686) |
| 0.4 | 35.3 | GO:0043202 | lysosomal lumen(GO:0043202) |
| 0.4 | 5.3 | GO:0000974 | Prp19 complex(GO:0000974) |
| 0.4 | 18.1 | GO:0005581 | collagen trimer(GO:0005581) |
| 0.4 | 9.2 | GO:0036452 | ESCRT complex(GO:0036452) |
| 0.4 | 3.2 | GO:0033180 | proton-transporting V-type ATPase, V1 domain(GO:0033180) |
| 0.4 | 9.1 | GO:0030992 | intraciliary transport particle B(GO:0030992) |
| 0.4 | 4.7 | GO:0031011 | Ino80 complex(GO:0031011) DNA helicase complex(GO:0033202) |
| 0.4 | 1.5 | GO:0048179 | activin receptor complex(GO:0048179) |
| 0.4 | 82.5 | GO:0005788 | endoplasmic reticulum lumen(GO:0005788) |
| 0.4 | 6.5 | GO:0070469 | respiratory chain(GO:0070469) |
| 0.4 | 1.1 | GO:0016514 | SWI/SNF complex(GO:0016514) |
| 0.4 | 1.9 | GO:0005652 | nuclear lamina(GO:0005652) |
| 0.4 | 4.9 | GO:0044613 | nuclear pore central transport channel(GO:0044613) |
| 0.4 | 4.1 | GO:0042589 | zymogen granule membrane(GO:0042589) |
| 0.4 | 3.3 | GO:0033179 | proton-transporting two-sector ATPase complex, proton-transporting domain(GO:0033177) proton-transporting V-type ATPase, V0 domain(GO:0033179) |
| 0.4 | 4.7 | GO:0005642 | annulate lamellae(GO:0005642) |
| 0.4 | 21.2 | GO:0000779 | condensed chromosome, centromeric region(GO:0000779) |
| 0.4 | 8.5 | GO:0000421 | autophagosome membrane(GO:0000421) |
| 0.4 | 7.4 | GO:0097342 | ripoptosome(GO:0097342) |
| 0.4 | 26.1 | GO:0005811 | lipid particle(GO:0005811) |
| 0.3 | 1.4 | GO:0032937 | SREBP-SCAP-Insig complex(GO:0032937) |
| 0.3 | 17.8 | GO:0044216 | other organism(GO:0044215) other organism cell(GO:0044216) other organism part(GO:0044217) |
| 0.3 | 10.1 | GO:0035577 | azurophil granule membrane(GO:0035577) |
| 0.3 | 1.4 | GO:0032311 | angiogenin-PRI complex(GO:0032311) |
| 0.3 | 4.4 | GO:0070578 | RISC-loading complex(GO:0070578) |
| 0.3 | 2.0 | GO:0000125 | PCAF complex(GO:0000125) |
| 0.3 | 2.7 | GO:0005664 | origin recognition complex(GO:0000808) nuclear origin of replication recognition complex(GO:0005664) |
| 0.3 | 2.6 | GO:0030478 | actin cap(GO:0030478) |
| 0.3 | 3.6 | GO:0031371 | ubiquitin conjugating enzyme complex(GO:0031371) |
| 0.3 | 87.4 | GO:0031012 | extracellular matrix(GO:0031012) |
| 0.3 | 7.5 | GO:0044665 | MLL1/2 complex(GO:0044665) MLL1 complex(GO:0071339) |
| 0.3 | 3.2 | GO:0000178 | exosome (RNase complex)(GO:0000178) |
| 0.3 | 9.0 | GO:0005876 | spindle microtubule(GO:0005876) |
| 0.3 | 0.6 | GO:0033176 | proton-transporting V-type ATPase complex(GO:0033176) |
| 0.3 | 1.3 | GO:0043527 | tRNA methyltransferase complex(GO:0043527) |
| 0.3 | 3.5 | GO:0005666 | DNA-directed RNA polymerase III complex(GO:0005666) |
| 0.3 | 0.9 | GO:0070701 | mucus layer(GO:0070701) |
| 0.3 | 3.3 | GO:0016593 | Cdc73/Paf1 complex(GO:0016593) |
| 0.3 | 0.3 | GO:0002139 | stereocilia coupling link(GO:0002139) |
| 0.3 | 0.6 | GO:0030314 | junctional membrane complex(GO:0030314) |
| 0.3 | 1.8 | GO:0005945 | 6-phosphofructokinase complex(GO:0005945) |
| 0.3 | 1.5 | GO:0016533 | cyclin-dependent protein kinase 5 holoenzyme complex(GO:0016533) |
| 0.3 | 1.5 | GO:0070847 | core mediator complex(GO:0070847) |
| 0.3 | 4.0 | GO:0097526 | spliceosomal tri-snRNP complex(GO:0097526) |
| 0.3 | 5.0 | GO:0000776 | kinetochore(GO:0000776) |
| 0.3 | 10.6 | GO:0031093 | platelet alpha granule lumen(GO:0031093) |
| 0.3 | 2.1 | GO:0030128 | clathrin coat of endocytic vesicle(GO:0030128) |
| 0.3 | 5.3 | GO:0001533 | cornified envelope(GO:0001533) |
| 0.3 | 7.4 | GO:0000791 | euchromatin(GO:0000791) |
| 0.3 | 0.8 | GO:0034751 | aryl hydrocarbon receptor complex(GO:0034751) |
| 0.3 | 1.0 | GO:0031467 | Cul7-RING ubiquitin ligase complex(GO:0031467) |
| 0.3 | 2.0 | GO:0000347 | THO complex(GO:0000347) THO complex part of transcription export complex(GO:0000445) |
| 0.2 | 2.7 | GO:0030684 | preribosome(GO:0030684) |
| 0.2 | 512.6 | GO:0070062 | extracellular exosome(GO:0070062) |
| 0.2 | 2.8 | GO:0016602 | CCAAT-binding factor complex(GO:0016602) |
| 0.2 | 0.9 | GO:0097165 | nuclear stress granule(GO:0097165) |
| 0.2 | 0.2 | GO:0046581 | intercellular canaliculus(GO:0046581) |
| 0.2 | 1.7 | GO:0005672 | transcription factor TFIIA complex(GO:0005672) |
| 0.2 | 5.4 | GO:0031306 | intrinsic component of mitochondrial outer membrane(GO:0031306) |
| 0.2 | 0.4 | GO:0044305 | calyx of Held(GO:0044305) |
| 0.2 | 1.1 | GO:1990131 | EGO complex(GO:0034448) Gtr1-Gtr2 GTPase complex(GO:1990131) |
| 0.2 | 0.7 | GO:0031415 | NatA complex(GO:0031415) |
| 0.2 | 1.1 | GO:0097550 | transcriptional preinitiation complex(GO:0097550) |
| 0.2 | 1.1 | GO:0002116 | semaphorin receptor complex(GO:0002116) |
| 0.2 | 5.0 | GO:0005791 | rough endoplasmic reticulum(GO:0005791) |
| 0.2 | 6.6 | GO:0005840 | ribosome(GO:0005840) |
| 0.2 | 4.5 | GO:0005881 | cytoplasmic microtubule(GO:0005881) |
| 0.1 | 2.5 | GO:0031588 | nucleotide-activated protein kinase complex(GO:0031588) |
| 0.1 | 3.6 | GO:0000159 | protein phosphatase type 2A complex(GO:0000159) |
| 0.1 | 0.4 | GO:0017109 | glutamate-cysteine ligase complex(GO:0017109) |
| 0.1 | 3.7 | GO:0005892 | acetylcholine-gated channel complex(GO:0005892) |
| 0.1 | 0.4 | GO:0071204 | histone pre-mRNA 3'end processing complex(GO:0071204) |
| 0.1 | 1.0 | GO:1990712 | HFE-transferrin receptor complex(GO:1990712) |
| 0.1 | 0.8 | GO:0098984 | neuron to neuron synapse(GO:0098984) |
| 0.1 | 1.4 | GO:0005662 | DNA replication factor A complex(GO:0005662) |
| 0.1 | 1.5 | GO:0005669 | transcription factor TFIID complex(GO:0005669) |
| 0.1 | 0.3 | GO:0030956 | glutamyl-tRNA(Gln) amidotransferase complex(GO:0030956) |
| 0.1 | 0.5 | GO:0032541 | cortical endoplasmic reticulum(GO:0032541) |
| 0.1 | 13.9 | GO:0045177 | apical part of cell(GO:0045177) |
| 0.1 | 0.7 | GO:0000930 | gamma-tubulin complex(GO:0000930) |
| 0.1 | 0.4 | GO:0098559 | cytoplasmic side of early endosome membrane(GO:0098559) |
| 0.1 | 0.3 | GO:0030891 | VCB complex(GO:0030891) |
| 0.1 | 0.1 | GO:0000333 | telomerase catalytic core complex(GO:0000333) |
| 0.1 | 10.5 | GO:0005743 | mitochondrial inner membrane(GO:0005743) |
| 0.1 | 0.9 | GO:0043034 | costamere(GO:0043034) |
| 0.1 | 0.2 | GO:0033553 | rDNA heterochromatin(GO:0033553) |
| 0.1 | 0.3 | GO:0036379 | myofilament(GO:0036379) |
| 0.1 | 2.8 | GO:0071013 | catalytic step 2 spliceosome(GO:0071013) |
| 0.0 | 0.2 | GO:0031466 | Cul5-RING ubiquitin ligase complex(GO:0031466) |
| 0.0 | 0.3 | GO:0070852 | cell body fiber(GO:0070852) |
| 0.0 | 1.4 | GO:0005758 | mitochondrial intermembrane space(GO:0005758) |
| 0.0 | 0.1 | GO:1990425 | ryanodine receptor complex(GO:1990425) |
| 0.0 | 0.2 | GO:0030896 | checkpoint clamp complex(GO:0030896) |
| 0.0 | 1.2 | GO:0005782 | peroxisomal matrix(GO:0005782) microbody lumen(GO:0031907) |
| 0.0 | 0.2 | GO:0036157 | outer dynein arm(GO:0036157) |
| 0.0 | 0.1 | GO:0032302 | MutSbeta complex(GO:0032302) |
| 0.0 | 0.3 | GO:0016581 | NuRD complex(GO:0016581) CHD-type complex(GO:0090545) |
| 0.0 | 0.1 | GO:0000145 | exocyst(GO:0000145) |
| 0.0 | 0.1 | GO:0000346 | transcription export complex(GO:0000346) |
Gene overrepresentation in molecular function category:
| Log-likelihood per target | Total log-likelihood | Term | Description |
|---|---|---|---|
| 14.9 | 44.7 | GO:0005046 | KDEL sequence binding(GO:0005046) |
| 10.5 | 63.0 | GO:0061575 | cyclin-dependent protein serine/threonine kinase activator activity(GO:0061575) |
| 6.7 | 20.0 | GO:0003974 | UDP-N-acetylglucosamine 4-epimerase activity(GO:0003974) UDP-glucose 4-epimerase activity(GO:0003978) |
| 5.6 | 44.5 | GO:0004634 | phosphopyruvate hydratase activity(GO:0004634) |
| 5.5 | 16.5 | GO:0004450 | isocitrate dehydrogenase (NADP+) activity(GO:0004450) |
| 5.2 | 26.0 | GO:0003870 | 5-aminolevulinate synthase activity(GO:0003870) N-succinyltransferase activity(GO:0016749) |
| 5.2 | 15.5 | GO:0035730 | S-nitrosoglutathione binding(GO:0035730) dinitrosyl-iron complex binding(GO:0035731) |
| 4.9 | 39.4 | GO:0008379 | thioredoxin peroxidase activity(GO:0008379) |
| 4.9 | 19.5 | GO:0004074 | biliverdin reductase activity(GO:0004074) |
| 4.8 | 29.1 | GO:0038062 | protein tyrosine kinase collagen receptor activity(GO:0038062) |
| 4.6 | 23.0 | GO:0033906 | hyaluronoglucuronidase activity(GO:0033906) |
| 4.5 | 62.5 | GO:0031014 | troponin T binding(GO:0031014) |
| 4.4 | 22.0 | GO:0019834 | phospholipase A2 inhibitor activity(GO:0019834) |
| 4.3 | 13.0 | GO:0004608 | phosphatidyl-N-methylethanolamine N-methyltransferase activity(GO:0000773) phosphatidylethanolamine N-methyltransferase activity(GO:0004608) phosphatidyl-N-dimethylethanolamine N-methyltransferase activity(GO:0080101) |
| 4.3 | 17.1 | GO:0032767 | copper-dependent protein binding(GO:0032767) |
| 4.2 | 25.5 | GO:0044020 | histone methyltransferase activity (H4-R3 specific)(GO:0044020) |
| 4.1 | 16.3 | GO:0070320 | inward rectifier potassium channel inhibitor activity(GO:0070320) |
| 4.0 | 4.0 | GO:0016748 | succinyltransferase activity(GO:0016748) |
| 3.9 | 15.6 | GO:0061714 | folic acid receptor activity(GO:0061714) |
| 3.8 | 11.5 | GO:0033981 | D-dopachrome decarboxylase activity(GO:0033981) |
| 3.8 | 60.7 | GO:1901612 | cardiolipin binding(GO:1901612) |
| 3.7 | 18.6 | GO:0019912 | cyclin-dependent protein kinase activating kinase activity(GO:0019912) |
| 3.6 | 94.9 | GO:0098641 | cadherin binding involved in cell-cell adhesion(GO:0098641) |
| 3.6 | 10.8 | GO:0032089 | NACHT domain binding(GO:0032089) |
| 3.6 | 14.3 | GO:0008177 | succinate dehydrogenase (ubiquinone) activity(GO:0008177) |
| 3.5 | 10.6 | GO:0004056 | argininosuccinate lyase activity(GO:0004056) |
| 3.5 | 10.4 | GO:0070364 | mitochondrial light strand promoter anti-sense binding(GO:0070361) mitochondrial heavy strand promoter anti-sense binding(GO:0070362) mitochondrial heavy strand promoter sense binding(GO:0070364) |
| 3.5 | 17.3 | GO:0033743 | peptide-methionine (R)-S-oxide reductase activity(GO:0033743) |
| 3.4 | 6.9 | GO:0009041 | uridylate kinase activity(GO:0009041) |
| 3.3 | 13.3 | GO:0003883 | CTP synthase activity(GO:0003883) |
| 3.3 | 10.0 | GO:0005055 | laminin receptor activity(GO:0005055) |
| 3.3 | 13.2 | GO:0008475 | procollagen-lysine 5-dioxygenase activity(GO:0008475) procollagen glucosyltransferase activity(GO:0033823) |
| 3.2 | 22.5 | GO:0061133 | endopeptidase activator activity(GO:0061133) |
| 3.2 | 12.9 | GO:0043262 | adenosine-diphosphatase activity(GO:0043262) |
| 3.2 | 19.2 | GO:0034186 | apolipoprotein A-I binding(GO:0034186) |
| 3.2 | 15.9 | GO:0047179 | platelet-activating factor acetyltransferase activity(GO:0047179) |
| 3.1 | 18.8 | GO:0004372 | glycine hydroxymethyltransferase activity(GO:0004372) threonine aldolase activity(GO:0004793) L-allo-threonine aldolase activity(GO:0008732) |
| 3.1 | 15.6 | GO:0004656 | procollagen-proline 4-dioxygenase activity(GO:0004656) |
| 3.1 | 65.4 | GO:0050786 | RAGE receptor binding(GO:0050786) |
| 3.1 | 18.4 | GO:0004301 | epoxide hydrolase activity(GO:0004301) |
| 3.0 | 9.0 | GO:0004766 | spermidine synthase activity(GO:0004766) |
| 3.0 | 9.0 | GO:0004613 | phosphoenolpyruvate carboxykinase activity(GO:0004611) phosphoenolpyruvate carboxykinase (GTP) activity(GO:0004613) |
| 3.0 | 20.8 | GO:0004849 | uridine kinase activity(GO:0004849) |
| 2.9 | 2.9 | GO:0047134 | protein-disulfide reductase activity(GO:0047134) |
| 2.9 | 25.8 | GO:0060228 | phosphatidylcholine-sterol O-acyltransferase activator activity(GO:0060228) |
| 2.8 | 22.6 | GO:1990599 | 3' overhang single-stranded DNA endodeoxyribonuclease activity(GO:1990599) |
| 2.8 | 11.1 | GO:0002060 | purine nucleobase binding(GO:0002060) |
| 2.7 | 24.4 | GO:0036402 | proteasome-activating ATPase activity(GO:0036402) |
| 2.7 | 18.7 | GO:0005497 | androgen binding(GO:0005497) |
| 2.6 | 13.1 | GO:0018479 | benzaldehyde dehydrogenase (NAD+) activity(GO:0018479) |
| 2.6 | 28.8 | GO:0004791 | thioredoxin-disulfide reductase activity(GO:0004791) |
| 2.6 | 10.3 | GO:0005006 | epidermal growth factor-activated receptor activity(GO:0005006) |
| 2.6 | 2.6 | GO:0016419 | [acyl-carrier-protein] S-malonyltransferase activity(GO:0004314) S-malonyltransferase activity(GO:0016419) malonyltransferase activity(GO:0016420) |
| 2.5 | 7.6 | GO:0047115 | phenanthrene 9,10-monooxygenase activity(GO:0018636) ketosteroid monooxygenase activity(GO:0047086) trans-1,2-dihydrobenzene-1,2-diol dehydrogenase activity(GO:0047115) |
| 2.5 | 10.1 | GO:0005169 | neurotrophin TRKB receptor binding(GO:0005169) |
| 2.5 | 20.0 | GO:0015186 | L-glutamine transmembrane transporter activity(GO:0015186) |
| 2.5 | 17.5 | GO:0016403 | dimethylargininase activity(GO:0016403) |
| 2.5 | 7.5 | GO:0000033 | alpha-1,3-mannosyltransferase activity(GO:0000033) |
| 2.5 | 14.8 | GO:0043023 | ribosomal large subunit binding(GO:0043023) |
| 2.4 | 14.7 | GO:0052650 | NADP-retinol dehydrogenase activity(GO:0052650) |
| 2.4 | 9.7 | GO:0004743 | pyruvate kinase activity(GO:0004743) |
| 2.4 | 23.8 | GO:0070492 | oligosaccharide binding(GO:0070492) |
| 2.4 | 9.5 | GO:0004853 | uroporphyrinogen decarboxylase activity(GO:0004853) |
| 2.3 | 11.7 | GO:0043141 | ATP-dependent 5'-3' DNA helicase activity(GO:0043141) |
| 2.3 | 9.4 | GO:0001512 | dihydronicotinamide riboside quinone reductase activity(GO:0001512) melatonin binding(GO:1904408) |
| 2.3 | 49.1 | GO:0008191 | metalloendopeptidase inhibitor activity(GO:0008191) |
| 2.3 | 18.7 | GO:0004308 | exo-alpha-sialidase activity(GO:0004308) alpha-sialidase activity(GO:0016997) |
| 2.3 | 11.6 | GO:0047844 | deoxycytidine deaminase activity(GO:0047844) |
| 2.3 | 9.2 | GO:0019798 | procollagen-proline 3-dioxygenase activity(GO:0019797) procollagen-proline dioxygenase activity(GO:0019798) |
| 2.3 | 9.1 | GO:0005163 | nerve growth factor receptor binding(GO:0005163) |
| 2.3 | 6.8 | GO:0004418 | hydroxymethylbilane synthase activity(GO:0004418) |
| 2.3 | 9.0 | GO:0008413 | 8-oxo-7,8-dihydroguanosine triphosphate pyrophosphatase activity(GO:0008413) 8-oxo-7,8-dihydrodeoxyguanosine triphosphate pyrophosphatase activity(GO:0035539) |
| 2.2 | 13.5 | GO:0032038 | myosin II heavy chain binding(GO:0032038) |
| 2.2 | 13.4 | GO:0016802 | adenosylhomocysteinase activity(GO:0004013) trialkylsulfonium hydrolase activity(GO:0016802) |
| 2.2 | 8.8 | GO:0004748 | ribonucleoside-diphosphate reductase activity, thioredoxin disulfide as acceptor(GO:0004748) oxidoreductase activity, acting on CH or CH2 groups, disulfide as acceptor(GO:0016728) ribonucleoside-diphosphate reductase activity(GO:0061731) |
| 2.2 | 6.5 | GO:0045550 | geranylgeranyl reductase activity(GO:0045550) |
| 2.1 | 14.9 | GO:0001849 | complement component C1q binding(GO:0001849) |
| 2.1 | 25.3 | GO:0031995 | insulin-like growth factor II binding(GO:0031995) |
| 2.1 | 6.2 | GO:0050613 | delta14-sterol reductase activity(GO:0050613) |
| 2.1 | 4.1 | GO:0035373 | chondroitin sulfate proteoglycan binding(GO:0035373) |
| 2.0 | 8.1 | GO:0032810 | sterol response element binding(GO:0032810) |
| 2.0 | 8.0 | GO:0004598 | peptidylglycine monooxygenase activity(GO:0004504) peptidylamidoglycolate lyase activity(GO:0004598) |
| 2.0 | 8.0 | GO:0052595 | tryptamine:oxygen oxidoreductase (deaminating) activity(GO:0052593) aminoacetone:oxygen oxidoreductase(deaminating) activity(GO:0052594) aliphatic-amine oxidase activity(GO:0052595) phenethylamine:oxygen oxidoreductase (deaminating) activity(GO:0052596) |
| 2.0 | 6.0 | GO:0010858 | calcium-dependent protein kinase inhibitor activity(GO:0008427) calcium-dependent protein kinase regulator activity(GO:0010858) |
| 2.0 | 13.7 | GO:0034513 | box H/ACA snoRNA binding(GO:0034513) |
| 2.0 | 5.9 | GO:0031403 | lithium ion binding(GO:0031403) |
| 2.0 | 5.9 | GO:0042947 | glucoside transmembrane transporter activity(GO:0042947) |
| 1.9 | 7.7 | GO:0070404 | NADH binding(GO:0070404) |
| 1.9 | 11.6 | GO:0032190 | acrosin binding(GO:0032190) |
| 1.9 | 17.3 | GO:0089720 | caspase binding(GO:0089720) |
| 1.9 | 5.8 | GO:0015140 | malate transmembrane transporter activity(GO:0015140) |
| 1.9 | 15.2 | GO:0015288 | porin activity(GO:0015288) |
| 1.9 | 5.6 | GO:0035375 | zymogen binding(GO:0035375) |
| 1.8 | 7.4 | GO:0035402 | histone kinase activity (H3-T11 specific)(GO:0035402) |
| 1.8 | 5.5 | GO:0004582 | dolichyl-phosphate beta-D-mannosyltransferase activity(GO:0004582) |
| 1.8 | 21.9 | GO:0004526 | ribonuclease P activity(GO:0004526) |
| 1.8 | 9.1 | GO:0052655 | branched-chain-amino-acid transaminase activity(GO:0004084) L-leucine transaminase activity(GO:0052654) L-valine transaminase activity(GO:0052655) L-isoleucine transaminase activity(GO:0052656) |
| 1.8 | 5.4 | GO:0008426 | protein kinase C inhibitor activity(GO:0008426) |
| 1.8 | 10.8 | GO:0004839 | ubiquitin activating enzyme activity(GO:0004839) |
| 1.8 | 5.4 | GO:0031177 | phosphopantetheine binding(GO:0031177) |
| 1.8 | 7.2 | GO:0051733 | ATP-dependent polydeoxyribonucleotide 5'-hydroxyl-kinase activity(GO:0046404) polydeoxyribonucleotide kinase activity(GO:0051733) ATP-dependent polynucleotide kinase activity(GO:0051734) |
| 1.8 | 5.3 | GO:0030337 | DNA polymerase processivity factor activity(GO:0030337) |
| 1.8 | 8.8 | GO:0070576 | vitamin D 24-hydroxylase activity(GO:0070576) |
| 1.8 | 15.9 | GO:0016206 | catechol O-methyltransferase activity(GO:0016206) |
| 1.8 | 8.8 | GO:0004337 | dimethylallyltranstransferase activity(GO:0004161) geranyltranstransferase activity(GO:0004337) |
| 1.7 | 10.4 | GO:0019238 | cyclohydrolase activity(GO:0019238) |
| 1.7 | 5.2 | GO:0000248 | C-5 sterol desaturase activity(GO:0000248) sterol desaturase activity(GO:0070704) |
| 1.7 | 5.2 | GO:0055077 | gap junction hemi-channel activity(GO:0055077) |
| 1.7 | 8.4 | GO:0016531 | copper chaperone activity(GO:0016531) |
| 1.7 | 50.6 | GO:0070410 | co-SMAD binding(GO:0070410) |
| 1.7 | 6.7 | GO:0046573 | lactonohydrolase activity(GO:0046573) acyl-L-homoserine-lactone lactonohydrolase activity(GO:0102007) |
| 1.7 | 26.7 | GO:0001054 | RNA polymerase I activity(GO:0001054) |
| 1.7 | 11.7 | GO:0046912 | transferase activity, transferring acyl groups, acyl groups converted into alkyl on transfer(GO:0046912) |
| 1.7 | 6.7 | GO:0016971 | flavin-linked sulfhydryl oxidase activity(GO:0016971) thiol oxidase activity(GO:0016972) |
| 1.7 | 3.3 | GO:0016842 | amidine-lyase activity(GO:0016842) |
| 1.7 | 9.9 | GO:0004563 | beta-N-acetylhexosaminidase activity(GO:0004563) |
| 1.6 | 9.8 | GO:1990446 | U1 snRNP binding(GO:1990446) |
| 1.6 | 11.5 | GO:0033170 | DNA clamp loader activity(GO:0003689) protein-DNA loading ATPase activity(GO:0033170) |
| 1.6 | 6.5 | GO:0043515 | kinetochore binding(GO:0043515) |
| 1.6 | 8.0 | GO:0047066 | phospholipid-hydroperoxide glutathione peroxidase activity(GO:0047066) |
| 1.6 | 85.0 | GO:0008137 | NADH dehydrogenase (ubiquinone) activity(GO:0008137) NADH dehydrogenase (quinone) activity(GO:0050136) |
| 1.6 | 11.1 | GO:0032217 | riboflavin transporter activity(GO:0032217) |
| 1.6 | 3.2 | GO:0051870 | methotrexate binding(GO:0051870) |
| 1.6 | 12.6 | GO:0019237 | centromeric DNA binding(GO:0019237) |
| 1.6 | 14.2 | GO:0030621 | U4 snRNA binding(GO:0030621) |
| 1.6 | 7.8 | GO:0031871 | proteinase activated receptor binding(GO:0031871) |
| 1.6 | 4.7 | GO:0034189 | very-low-density lipoprotein particle binding(GO:0034189) |
| 1.6 | 9.3 | GO:0004704 | NF-kappaB-inducing kinase activity(GO:0004704) |
| 1.5 | 72.8 | GO:0061631 | ubiquitin conjugating enzyme activity(GO:0061631) |
| 1.5 | 21.6 | GO:1990459 | transferrin receptor binding(GO:1990459) |
| 1.5 | 21.4 | GO:0032050 | clathrin heavy chain binding(GO:0032050) |
| 1.5 | 4.6 | GO:0010698 | acetyltransferase activator activity(GO:0010698) |
| 1.5 | 3.0 | GO:0004720 | protein-lysine 6-oxidase activity(GO:0004720) |
| 1.5 | 9.1 | GO:0008309 | double-stranded DNA exodeoxyribonuclease activity(GO:0008309) |
| 1.5 | 12.1 | GO:0030292 | protein tyrosine kinase inhibitor activity(GO:0030292) |
| 1.5 | 3.0 | GO:0017057 | 6-phosphogluconolactonase activity(GO:0017057) |
| 1.5 | 12.0 | GO:0015450 | P-P-bond-hydrolysis-driven protein transmembrane transporter activity(GO:0015450) |
| 1.5 | 6.0 | GO:0016717 | oxidoreductase activity, acting on paired donors, with oxidation of a pair of donors resulting in the reduction of molecular oxygen to two molecules of water(GO:0016717) |
| 1.5 | 5.9 | GO:0004001 | adenosine kinase activity(GO:0004001) |
| 1.5 | 41.0 | GO:0017166 | vinculin binding(GO:0017166) |
| 1.5 | 14.6 | GO:1990381 | ubiquitin-specific protease binding(GO:1990381) |
| 1.5 | 132.2 | GO:0008307 | structural constituent of muscle(GO:0008307) |
| 1.5 | 13.1 | GO:0030882 | lipid antigen binding(GO:0030882) endogenous lipid antigen binding(GO:0030883) exogenous lipid antigen binding(GO:0030884) |
| 1.5 | 10.2 | GO:0030267 | hydroxypyruvate reductase activity(GO:0016618) glyoxylate reductase (NADP) activity(GO:0030267) |
| 1.4 | 15.7 | GO:0004332 | fructose-bisphosphate aldolase activity(GO:0004332) |
| 1.4 | 15.7 | GO:0098599 | palmitoyl-(protein) hydrolase activity(GO:0008474) palmitoyl hydrolase activity(GO:0098599) |
| 1.4 | 11.4 | GO:0042731 | PH domain binding(GO:0042731) |
| 1.4 | 14.2 | GO:0004579 | dolichyl-diphosphooligosaccharide-protein glycotransferase activity(GO:0004579) |
| 1.4 | 52.1 | GO:0001972 | retinoic acid binding(GO:0001972) |
| 1.4 | 11.2 | GO:0031994 | insulin-like growth factor I binding(GO:0031994) |
| 1.4 | 43.5 | GO:0004198 | calcium-dependent cysteine-type endopeptidase activity(GO:0004198) |
| 1.4 | 1.4 | GO:0015616 | DNA translocase activity(GO:0015616) |
| 1.4 | 12.6 | GO:0035174 | histone serine kinase activity(GO:0035174) |
| 1.4 | 9.7 | GO:0004514 | nicotinate-nucleotide diphosphorylase (carboxylating) activity(GO:0004514) |
| 1.4 | 1.4 | GO:0034416 | bisphosphoglycerate phosphatase activity(GO:0034416) |
| 1.4 | 4.2 | GO:0033699 | DNA 5'-adenosine monophosphate hydrolase activity(GO:0033699) |
| 1.4 | 5.5 | GO:0048408 | epidermal growth factor binding(GO:0048408) |
| 1.4 | 4.1 | GO:0004165 | dodecenoyl-CoA delta-isomerase activity(GO:0004165) |
| 1.4 | 5.5 | GO:0004090 | carbonyl reductase (NADPH) activity(GO:0004090) |
| 1.4 | 11.0 | GO:0035173 | histone kinase activity(GO:0035173) |
| 1.4 | 4.1 | GO:0060001 | minus-end directed microfilament motor activity(GO:0060001) |
| 1.4 | 6.9 | GO:0004045 | aminoacyl-tRNA hydrolase activity(GO:0004045) |
| 1.4 | 20.5 | GO:0017070 | U6 snRNA binding(GO:0017070) |
| 1.4 | 4.1 | GO:0080023 | 3R-hydroxyacyl-CoA dehydratase activity(GO:0080023) |
| 1.4 | 4.1 | GO:1904599 | advanced glycation end-product binding(GO:1904599) |
| 1.3 | 4.0 | GO:0003896 | DNA primase activity(GO:0003896) |
| 1.3 | 9.4 | GO:0050815 | phosphoserine binding(GO:0050815) |
| 1.3 | 4.0 | GO:0004758 | serine C-palmitoyltransferase activity(GO:0004758) C-palmitoyltransferase activity(GO:0016454) |
| 1.3 | 27.8 | GO:0016864 | protein disulfide isomerase activity(GO:0003756) intramolecular oxidoreductase activity, transposing S-S bonds(GO:0016864) |
| 1.3 | 18.5 | GO:0047372 | acylglycerol lipase activity(GO:0047372) |
| 1.3 | 5.3 | GO:0019828 | aspartic-type endopeptidase inhibitor activity(GO:0019828) |
| 1.3 | 3.9 | GO:0071208 | histone pre-mRNA DCP binding(GO:0071208) |
| 1.3 | 10.5 | GO:0086083 | cell adhesive protein binding involved in bundle of His cell-Purkinje myocyte communication(GO:0086083) |
| 1.3 | 7.9 | GO:0043120 | tumor necrosis factor binding(GO:0043120) |
| 1.3 | 17.0 | GO:0005432 | calcium:sodium antiporter activity(GO:0005432) |
| 1.3 | 1.3 | GO:0046848 | hydroxyapatite binding(GO:0046848) |
| 1.3 | 5.2 | GO:0038132 | neuregulin binding(GO:0038132) |
| 1.3 | 2.6 | GO:0031852 | mu-type opioid receptor binding(GO:0031852) |
| 1.3 | 5.2 | GO:0004909 | interleukin-1, Type I, activating receptor activity(GO:0004909) |
| 1.3 | 12.9 | GO:0001042 | RNA polymerase I core binding(GO:0001042) |
| 1.3 | 3.9 | GO:0050509 | N-acetylglucosaminyl-proteoglycan 4-beta-glucuronosyltransferase activity(GO:0050509) |
| 1.3 | 29.5 | GO:0004550 | nucleoside diphosphate kinase activity(GO:0004550) |
| 1.3 | 5.1 | GO:0001094 | TFIID-class transcription factor binding(GO:0001094) |
| 1.3 | 30.5 | GO:0031369 | translation initiation factor binding(GO:0031369) |
| 1.3 | 5.0 | GO:0015307 | drug:proton antiporter activity(GO:0015307) |
| 1.2 | 13.7 | GO:0051371 | muscle alpha-actinin binding(GO:0051371) |
| 1.2 | 1.2 | GO:0004576 | oligosaccharyl transferase activity(GO:0004576) |
| 1.2 | 19.9 | GO:0016208 | AMP binding(GO:0016208) |
| 1.2 | 5.0 | GO:0004360 | glutamine-fructose-6-phosphate transaminase (isomerizing) activity(GO:0004360) |
| 1.2 | 2.5 | GO:0016418 | S-acetyltransferase activity(GO:0016418) |
| 1.2 | 16.0 | GO:0016290 | palmitoyl-CoA hydrolase activity(GO:0016290) |
| 1.2 | 7.4 | GO:0004735 | pyrroline-5-carboxylate reductase activity(GO:0004735) |
| 1.2 | 135.2 | GO:0005518 | collagen binding(GO:0005518) |
| 1.2 | 2.4 | GO:0047006 | 17-alpha,20-alpha-dihydroxypregn-4-en-3-one dehydrogenase activity(GO:0047006) |
| 1.2 | 3.6 | GO:0003845 | 11-beta-hydroxysteroid dehydrogenase [NAD(P)] activity(GO:0003845) |
| 1.2 | 30.9 | GO:0005527 | macrolide binding(GO:0005527) FK506 binding(GO:0005528) |
| 1.2 | 9.4 | GO:0004784 | superoxide dismutase activity(GO:0004784) oxidoreductase activity, acting on superoxide radicals as acceptor(GO:0016721) |
| 1.2 | 10.6 | GO:0048407 | platelet-derived growth factor binding(GO:0048407) |
| 1.2 | 17.6 | GO:0003688 | DNA replication origin binding(GO:0003688) |
| 1.2 | 1.2 | GO:0034617 | tetrahydrobiopterin binding(GO:0034617) |
| 1.1 | 2.3 | GO:0042609 | CD4 receptor binding(GO:0042609) |
| 1.1 | 11.4 | GO:0070087 | chromo shadow domain binding(GO:0070087) |
| 1.1 | 9.1 | GO:0102338 | fatty acid elongase activity(GO:0009922) 3-oxo-arachidoyl-CoA synthase activity(GO:0102336) 3-oxo-cerotoyl-CoA synthase activity(GO:0102337) 3-oxo-lignoceronyl-CoA synthase activity(GO:0102338) |
| 1.1 | 5.7 | GO:0018812 | 3-hydroxyacyl-CoA dehydratase activity(GO:0018812) |
| 1.1 | 27.3 | GO:0070628 | proteasome binding(GO:0070628) |
| 1.1 | 3.4 | GO:0004345 | glucose-6-phosphate dehydrogenase activity(GO:0004345) |
| 1.1 | 12.3 | GO:1990825 | sequence-specific mRNA binding(GO:1990825) |
| 1.1 | 5.6 | GO:0016453 | C-acetyltransferase activity(GO:0016453) |
| 1.1 | 9.0 | GO:0045545 | syndecan binding(GO:0045545) |
| 1.1 | 5.6 | GO:0061676 | importin-alpha family protein binding(GO:0061676) |
| 1.1 | 4.4 | GO:0004924 | oncostatin-M receptor activity(GO:0004924) |
| 1.1 | 3.3 | GO:0004638 | phosphoribosylaminoimidazole carboxylase activity(GO:0004638) phosphoribosylaminoimidazolesuccinocarboxamide synthase activity(GO:0004639) |
| 1.1 | 8.7 | GO:0015349 | thyroid hormone transmembrane transporter activity(GO:0015349) |
| 1.1 | 3.3 | GO:0030549 | acetylcholine receptor activator activity(GO:0030549) |
| 1.1 | 16.3 | GO:0003993 | acid phosphatase activity(GO:0003993) |
| 1.1 | 4.3 | GO:0060230 | lipoprotein lipase activator activity(GO:0060230) |
| 1.1 | 17.3 | GO:0043236 | laminin binding(GO:0043236) |
| 1.1 | 3.2 | GO:0001002 | polymerase III regulatory region sequence-specific DNA binding(GO:0000992) RNA polymerase III type 1 promoter sequence-specific DNA binding(GO:0001002) RNA polymerase III type 2 promoter sequence-specific DNA binding(GO:0001003) |
| 1.1 | 3.2 | GO:0003923 | GPI-anchor transamidase activity(GO:0003923) |
| 1.1 | 3.2 | GO:0004616 | phosphogluconate dehydrogenase (decarboxylating) activity(GO:0004616) |
| 1.1 | 3.2 | GO:0003858 | 3-hydroxybutyrate dehydrogenase activity(GO:0003858) |
| 1.1 | 20.1 | GO:0035615 | clathrin adaptor activity(GO:0035615) endocytic adaptor activity(GO:0098748) |
| 1.1 | 4.2 | GO:0004466 | long-chain-acyl-CoA dehydrogenase activity(GO:0004466) |
| 1.1 | 6.3 | GO:0016361 | activin receptor activity, type I(GO:0016361) |
| 1.0 | 10.5 | GO:0004030 | aldehyde dehydrogenase [NAD(P)+] activity(GO:0004030) |
| 1.0 | 8.4 | GO:0004996 | thyroid-stimulating hormone receptor activity(GO:0004996) |
| 1.0 | 6.2 | GO:0004614 | phosphoglucomutase activity(GO:0004614) |
| 1.0 | 12.4 | GO:0016174 | NAD(P)H oxidase activity(GO:0016174) |
| 1.0 | 6.2 | GO:0017098 | sulfonylurea receptor binding(GO:0017098) |
| 1.0 | 8.3 | GO:0038085 | vascular endothelial growth factor binding(GO:0038085) |
| 1.0 | 1.0 | GO:0008312 | 7S RNA binding(GO:0008312) |
| 1.0 | 3.1 | GO:0015433 | peptide antigen-transporting ATPase activity(GO:0015433) |
| 1.0 | 14.4 | GO:0004861 | cyclin-dependent protein serine/threonine kinase inhibitor activity(GO:0004861) |
| 1.0 | 28.8 | GO:0004129 | cytochrome-c oxidase activity(GO:0004129) heme-copper terminal oxidase activity(GO:0015002) oxidoreductase activity, acting on a heme group of donors, oxygen as acceptor(GO:0016676) |
| 1.0 | 6.1 | GO:0042392 | sphingosine-1-phosphate phosphatase activity(GO:0042392) |
| 1.0 | 5.1 | GO:0003989 | acetyl-CoA carboxylase activity(GO:0003989) |
| 1.0 | 3.0 | GO:0034736 | sterol O-acyltransferase activity(GO:0004772) cholesterol O-acyltransferase activity(GO:0034736) |
| 1.0 | 6.1 | GO:0004046 | aminoacylase activity(GO:0004046) |
| 1.0 | 4.1 | GO:0005148 | prolactin receptor binding(GO:0005148) |
| 1.0 | 3.0 | GO:0097259 | tocopherol omega-hydroxylase activity(GO:0052870) alpha-tocopherol omega-hydroxylase activity(GO:0052871) 20-hydroxy-leukotriene B4 omega oxidase activity(GO:0097258) 20-aldehyde-leukotriene B4 20-monooxygenase activity(GO:0097259) |
| 1.0 | 1.0 | GO:1902271 | D3 vitamins binding(GO:1902271) |
| 1.0 | 3.0 | GO:0001596 | angiotensin type I receptor activity(GO:0001596) |
| 1.0 | 3.0 | GO:0008106 | alcohol dehydrogenase (NADP+) activity(GO:0008106) |
| 1.0 | 7.0 | GO:0048495 | Roundabout binding(GO:0048495) |
| 1.0 | 7.0 | GO:0097506 | uracil DNA N-glycosylase activity(GO:0004844) deaminated base DNA N-glycosylase activity(GO:0097506) |
| 1.0 | 12.0 | GO:0015129 | lactate transmembrane transporter activity(GO:0015129) |
| 1.0 | 3.0 | GO:0055100 | adiponectin binding(GO:0055100) |
| 1.0 | 3.0 | GO:0060002 | plus-end directed microfilament motor activity(GO:0060002) |
| 1.0 | 3.9 | GO:0008508 | bile acid:sodium symporter activity(GO:0008508) |
| 1.0 | 208.8 | GO:0003735 | structural constituent of ribosome(GO:0003735) |
| 1.0 | 22.2 | GO:0030898 | actin-dependent ATPase activity(GO:0030898) |
| 1.0 | 2.9 | GO:0000064 | L-ornithine transmembrane transporter activity(GO:0000064) |
| 1.0 | 23.0 | GO:0004602 | glutathione peroxidase activity(GO:0004602) |
| 1.0 | 2.9 | GO:0035650 | AP-1 adaptor complex binding(GO:0035650) AP-3 adaptor complex binding(GO:0035651) |
| 1.0 | 39.2 | GO:0003743 | translation initiation factor activity(GO:0003743) |
| 1.0 | 3.8 | GO:0004348 | glucosylceramidase activity(GO:0004348) |
| 1.0 | 20.0 | GO:0001164 | RNA polymerase I regulatory region DNA binding(GO:0001013) RNA polymerase I regulatory region sequence-specific DNA binding(GO:0001163) RNA polymerase I CORE element sequence-specific DNA binding(GO:0001164) |
| 0.9 | 11.4 | GO:0043295 | glutathione binding(GO:0043295) |
| 0.9 | 9.4 | GO:0000340 | RNA 7-methylguanosine cap binding(GO:0000340) |
| 0.9 | 10.4 | GO:0016641 | oxidoreductase activity, acting on the CH-NH2 group of donors, oxygen as acceptor(GO:0016641) |
| 0.9 | 1.9 | GO:0051575 | 5'-deoxyribose-5-phosphate lyase activity(GO:0051575) |
| 0.9 | 1.9 | GO:0038025 | reelin receptor activity(GO:0038025) |
| 0.9 | 2.8 | GO:0051537 | 2 iron, 2 sulfur cluster binding(GO:0051537) |
| 0.9 | 8.4 | GO:0017176 | phosphatidylinositol N-acetylglucosaminyltransferase activity(GO:0017176) |
| 0.9 | 20.4 | GO:0070064 | proline-rich region binding(GO:0070064) |
| 0.9 | 18.5 | GO:0000400 | four-way junction DNA binding(GO:0000400) |
| 0.9 | 5.5 | GO:1990226 | histone methyltransferase binding(GO:1990226) |
| 0.9 | 0.9 | GO:0005017 | platelet-derived growth factor-activated receptor activity(GO:0005017) |
| 0.9 | 24.8 | GO:0030296 | protein tyrosine kinase activator activity(GO:0030296) |
| 0.9 | 0.9 | GO:0005172 | vascular endothelial growth factor receptor binding(GO:0005172) |
| 0.9 | 5.4 | GO:0071253 | connexin binding(GO:0071253) |
| 0.9 | 0.9 | GO:0001007 | transcription factor activity, RNA polymerase III transcription factor binding(GO:0001007) |
| 0.9 | 25.1 | GO:0034236 | protein kinase A catalytic subunit binding(GO:0034236) |
| 0.9 | 3.6 | GO:0004088 | carbamoyl-phosphate synthase (ammonia) activity(GO:0004087) carbamoyl-phosphate synthase (glutamine-hydrolyzing) activity(GO:0004088) |
| 0.9 | 2.7 | GO:0019166 | trans-2-enoyl-CoA reductase (NADPH) activity(GO:0019166) |
| 0.9 | 4.4 | GO:0004122 | cystathionine beta-synthase activity(GO:0004122) |
| 0.9 | 3.6 | GO:0045118 | azole transporter activity(GO:0045118) |
| 0.9 | 14.0 | GO:0008432 | JUN kinase binding(GO:0008432) |
| 0.9 | 4.4 | GO:0004549 | tRNA-specific ribonuclease activity(GO:0004549) |
| 0.9 | 1.7 | GO:0035529 | NADH pyrophosphatase activity(GO:0035529) |
| 0.9 | 2.6 | GO:0080130 | L-phenylalanine:2-oxoglutarate aminotransferase activity(GO:0080130) |
| 0.9 | 2.6 | GO:0015254 | glycerol channel activity(GO:0015254) |
| 0.9 | 12.0 | GO:0008253 | 5'-nucleotidase activity(GO:0008253) |
| 0.9 | 5.1 | GO:0004310 | farnesyl-diphosphate farnesyltransferase activity(GO:0004310) squalene synthase activity(GO:0051996) |
| 0.8 | 341.5 | GO:0045296 | cadherin binding(GO:0045296) |
| 0.8 | 5.8 | GO:0005534 | galactose binding(GO:0005534) |
| 0.8 | 8.3 | GO:0043138 | 3'-5' DNA helicase activity(GO:0043138) |
| 0.8 | 5.0 | GO:0030023 | extracellular matrix constituent conferring elasticity(GO:0030023) |
| 0.8 | 9.9 | GO:0032052 | bile acid binding(GO:0032052) |
| 0.8 | 7.4 | GO:0039706 | co-receptor binding(GO:0039706) |
| 0.8 | 3.3 | GO:0016019 | peptidoglycan receptor activity(GO:0016019) |
| 0.8 | 3.3 | GO:0004687 | myosin light chain kinase activity(GO:0004687) |
| 0.8 | 3.3 | GO:0019107 | glycylpeptide N-tetradecanoyltransferase activity(GO:0004379) myristoyltransferase activity(GO:0019107) |
| 0.8 | 17.1 | GO:0005385 | zinc ion transmembrane transporter activity(GO:0005385) |
| 0.8 | 4.8 | GO:0016725 | oxidoreductase activity, acting on CH or CH2 groups(GO:0016725) |
| 0.8 | 1.6 | GO:0050220 | prostaglandin-E synthase activity(GO:0050220) |
| 0.8 | 4.0 | GO:0004882 | androgen receptor activity(GO:0004882) |
| 0.8 | 3.2 | GO:0004775 | succinate-CoA ligase (ADP-forming) activity(GO:0004775) |
| 0.8 | 4.0 | GO:0016882 | cyclo-ligase activity(GO:0016882) |
| 0.8 | 10.4 | GO:0004029 | aldehyde dehydrogenase (NAD) activity(GO:0004029) |
| 0.8 | 2.4 | GO:0004750 | ribulose-phosphate 3-epimerase activity(GO:0004750) |
| 0.8 | 4.8 | GO:0016918 | retinal binding(GO:0016918) |
| 0.8 | 8.7 | GO:0048027 | mRNA 5'-UTR binding(GO:0048027) |
| 0.8 | 0.8 | GO:0004382 | guanosine-diphosphatase activity(GO:0004382) |
| 0.8 | 0.8 | GO:0004315 | 3-oxoacyl-[acyl-carrier-protein] synthase activity(GO:0004315) |
| 0.8 | 3.1 | GO:0052851 | cupric reductase activity(GO:0008823) ferric-chelate reductase (NADPH) activity(GO:0052851) |
| 0.8 | 3.1 | GO:0043024 | ribosomal small subunit binding(GO:0043024) |
| 0.8 | 4.7 | GO:0000293 | ferric-chelate reductase activity(GO:0000293) |
| 0.8 | 9.3 | GO:0051434 | BH3 domain binding(GO:0051434) |
| 0.8 | 3.0 | GO:0030172 | troponin C binding(GO:0030172) |
| 0.8 | 3.8 | GO:0047374 | methylumbelliferyl-acetate deacetylase activity(GO:0047374) |
| 0.7 | 22.7 | GO:0004003 | ATP-dependent DNA helicase activity(GO:0004003) |
| 0.7 | 2.9 | GO:0015183 | L-aspartate transmembrane transporter activity(GO:0015183) |
| 0.7 | 3.7 | GO:0004392 | heme oxygenase (decyclizing) activity(GO:0004392) |
| 0.7 | 13.8 | GO:0035256 | G-protein coupled glutamate receptor binding(GO:0035256) |
| 0.7 | 2.2 | GO:0008424 | glycoprotein 6-alpha-L-fucosyltransferase activity(GO:0008424) alpha-(1->6)-fucosyltransferase activity(GO:0046921) |
| 0.7 | 7.2 | GO:0032036 | myosin heavy chain binding(GO:0032036) |
| 0.7 | 2.2 | GO:0016822 | hydrolase activity, acting on acid carbon-carbon bonds(GO:0016822) hydrolase activity, acting on acid carbon-carbon bonds, in ketonic substances(GO:0016823) |
| 0.7 | 7.9 | GO:0001968 | fibronectin binding(GO:0001968) |
| 0.7 | 1.4 | GO:0016774 | phosphotransferase activity, carboxyl group as acceptor(GO:0016774) |
| 0.7 | 5.7 | GO:0097643 | amylin receptor activity(GO:0097643) |
| 0.7 | 2.1 | GO:0005176 | ErbB-2 class receptor binding(GO:0005176) |
| 0.7 | 2.1 | GO:0016784 | 3-mercaptopyruvate sulfurtransferase activity(GO:0016784) |
| 0.7 | 4.9 | GO:0005161 | platelet-derived growth factor receptor binding(GO:0005161) |
| 0.7 | 4.2 | GO:0000990 | transcription factor activity, core RNA polymerase binding(GO:0000990) |
| 0.7 | 3.5 | GO:0005157 | macrophage colony-stimulating factor receptor binding(GO:0005157) |
| 0.7 | 13.9 | GO:0008510 | sodium:bicarbonate symporter activity(GO:0008510) |
| 0.7 | 2.8 | GO:0000026 | alpha-1,2-mannosyltransferase activity(GO:0000026) |
| 0.7 | 6.9 | GO:0002151 | G-quadruplex RNA binding(GO:0002151) |
| 0.7 | 2.8 | GO:0030060 | L-malate dehydrogenase activity(GO:0030060) |
| 0.7 | 5.5 | GO:0008569 | ATP-dependent microtubule motor activity, minus-end-directed(GO:0008569) |
| 0.7 | 85.8 | GO:0005178 | integrin binding(GO:0005178) |
| 0.7 | 13.7 | GO:0005337 | nucleoside transmembrane transporter activity(GO:0005337) |
| 0.7 | 3.4 | GO:0005294 | neutral L-amino acid secondary active transmembrane transporter activity(GO:0005294) |
| 0.7 | 5.5 | GO:0031433 | telethonin binding(GO:0031433) |
| 0.7 | 7.5 | GO:0016861 | intramolecular oxidoreductase activity, interconverting aldoses and ketoses(GO:0016861) |
| 0.7 | 5.4 | GO:0008121 | ubiquinol-cytochrome-c reductase activity(GO:0008121) oxidoreductase activity, acting on diphenols and related substances as donors, cytochrome as acceptor(GO:0016681) |
| 0.7 | 6.0 | GO:0004726 | non-membrane spanning protein tyrosine phosphatase activity(GO:0004726) |
| 0.7 | 3.3 | GO:0008889 | glycerophosphodiester phosphodiesterase activity(GO:0008889) |
| 0.7 | 2.0 | GO:0005173 | stem cell factor receptor binding(GO:0005173) |
| 0.7 | 5.9 | GO:0016500 | protein-hormone receptor activity(GO:0016500) |
| 0.7 | 2.0 | GO:0030156 | benzodiazepine receptor binding(GO:0030156) |
| 0.6 | 2.6 | GO:0004739 | pyruvate dehydrogenase (acetyl-transferring) activity(GO:0004739) |
| 0.6 | 14.3 | GO:0001848 | complement binding(GO:0001848) |
| 0.6 | 8.4 | GO:0017017 | MAP kinase tyrosine/serine/threonine phosphatase activity(GO:0017017) |
| 0.6 | 2.6 | GO:0003976 | UDP-N-acetylglucosamine-lysosomal-enzyme N-acetylglucosaminephosphotransferase activity(GO:0003976) |
| 0.6 | 3.9 | GO:0022897 | peptide:proton symporter activity(GO:0015333) proton-dependent peptide secondary active transmembrane transporter activity(GO:0022897) |
| 0.6 | 1.9 | GO:0031753 | endothelial differentiation G-protein coupled receptor binding(GO:0031753) Edg-2 lysophosphatidic acid receptor binding(GO:0031755) |
| 0.6 | 19.9 | GO:0051059 | NF-kappaB binding(GO:0051059) |
| 0.6 | 0.6 | GO:0033549 | MAP kinase phosphatase activity(GO:0033549) |
| 0.6 | 2.5 | GO:0004852 | uroporphyrinogen-III synthase activity(GO:0004852) |
| 0.6 | 3.8 | GO:0015057 | thrombin receptor activity(GO:0015057) |
| 0.6 | 26.6 | GO:0008138 | protein tyrosine/serine/threonine phosphatase activity(GO:0008138) |
| 0.6 | 1.9 | GO:0004862 | cAMP-dependent protein kinase inhibitor activity(GO:0004862) |
| 0.6 | 6.9 | GO:0019966 | interleukin-1 binding(GO:0019966) |
| 0.6 | 3.8 | GO:0048185 | activin binding(GO:0048185) |
| 0.6 | 0.6 | GO:0031432 | titin binding(GO:0031432) RNA polymerase II sequence-specific DNA binding transcription factor binding(GO:0061629) |
| 0.6 | 24.8 | GO:0009055 | electron carrier activity(GO:0009055) |
| 0.6 | 19.0 | GO:0031492 | nucleosomal DNA binding(GO:0031492) |
| 0.6 | 3.0 | GO:0004126 | cytidine deaminase activity(GO:0004126) |
| 0.6 | 5.9 | GO:0001135 | transcription factor activity, RNA polymerase II transcription factor recruiting(GO:0001135) |
| 0.6 | 2.9 | GO:0003920 | GMP reductase activity(GO:0003920) oxidoreductase activity, acting on NAD(P)H, nitrogenous group as acceptor(GO:0016657) |
| 0.6 | 2.3 | GO:0046933 | proton-transporting ATP synthase activity, rotational mechanism(GO:0046933) |
| 0.6 | 1.7 | GO:0005459 | UDP-galactose transmembrane transporter activity(GO:0005459) |
| 0.6 | 26.9 | GO:0050699 | WW domain binding(GO:0050699) |
| 0.6 | 7.8 | GO:0031386 | protein tag(GO:0031386) |
| 0.6 | 2.2 | GO:0004630 | phospholipase D activity(GO:0004630) |
| 0.6 | 0.6 | GO:0031544 | peptidyl-proline 3-dioxygenase activity(GO:0031544) |
| 0.6 | 3.3 | GO:0047057 | oxidoreductase activity, acting on the CH-OH group of donors, disulfide as acceptor(GO:0016900) vitamin-K-epoxide reductase (warfarin-sensitive) activity(GO:0047057) |
| 0.6 | 2.2 | GO:0004706 | JUN kinase kinase kinase activity(GO:0004706) |
| 0.6 | 5.0 | GO:0016846 | carbon-sulfur lyase activity(GO:0016846) |
| 0.5 | 3.3 | GO:0005047 | signal recognition particle binding(GO:0005047) |
| 0.5 | 12.5 | GO:0070003 | threonine-type endopeptidase activity(GO:0004298) threonine-type peptidase activity(GO:0070003) |
| 0.5 | 1.6 | GO:0004958 | prostaglandin F receptor activity(GO:0004958) |
| 0.5 | 3.2 | GO:0045029 | UDP-activated nucleotide receptor activity(GO:0045029) |
| 0.5 | 11.8 | GO:0008242 | omega peptidase activity(GO:0008242) |
| 0.5 | 8.0 | GO:0043522 | leucine zipper domain binding(GO:0043522) |
| 0.5 | 1.6 | GO:0008431 | vitamin E binding(GO:0008431) |
| 0.5 | 42.2 | GO:0005201 | extracellular matrix structural constituent(GO:0005201) |
| 0.5 | 4.8 | GO:0050431 | transforming growth factor beta binding(GO:0050431) |
| 0.5 | 3.2 | GO:0016435 | rRNA (guanine) methyltransferase activity(GO:0016435) |
| 0.5 | 5.3 | GO:0009982 | pseudouridine synthase activity(GO:0009982) |
| 0.5 | 4.8 | GO:0016628 | oxidoreductase activity, acting on the CH-CH group of donors, NAD or NADP as acceptor(GO:0016628) |
| 0.5 | 1.6 | GO:0042020 | interleukin-23 binding(GO:0042019) interleukin-23 receptor activity(GO:0042020) |
| 0.5 | 5.2 | GO:0070878 | primary miRNA binding(GO:0070878) |
| 0.5 | 1.5 | GO:0015226 | amino-acid betaine transmembrane transporter activity(GO:0015199) carnitine transmembrane transporter activity(GO:0015226) |
| 0.5 | 14.9 | GO:0017056 | structural constituent of nuclear pore(GO:0017056) |
| 0.5 | 1.0 | GO:0030548 | acetylcholine receptor regulator activity(GO:0030548) neurotransmitter receptor regulator activity(GO:0099602) |
| 0.5 | 2.5 | GO:0004663 | Rab geranylgeranyltransferase activity(GO:0004663) |
| 0.5 | 2.0 | GO:0030628 | pre-mRNA 3'-splice site binding(GO:0030628) |
| 0.5 | 1.0 | GO:0051011 | microtubule minus-end binding(GO:0051011) |
| 0.5 | 1.5 | GO:0070984 | SET domain binding(GO:0070984) |
| 0.5 | 1.5 | GO:0043546 | molybdopterin cofactor binding(GO:0043546) |
| 0.5 | 1.5 | GO:0098821 | BMP receptor activity(GO:0098821) |
| 0.5 | 6.4 | GO:0001730 | 2'-5'-oligoadenylate synthetase activity(GO:0001730) |
| 0.5 | 1.5 | GO:0016309 | 1-phosphatidylinositol-5-phosphate 4-kinase activity(GO:0016309) |
| 0.5 | 1.0 | GO:0016715 | oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, reduced ascorbate as one donor, and incorporation of one atom of oxygen(GO:0016715) |
| 0.5 | 1.9 | GO:1904929 | coreceptor activity involved in Wnt signaling pathway, planar cell polarity pathway(GO:1904929) |
| 0.5 | 1.9 | GO:0004925 | prolactin receptor activity(GO:0004925) |
| 0.5 | 2.4 | GO:0008479 | queuine tRNA-ribosyltransferase activity(GO:0008479) |
| 0.5 | 1.5 | GO:0070568 | guanylyltransferase activity(GO:0070568) |
| 0.5 | 3.4 | GO:0042799 | histone methyltransferase activity (H4-K20 specific)(GO:0042799) |
| 0.5 | 4.3 | GO:0004745 | retinol dehydrogenase activity(GO:0004745) |
| 0.5 | 1.4 | GO:0003860 | 3-hydroxyisobutyryl-CoA hydrolase activity(GO:0003860) |
| 0.5 | 0.5 | GO:0004566 | beta-glucuronidase activity(GO:0004566) |
| 0.5 | 1.4 | GO:0031731 | CCR6 chemokine receptor binding(GO:0031731) |
| 0.5 | 2.8 | GO:0010997 | anaphase-promoting complex binding(GO:0010997) |
| 0.5 | 0.9 | GO:0086075 | gap junction channel activity involved in cardiac conduction electrical coupling(GO:0086075) |
| 0.5 | 1.4 | GO:0050501 | hyaluronan synthase activity(GO:0050501) |
| 0.5 | 2.8 | GO:0016015 | morphogen activity(GO:0016015) |
| 0.5 | 1.8 | GO:0005412 | glucose:sodium symporter activity(GO:0005412) |
| 0.5 | 2.3 | GO:0004991 | parathyroid hormone receptor activity(GO:0004991) |
| 0.5 | 3.2 | GO:0004797 | thymidine kinase activity(GO:0004797) |
| 0.5 | 16.3 | GO:0005044 | scavenger receptor activity(GO:0005044) |
| 0.5 | 6.3 | GO:0031489 | myosin V binding(GO:0031489) |
| 0.5 | 2.3 | GO:0034714 | type III transforming growth factor beta receptor binding(GO:0034714) |
| 0.5 | 4.1 | GO:0030976 | thiamine pyrophosphate binding(GO:0030976) |
| 0.5 | 1.8 | GO:0047708 | biotinidase activity(GO:0047708) |
| 0.4 | 1.8 | GO:0045569 | TRAIL binding(GO:0045569) |
| 0.4 | 4.5 | GO:0003857 | 3-hydroxyacyl-CoA dehydrogenase activity(GO:0003857) |
| 0.4 | 3.1 | GO:0008454 | alpha-1,3-mannosylglycoprotein 4-beta-N-acetylglucosaminyltransferase activity(GO:0008454) |
| 0.4 | 1.8 | GO:0005499 | vitamin D binding(GO:0005499) |
| 0.4 | 11.3 | GO:0008574 | ATP-dependent microtubule motor activity, plus-end-directed(GO:0008574) |
| 0.4 | 1.7 | GO:0030492 | hemoglobin binding(GO:0030492) |
| 0.4 | 8.2 | GO:0008301 | DNA binding, bending(GO:0008301) |
| 0.4 | 2.6 | GO:0000179 | rRNA (adenine-N6,N6-)-dimethyltransferase activity(GO:0000179) |
| 0.4 | 1.3 | GO:0008553 | hydrogen-exporting ATPase activity, phosphorylative mechanism(GO:0008553) |
| 0.4 | 3.8 | GO:0003831 | beta-N-acetylglucosaminylglycopeptide beta-1,4-galactosyltransferase activity(GO:0003831) |
| 0.4 | 2.6 | GO:0050291 | sphingosine N-acyltransferase activity(GO:0050291) |
| 0.4 | 0.8 | GO:0031694 | alpha-2A adrenergic receptor binding(GO:0031694) |
| 0.4 | 0.8 | GO:0070653 | high-density lipoprotein particle receptor binding(GO:0070653) |
| 0.4 | 4.6 | GO:0019869 | chloride channel inhibitor activity(GO:0019869) |
| 0.4 | 13.9 | GO:0005109 | frizzled binding(GO:0005109) |
| 0.4 | 1.7 | GO:0004749 | ribose phosphate diphosphokinase activity(GO:0004749) |
| 0.4 | 8.8 | GO:0031491 | nucleosome binding(GO:0031491) |
| 0.4 | 0.4 | GO:0051731 | polynucleotide 5'-hydroxyl-kinase activity(GO:0051731) |
| 0.4 | 2.1 | GO:0000339 | RNA cap binding(GO:0000339) |
| 0.4 | 0.4 | GO:0004833 | tryptophan 2,3-dioxygenase activity(GO:0004833) |
| 0.4 | 5.4 | GO:0070567 | cytidylyltransferase activity(GO:0070567) |
| 0.4 | 14.5 | GO:0008143 | poly(A) binding(GO:0008143) |
| 0.4 | 3.3 | GO:0004111 | creatine kinase activity(GO:0004111) |
| 0.4 | 4.1 | GO:0042056 | chemoattractant activity(GO:0042056) |
| 0.4 | 0.8 | GO:0004146 | dihydrofolate reductase activity(GO:0004146) |
| 0.4 | 36.5 | GO:0004867 | serine-type endopeptidase inhibitor activity(GO:0004867) |
| 0.4 | 5.2 | GO:0042975 | peroxisome proliferator activated receptor binding(GO:0042975) |
| 0.4 | 1.2 | GO:0060422 | peptidyl-dipeptidase inhibitor activity(GO:0060422) |
| 0.4 | 3.6 | GO:0045236 | CXCR chemokine receptor binding(GO:0045236) |
| 0.4 | 4.4 | GO:0055103 | ligase regulator activity(GO:0055103) |
| 0.4 | 1.2 | GO:0004961 | thromboxane receptor activity(GO:0004960) thromboxane A2 receptor activity(GO:0004961) |
| 0.4 | 2.4 | GO:0050543 | icosatetraenoic acid binding(GO:0050543) |
| 0.4 | 1.6 | GO:0015111 | iodide transmembrane transporter activity(GO:0015111) |
| 0.4 | 3.5 | GO:0019215 | intermediate filament binding(GO:0019215) |
| 0.4 | 0.8 | GO:0019206 | nucleoside kinase activity(GO:0019206) |
| 0.4 | 1.2 | GO:1990050 | phosphatidic acid transporter activity(GO:1990050) |
| 0.4 | 2.3 | GO:0004523 | RNA-DNA hybrid ribonuclease activity(GO:0004523) |
| 0.4 | 1.9 | GO:0016004 | phospholipase activator activity(GO:0016004) |
| 0.4 | 0.4 | GO:0047787 | delta4-3-oxosteroid 5beta-reductase activity(GO:0047787) |
| 0.4 | 3.0 | GO:1990829 | C-rich single-stranded DNA binding(GO:1990829) |
| 0.4 | 1.9 | GO:0004800 | thyroxine 5'-deiodinase activity(GO:0004800) |
| 0.4 | 8.6 | GO:0004812 | aminoacyl-tRNA ligase activity(GO:0004812) ligase activity, forming carbon-oxygen bonds(GO:0016875) ligase activity, forming aminoacyl-tRNA and related compounds(GO:0016876) |
| 0.4 | 2.6 | GO:0016167 | glial cell-derived neurotrophic factor receptor activity(GO:0016167) |
| 0.4 | 97.8 | GO:0004252 | serine-type endopeptidase activity(GO:0004252) |
| 0.4 | 18.6 | GO:0019212 | phosphatase inhibitor activity(GO:0019212) |
| 0.4 | 39.2 | GO:0020037 | heme binding(GO:0020037) |
| 0.4 | 0.7 | GO:0070905 | serine binding(GO:0070905) |
| 0.4 | 2.6 | GO:0016868 | intramolecular transferase activity, phosphotransferases(GO:0016868) |
| 0.4 | 3.3 | GO:0046703 | natural killer cell lectin-like receptor binding(GO:0046703) |
| 0.4 | 1.1 | GO:0042289 | MHC class II protein binding(GO:0042289) |
| 0.4 | 1.5 | GO:0016404 | 15-hydroxyprostaglandin dehydrogenase (NAD+) activity(GO:0016404) |
| 0.4 | 5.8 | GO:0045505 | dynein intermediate chain binding(GO:0045505) |
| 0.4 | 1.4 | GO:0016230 | sphingomyelin phosphodiesterase activator activity(GO:0016230) |
| 0.4 | 2.5 | GO:0036435 | K48-linked polyubiquitin binding(GO:0036435) |
| 0.4 | 1.1 | GO:0004937 | alpha1-adrenergic receptor activity(GO:0004937) |
| 0.4 | 0.4 | GO:0004461 | lactose synthase activity(GO:0004461) |
| 0.4 | 1.4 | GO:0005520 | insulin-like growth factor binding(GO:0005520) |
| 0.3 | 1.4 | GO:0003963 | RNA-3'-phosphate cyclase activity(GO:0003963) |
| 0.3 | 5.6 | GO:0008179 | adenylate cyclase binding(GO:0008179) |
| 0.3 | 1.0 | GO:0005219 | ryanodine-sensitive calcium-release channel activity(GO:0005219) calcium-induced calcium release activity(GO:0048763) |
| 0.3 | 0.3 | GO:0051429 | corticotropin-releasing hormone receptor binding(GO:0051429) corticotropin-releasing hormone receptor 1 binding(GO:0051430) |
| 0.3 | 2.8 | GO:0030284 | estrogen receptor activity(GO:0030284) |
| 0.3 | 36.8 | GO:0008201 | heparin binding(GO:0008201) |
| 0.3 | 2.1 | GO:0035613 | RNA stem-loop binding(GO:0035613) |
| 0.3 | 11.7 | GO:0043021 | ribonucleoprotein complex binding(GO:0043021) |
| 0.3 | 6.2 | GO:0097602 | cullin family protein binding(GO:0097602) |
| 0.3 | 13.7 | GO:0003730 | mRNA 3'-UTR binding(GO:0003730) |
| 0.3 | 2.1 | GO:0060698 | endoribonuclease inhibitor activity(GO:0060698) |
| 0.3 | 1.7 | GO:0004066 | asparagine synthase (glutamine-hydrolyzing) activity(GO:0004066) |
| 0.3 | 1.4 | GO:0008428 | ribonuclease inhibitor activity(GO:0008428) |
| 0.3 | 3.0 | GO:0015125 | bile acid transmembrane transporter activity(GO:0015125) |
| 0.3 | 2.0 | GO:0034235 | GPI anchor binding(GO:0034235) |
| 0.3 | 1.0 | GO:0004980 | melanocyte-stimulating hormone receptor activity(GO:0004980) |
| 0.3 | 2.3 | GO:0016775 | phosphotransferase activity, nitrogenous group as acceptor(GO:0016775) |
| 0.3 | 6.9 | GO:0005487 | nucleocytoplasmic transporter activity(GO:0005487) |
| 0.3 | 2.6 | GO:0008494 | translation activator activity(GO:0008494) |
| 0.3 | 2.6 | GO:0045499 | chemorepellent activity(GO:0045499) |
| 0.3 | 5.3 | GO:0044213 | intronic transcription regulatory region sequence-specific DNA binding(GO:0001161) intronic transcription regulatory region DNA binding(GO:0044213) |
| 0.3 | 1.6 | GO:0050833 | pyruvate transmembrane transporter activity(GO:0050833) |
| 0.3 | 13.7 | GO:0050681 | androgen receptor binding(GO:0050681) |
| 0.3 | 1.3 | GO:0004906 | interferon-gamma receptor activity(GO:0004906) |
| 0.3 | 2.9 | GO:0050692 | DBD domain binding(GO:0050692) |
| 0.3 | 4.5 | GO:0045295 | gamma-catenin binding(GO:0045295) |
| 0.3 | 1.6 | GO:0016744 | transferase activity, transferring aldehyde or ketonic groups(GO:0016744) |
| 0.3 | 8.6 | GO:0044183 | protein binding involved in protein folding(GO:0044183) |
| 0.3 | 3.1 | GO:0043495 | protein anchor(GO:0043495) |
| 0.3 | 5.6 | GO:0017025 | TBP-class protein binding(GO:0017025) |
| 0.3 | 3.7 | GO:0019534 | toxin transporter activity(GO:0019534) |
| 0.3 | 2.4 | GO:0045159 | myosin II binding(GO:0045159) |
| 0.3 | 5.5 | GO:0016018 | cyclosporin A binding(GO:0016018) |
| 0.3 | 3.0 | GO:0005149 | interleukin-1 receptor binding(GO:0005149) |
| 0.3 | 2.7 | GO:0035251 | UDP-glucosyltransferase activity(GO:0035251) |
| 0.3 | 3.0 | GO:0051428 | peptide hormone receptor binding(GO:0051428) |
| 0.3 | 2.4 | GO:0016273 | arginine N-methyltransferase activity(GO:0016273) protein-arginine N-methyltransferase activity(GO:0016274) |
| 0.3 | 1.8 | GO:0003872 | 6-phosphofructokinase activity(GO:0003872) |
| 0.3 | 1.5 | GO:0008332 | low voltage-gated calcium channel activity(GO:0008332) |
| 0.3 | 4.1 | GO:0019870 | potassium channel inhibitor activity(GO:0019870) |
| 0.3 | 0.9 | GO:0036033 | mediator complex binding(GO:0036033) |
| 0.3 | 2.6 | GO:0001056 | RNA polymerase III activity(GO:0001056) |
| 0.3 | 1.7 | GO:0030942 | endoplasmic reticulum signal peptide binding(GO:0030942) |
| 0.3 | 8.4 | GO:0051183 | vitamin transporter activity(GO:0051183) |
| 0.3 | 4.5 | GO:0070182 | DNA polymerase binding(GO:0070182) |
| 0.3 | 2.2 | GO:0005000 | vasopressin receptor activity(GO:0005000) |
| 0.3 | 4.1 | GO:0042813 | Wnt-activated receptor activity(GO:0042813) |
| 0.3 | 1.3 | GO:0016934 | extracellular-glycine-gated ion channel activity(GO:0016933) extracellular-glycine-gated chloride channel activity(GO:0016934) |
| 0.3 | 4.3 | GO:0034237 | protein kinase A regulatory subunit binding(GO:0034237) |
| 0.3 | 2.7 | GO:0016421 | CoA carboxylase activity(GO:0016421) |
| 0.3 | 11.8 | GO:0005154 | epidermal growth factor receptor binding(GO:0005154) |
| 0.3 | 2.1 | GO:0004322 | ferroxidase activity(GO:0004322) oxidoreductase activity, oxidizing metal ions, oxygen as acceptor(GO:0016724) |
| 0.3 | 6.1 | GO:0030331 | estrogen receptor binding(GO:0030331) |
| 0.3 | 1.8 | GO:0047429 | nucleoside-triphosphate diphosphatase activity(GO:0047429) |
| 0.3 | 1.3 | GO:0097603 | temperature-gated ion channel activity(GO:0097603) |
| 0.3 | 0.8 | GO:0080019 | fatty-acyl-CoA reductase (alcohol-forming) activity(GO:0080019) |
| 0.3 | 2.6 | GO:0008171 | O-methyltransferase activity(GO:0008171) |
| 0.3 | 5.7 | GO:0070006 | metalloaminopeptidase activity(GO:0070006) |
| 0.3 | 1.3 | GO:0004300 | enoyl-CoA hydratase activity(GO:0004300) |
| 0.3 | 12.7 | GO:0097472 | cyclin-dependent protein kinase activity(GO:0097472) |
| 0.3 | 6.9 | GO:0000993 | RNA polymerase II core binding(GO:0000993) |
| 0.3 | 2.8 | GO:0033038 | bitter taste receptor activity(GO:0033038) |
| 0.3 | 1.0 | GO:0008160 | protein tyrosine phosphatase activator activity(GO:0008160) |
| 0.2 | 6.0 | GO:0051721 | protein phosphatase 2A binding(GO:0051721) |
| 0.2 | 1.0 | GO:0016524 | latrotoxin receptor activity(GO:0016524) |
| 0.2 | 1.0 | GO:0001134 | transcription factor activity, transcription factor recruiting(GO:0001134) |
| 0.2 | 1.5 | GO:1904264 | ubiquitin protein ligase activity involved in ERAD pathway(GO:1904264) |
| 0.2 | 1.9 | GO:0044548 | S100 protein binding(GO:0044548) |
| 0.2 | 2.2 | GO:0019211 | phosphatase activator activity(GO:0019211) |
| 0.2 | 4.8 | GO:0003785 | actin monomer binding(GO:0003785) |
| 0.2 | 1.7 | GO:0051400 | BH domain binding(GO:0051400) |
| 0.2 | 4.7 | GO:0071855 | neuropeptide receptor binding(GO:0071855) |
| 0.2 | 0.7 | GO:0005072 | transforming growth factor beta receptor, cytoplasmic mediator activity(GO:0005072) |
| 0.2 | 1.8 | GO:0030275 | LRR domain binding(GO:0030275) |
| 0.2 | 0.5 | GO:1990948 | ligase inhibitor activity(GO:0055104) ubiquitin ligase inhibitor activity(GO:1990948) |
| 0.2 | 8.0 | GO:0042379 | chemokine receptor binding(GO:0042379) |
| 0.2 | 0.9 | GO:0008097 | 5S rRNA binding(GO:0008097) |
| 0.2 | 0.4 | GO:0022850 | serotonin-gated cation channel activity(GO:0022850) |
| 0.2 | 16.0 | GO:0019003 | GDP binding(GO:0019003) |
| 0.2 | 0.7 | GO:0016624 | oxidoreductase activity, acting on the aldehyde or oxo group of donors, disulfide as acceptor(GO:0016624) |
| 0.2 | 1.8 | GO:0050694 | galactosylceramide sulfotransferase activity(GO:0001733) galactose 3-O-sulfotransferase activity(GO:0050694) |
| 0.2 | 0.7 | GO:0008336 | gamma-butyrobetaine dioxygenase activity(GO:0008336) |
| 0.2 | 1.7 | GO:0070569 | uridylyltransferase activity(GO:0070569) |
| 0.2 | 2.2 | GO:0017128 | phospholipid scramblase activity(GO:0017128) |
| 0.2 | 2.2 | GO:0010314 | phosphatidylinositol-5-phosphate binding(GO:0010314) |
| 0.2 | 1.9 | GO:0046790 | virion binding(GO:0046790) |
| 0.2 | 0.6 | GO:0005011 | macrophage colony-stimulating factor receptor activity(GO:0005011) |
| 0.2 | 0.4 | GO:0003958 | NADPH-hemoprotein reductase activity(GO:0003958) |
| 0.2 | 0.6 | GO:0004024 | alcohol dehydrogenase activity, zinc-dependent(GO:0004024) |
| 0.2 | 2.1 | GO:1990247 | N6-methyladenosine-containing RNA binding(GO:1990247) |
| 0.2 | 0.8 | GO:0004102 | choline O-acetyltransferase activity(GO:0004102) |
| 0.2 | 0.8 | GO:0016427 | tRNA (cytosine) methyltransferase activity(GO:0016427) |
| 0.2 | 0.8 | GO:0034185 | apolipoprotein binding(GO:0034185) |
| 0.2 | 0.6 | GO:0002113 | interleukin-33 binding(GO:0002113) |
| 0.2 | 1.0 | GO:0008073 | ornithine decarboxylase inhibitor activity(GO:0008073) |
| 0.2 | 2.0 | GO:0042809 | vitamin D receptor binding(GO:0042809) |
| 0.2 | 83.5 | GO:0005198 | structural molecule activity(GO:0005198) |
| 0.2 | 2.2 | GO:0008187 | poly-pyrimidine tract binding(GO:0008187) |
| 0.2 | 0.6 | GO:0050510 | N-acetylgalactosaminyl-proteoglycan 3-beta-glucuronosyltransferase activity(GO:0050510) |
| 0.2 | 0.2 | GO:0004167 | dopachrome isomerase activity(GO:0004167) |
| 0.2 | 0.4 | GO:0031685 | adenosine receptor binding(GO:0031685) |
| 0.2 | 1.0 | GO:0015165 | pyrimidine nucleotide-sugar transmembrane transporter activity(GO:0015165) |
| 0.2 | 6.6 | GO:0015464 | acetylcholine receptor activity(GO:0015464) |
| 0.2 | 0.2 | GO:0016866 | intramolecular transferase activity(GO:0016866) |
| 0.2 | 25.7 | GO:0005125 | cytokine activity(GO:0005125) |
| 0.2 | 0.8 | GO:0015315 | hexose phosphate transmembrane transporter activity(GO:0015119) organophosphate:inorganic phosphate antiporter activity(GO:0015315) hexose-phosphate:inorganic phosphate antiporter activity(GO:0015526) glucose 6-phosphate:inorganic phosphate antiporter activity(GO:0061513) |
| 0.2 | 6.7 | GO:0017091 | AU-rich element binding(GO:0017091) |
| 0.2 | 0.9 | GO:0004995 | tachykinin receptor activity(GO:0004995) |
| 0.2 | 0.5 | GO:0004531 | deoxyribonuclease II activity(GO:0004531) |
| 0.2 | 0.9 | GO:0005094 | Rho GDP-dissociation inhibitor activity(GO:0005094) |
| 0.2 | 2.7 | GO:0009931 | calcium-dependent protein serine/threonine kinase activity(GO:0009931) |
| 0.2 | 1.3 | GO:0004977 | melanocortin receptor activity(GO:0004977) |
| 0.2 | 1.4 | GO:0030546 | receptor activator activity(GO:0030546) |
| 0.2 | 0.5 | GO:0016262 | protein N-acetylglucosaminyltransferase activity(GO:0016262) |
| 0.2 | 0.4 | GO:0016838 | carbon-oxygen lyase activity, acting on phosphates(GO:0016838) |
| 0.2 | 1.2 | GO:0046906 | tetrapyrrole binding(GO:0046906) |
| 0.2 | 7.7 | GO:0001105 | RNA polymerase II transcription coactivator activity(GO:0001105) |
| 0.2 | 0.9 | GO:0019531 | oxalate transmembrane transporter activity(GO:0019531) |
| 0.2 | 1.2 | GO:0005160 | transforming growth factor beta receptor binding(GO:0005160) |
| 0.2 | 0.5 | GO:0019150 | D-ribulokinase activity(GO:0019150) |
| 0.2 | 0.3 | GO:0050145 | nucleoside phosphate kinase activity(GO:0050145) |
| 0.2 | 1.8 | GO:0051378 | amine binding(GO:0043176) serotonin binding(GO:0051378) |
| 0.2 | 0.5 | GO:0004117 | calmodulin-dependent cyclic-nucleotide phosphodiesterase activity(GO:0004117) |
| 0.2 | 1.3 | GO:0042165 | neurotransmitter binding(GO:0042165) |
| 0.2 | 1.0 | GO:0010465 | nerve growth factor receptor activity(GO:0010465) |
| 0.2 | 4.8 | GO:0005123 | death receptor binding(GO:0005123) |
| 0.2 | 2.1 | GO:0005159 | insulin-like growth factor receptor binding(GO:0005159) |
| 0.2 | 1.1 | GO:0015101 | organic cation transmembrane transporter activity(GO:0015101) |
| 0.2 | 0.6 | GO:0035033 | histone deacetylase regulator activity(GO:0035033) |
| 0.2 | 0.3 | GO:0004104 | cholinesterase activity(GO:0004104) |
| 0.2 | 1.1 | GO:0008109 | N-acetyllactosaminide beta-1,6-N-acetylglucosaminyltransferase activity(GO:0008109) |
| 0.2 | 1.5 | GO:0016783 | sulfurtransferase activity(GO:0016783) |
| 0.2 | 0.5 | GO:0061649 | ubiquitinated histone binding(GO:0061649) |
| 0.2 | 3.0 | GO:0004806 | triglyceride lipase activity(GO:0004806) |
| 0.2 | 1.4 | GO:0004969 | histamine receptor activity(GO:0004969) |
| 0.1 | 0.4 | GO:0004060 | arylamine N-acetyltransferase activity(GO:0004060) |
| 0.1 | 7.0 | GO:0035035 | histone acetyltransferase binding(GO:0035035) |
| 0.1 | 0.4 | GO:0019862 | IgA binding(GO:0019862) |
| 0.1 | 0.1 | GO:0097108 | hedgehog family protein binding(GO:0097108) |
| 0.1 | 0.8 | GO:0004897 | ciliary neurotrophic factor receptor activity(GO:0004897) |
| 0.1 | 0.1 | GO:0015556 | C4-dicarboxylate transmembrane transporter activity(GO:0015556) |
| 0.1 | 0.4 | GO:0047223 | beta-1,3-galactosyl-O-glycosyl-glycoprotein beta-1,3-N-acetylglucosaminyltransferase activity(GO:0047223) |
| 0.1 | 0.9 | GO:0001075 | transcription factor activity, RNA polymerase II core promoter sequence-specific binding involved in preinitiation complex assembly(GO:0001075) |
| 0.1 | 1.4 | GO:0016538 | cyclin-dependent protein serine/threonine kinase regulator activity(GO:0016538) |
| 0.1 | 0.5 | GO:0047298 | 4-aminobutyrate transaminase activity(GO:0003867) succinate-semialdehyde dehydrogenase binding(GO:0032145) (S)-3-amino-2-methylpropionate transaminase activity(GO:0047298) |
| 0.1 | 0.4 | GO:0005124 | scavenger receptor binding(GO:0005124) |
| 0.1 | 0.4 | GO:0004357 | glutamate-cysteine ligase activity(GO:0004357) |
| 0.1 | 0.5 | GO:0008158 | hedgehog receptor activity(GO:0008158) |
| 0.1 | 1.4 | GO:0070034 | telomerase RNA binding(GO:0070034) |
| 0.1 | 1.0 | GO:0005243 | gap junction channel activity(GO:0005243) |
| 0.1 | 0.4 | GO:0005042 | netrin receptor activity(GO:0005042) |
| 0.1 | 0.4 | GO:0005519 | cytoskeletal regulatory protein binding(GO:0005519) |
| 0.1 | 3.0 | GO:0003887 | DNA-directed DNA polymerase activity(GO:0003887) |
| 0.1 | 0.5 | GO:0048406 | nerve growth factor binding(GO:0048406) |
| 0.1 | 0.7 | GO:0017060 | 3-galactosyl-N-acetylglucosaminide 4-alpha-L-fucosyltransferase activity(GO:0017060) |
| 0.1 | 0.6 | GO:0008483 | transaminase activity(GO:0008483) |
| 0.1 | 2.1 | GO:0000049 | tRNA binding(GO:0000049) |
| 0.1 | 1.2 | GO:0047760 | butyrate-CoA ligase activity(GO:0047760) |
| 0.1 | 0.2 | GO:0097199 | cysteine-type endopeptidase activity involved in apoptotic signaling pathway(GO:0097199) |
| 0.1 | 0.4 | GO:0061769 | ribosylnicotinamide kinase activity(GO:0050262) ribosylnicotinate kinase activity(GO:0061769) |
| 0.1 | 0.2 | GO:0008384 | IkappaB kinase activity(GO:0008384) |
| 0.1 | 0.8 | GO:0000268 | peroxisome targeting sequence binding(GO:0000268) |
| 0.1 | 1.5 | GO:0000030 | mannosyltransferase activity(GO:0000030) |
| 0.1 | 0.4 | GO:0004769 | steroid delta-isomerase activity(GO:0004769) |
| 0.1 | 0.1 | GO:0016433 | rRNA (adenine) methyltransferase activity(GO:0016433) |
| 0.1 | 0.7 | GO:0071949 | FAD binding(GO:0071949) |
| 0.1 | 2.0 | GO:0016702 | oxidoreductase activity, acting on single donors with incorporation of molecular oxygen, incorporation of two atoms of oxygen(GO:0016702) |
| 0.1 | 0.3 | GO:0050567 | glutaminyl-tRNA synthase (glutamine-hydrolyzing) activity(GO:0050567) |
| 0.1 | 0.3 | GO:0004473 | malic enzyme activity(GO:0004470) malate dehydrogenase (decarboxylating) (NAD+) activity(GO:0004471) malate dehydrogenase (decarboxylating) (NADP+) activity(GO:0004473) oxaloacetate decarboxylase activity(GO:0008948) |
| 0.1 | 0.2 | GO:0070735 | protein-glycine ligase activity(GO:0070735) |
| 0.1 | 0.5 | GO:0097016 | L27 domain binding(GO:0097016) |
| 0.1 | 0.4 | GO:0000014 | single-stranded DNA endodeoxyribonuclease activity(GO:0000014) |
| 0.1 | 0.8 | GO:0060072 | large conductance calcium-activated potassium channel activity(GO:0060072) |
| 0.1 | 0.5 | GO:0005024 | transforming growth factor beta-activated receptor activity(GO:0005024) transforming growth factor beta receptor activity, type I(GO:0005025) |
| 0.1 | 1.4 | GO:0016667 | oxidoreductase activity, acting on a sulfur group of donors(GO:0016667) |
| 0.1 | 0.3 | GO:0035312 | 5'-3' exodeoxyribonuclease activity(GO:0035312) |
| 0.1 | 0.1 | GO:0000253 | 3-keto sterol reductase activity(GO:0000253) |
| 0.1 | 1.4 | GO:0010485 | H4 histone acetyltransferase activity(GO:0010485) |
| 0.1 | 2.1 | GO:0030742 | GTP-dependent protein binding(GO:0030742) |
| 0.1 | 1.3 | GO:0016709 | oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, NAD(P)H as one donor, and incorporation of one atom of oxygen(GO:0016709) |
| 0.1 | 0.6 | GO:0050682 | AF-2 domain binding(GO:0050682) |
| 0.1 | 0.4 | GO:0046923 | ER retention sequence binding(GO:0046923) |
| 0.1 | 0.2 | GO:0004556 | alpha-amylase activity(GO:0004556) |
| 0.1 | 2.4 | GO:0047555 | 3',5'-cyclic-GMP phosphodiesterase activity(GO:0047555) |
| 0.1 | 0.2 | GO:0036505 | prosaposin receptor activity(GO:0036505) |
| 0.1 | 0.8 | GO:0004985 | opioid receptor activity(GO:0004985) |
| 0.1 | 0.4 | GO:0004692 | cGMP-dependent protein kinase activity(GO:0004692) |
| 0.1 | 0.8 | GO:0004065 | arylsulfatase activity(GO:0004065) |
| 0.1 | 0.1 | GO:0036312 | phosphatidylinositol 3-kinase regulatory subunit binding(GO:0036312) |
| 0.1 | 0.3 | GO:0015056 | corticotrophin-releasing factor receptor activity(GO:0015056) |
| 0.1 | 3.9 | GO:0051117 | ATPase binding(GO:0051117) |
| 0.1 | 2.0 | GO:0008536 | Ran GTPase binding(GO:0008536) |
| 0.1 | 0.4 | GO:0004035 | alkaline phosphatase activity(GO:0004035) |
| 0.1 | 0.4 | GO:0031434 | mitogen-activated protein kinase kinase binding(GO:0031434) |
| 0.1 | 0.2 | GO:0047288 | monosialoganglioside sialyltransferase activity(GO:0047288) |
| 0.1 | 1.4 | GO:0051539 | 4 iron, 4 sulfur cluster binding(GO:0051539) |
| 0.1 | 0.1 | GO:0002054 | nucleobase binding(GO:0002054) |
| 0.1 | 3.1 | GO:0008083 | growth factor activity(GO:0008083) |
| 0.1 | 2.1 | GO:0016765 | transferase activity, transferring alkyl or aryl (other than methyl) groups(GO:0016765) |
| 0.1 | 2.8 | GO:0051082 | unfolded protein binding(GO:0051082) |
| 0.1 | 0.5 | GO:0030371 | translation repressor activity(GO:0030371) |
| 0.1 | 0.3 | GO:0004064 | arylesterase activity(GO:0004064) |
| 0.0 | 1.2 | GO:0001671 | ATPase activator activity(GO:0001671) |
| 0.0 | 0.5 | GO:0017134 | fibroblast growth factor binding(GO:0017134) |
| 0.0 | 0.2 | GO:0017150 | tRNA dihydrouridine synthase activity(GO:0017150) |
| 0.0 | 0.0 | GO:0001758 | retinal dehydrogenase activity(GO:0001758) |
| 0.0 | 0.2 | GO:0003827 | alpha-1,3-mannosylglycoprotein 2-beta-N-acetylglucosaminyltransferase activity(GO:0003827) |
| 0.0 | 0.6 | GO:0031210 | phosphatidylcholine binding(GO:0031210) |
| 0.0 | 0.3 | GO:0005131 | growth hormone receptor binding(GO:0005131) |
| 0.0 | 0.2 | GO:0004887 | thyroid hormone receptor activity(GO:0004887) |
| 0.0 | 0.1 | GO:0003960 | NADPH:quinone reductase activity(GO:0003960) |
| 0.0 | 0.1 | GO:0004679 | AMP-activated protein kinase activity(GO:0004679) |
| 0.0 | 0.3 | GO:0022841 | potassium ion leak channel activity(GO:0022841) |
| 0.0 | 5.9 | GO:0003924 | GTPase activity(GO:0003924) |
| 0.0 | 0.1 | GO:0032139 | dinucleotide insertion or deletion binding(GO:0032139) |
| 0.0 | 0.4 | GO:0015245 | fatty acid transporter activity(GO:0015245) |
| 0.0 | 0.1 | GO:0004047 | aminomethyltransferase activity(GO:0004047) |
| 0.0 | 0.0 | GO:0004910 | interleukin-1, Type II, blocking receptor activity(GO:0004910) |
| 0.0 | 0.0 | GO:0032422 | purine-rich negative regulatory element binding(GO:0032422) |
| 0.0 | 0.0 | GO:0015065 | uridine nucleotide receptor activity(GO:0015065) G-protein coupled pyrimidinergic nucleotide receptor activity(GO:0071553) |
| 0.0 | 0.2 | GO:0004767 | sphingomyelin phosphodiesterase activity(GO:0004767) |
| 0.0 | 0.3 | GO:0035497 | cAMP response element binding(GO:0035497) |
| 0.0 | 0.0 | GO:0004945 | angiotensin receptor activity(GO:0001595) angiotensin type II receptor activity(GO:0004945) |
| 0.0 | 0.1 | GO:0017151 | DEAD/H-box RNA helicase binding(GO:0017151) |
| 0.0 | 0.1 | GO:0044729 | hemi-methylated DNA-binding(GO:0044729) |
| 0.0 | 0.1 | GO:0005004 | GPI-linked ephrin receptor activity(GO:0005004) |
| 0.0 | 0.1 | GO:0004568 | chitinase activity(GO:0004568) chitin binding(GO:0008061) |
Gene overrepresentation in curated gene sets: canonical pathways category:
| Log-likelihood per target | Total log-likelihood | Term | Description |
|---|---|---|---|
| 2.6 | 70.9 | PID ARF 3PATHWAY | Arf1 pathway |
| 2.5 | 35.5 | SA G2 AND M PHASES | Cdc25 activates the cdc2/cyclin B complex to induce the G2/M transition. |
| 2.5 | 47.7 | PID INTEGRIN4 PATHWAY | Alpha6 beta4 integrin-ligand interactions |
| 1.9 | 140.4 | PID FOXM1 PATHWAY | FOXM1 transcription factor network |
| 1.8 | 160.4 | PID INTEGRIN1 PATHWAY | Beta1 integrin cell surface interactions |
| 1.2 | 34.8 | PID DNA PK PATHWAY | DNA-PK pathway in nonhomologous end joining |
| 1.2 | 46.1 | PID ATR PATHWAY | ATR signaling pathway |
| 1.1 | 89.5 | PID ECADHERIN STABILIZATION PATHWAY | Stabilization and expansion of the E-cadherin adherens junction |
| 1.1 | 31.8 | PID HDAC CLASSIII PATHWAY | Signaling events mediated by HDAC Class III |
| 1.1 | 31.7 | PID PRL SIGNALING EVENTS PATHWAY | Signaling events mediated by PRL |
| 1.1 | 43.6 | PID ALK1 PATHWAY | ALK1 signaling events |
| 1.1 | 60.9 | PID A6B1 A6B4 INTEGRIN PATHWAY | a6b1 and a6b4 Integrin signaling |
| 1.1 | 41.3 | PID SYNDECAN 1 PATHWAY | Syndecan-1-mediated signaling events |
| 1.1 | 6.4 | PID RETINOIC ACID PATHWAY | Retinoic acid receptors-mediated signaling |
| 1.0 | 63.3 | PID PLK1 PATHWAY | PLK1 signaling events |
| 1.0 | 32.7 | PID BARD1 PATHWAY | BARD1 signaling events |
| 0.9 | 116.6 | PID MYC ACTIV PATHWAY | Validated targets of C-MYC transcriptional activation |
| 0.9 | 237.6 | NABA ECM REGULATORS | Genes encoding enzymes and their regulators involved in the remodeling of the extracellular matrix |
| 0.8 | 31.1 | PID AURORA B PATHWAY | Aurora B signaling |
| 0.8 | 16.6 | SA PROGRAMMED CELL DEATH | Programmed cell death, or apoptosis, eliminates damaged or unneeded cells. |
| 0.8 | 18.8 | PID SYNDECAN 2 PATHWAY | Syndecan-2-mediated signaling events |
| 0.8 | 0.8 | ST GAQ PATHWAY | G alpha q Pathway |
| 0.8 | 3.8 | PID PI3K PLC TRK PATHWAY | Trk receptor signaling mediated by PI3K and PLC-gamma |
| 0.8 | 21.1 | PID AURORA A PATHWAY | Aurora A signaling |
| 0.8 | 46.6 | PID DELTA NP63 PATHWAY | Validated transcriptional targets of deltaNp63 isoforms |
| 0.7 | 44.8 | PID HNF3B PATHWAY | FOXA2 and FOXA3 transcription factor networks |
| 0.7 | 125.0 | NABA ECM GLYCOPROTEINS | Genes encoding structural ECM glycoproteins |
| 0.7 | 8.6 | NABA BASEMENT MEMBRANES | Genes encoding structural components of basement membranes |
| 0.7 | 32.6 | PID RET PATHWAY | Signaling events regulated by Ret tyrosine kinase |
| 0.7 | 21.4 | PID AVB3 OPN PATHWAY | Osteopontin-mediated events |
| 0.7 | 51.2 | PID E2F PATHWAY | E2F transcription factor network |
| 0.7 | 1.3 | ST JAK STAT PATHWAY | Jak-STAT Pathway |
| 0.7 | 6.5 | PID ERBB NETWORK PATHWAY | ErbB receptor signaling network |
| 0.6 | 29.1 | PID PS1 PATHWAY | Presenilin action in Notch and Wnt signaling |
| 0.6 | 8.8 | PID VEGF VEGFR PATHWAY | VEGF and VEGFR signaling network |
| 0.6 | 20.9 | PID LIS1 PATHWAY | Lissencephaly gene (LIS1) in neuronal migration and development |
| 0.6 | 0.6 | PID INTEGRIN CS PATHWAY | Integrin family cell surface interactions |
| 0.6 | 2.8 | PID EPHA2 FWD PATHWAY | EPHA2 forward signaling |
| 0.6 | 5.0 | SA G1 AND S PHASES | Cdk2, 4, and 6 bind cyclin D in G1, while cdk2/cyclin E promotes the G1/S transition. |
| 0.6 | 96.0 | NABA ECM AFFILIATED | Genes encoding proteins affiliated structurally or functionally to extracellular matrix proteins |
| 0.5 | 26.9 | PID BMP PATHWAY | BMP receptor signaling |
| 0.5 | 0.5 | SA TRKA RECEPTOR | The TrkA receptor binds nerve growth factor to activate MAP kinase pathways and promote cell growth. |
| 0.5 | 15.1 | PID ERB GENOMIC PATHWAY | Validated nuclear estrogen receptor beta network |
| 0.5 | 11.8 | PID PTP1B PATHWAY | Signaling events mediated by PTP1B |
| 0.5 | 21.5 | PID RHOA PATHWAY | RhoA signaling pathway |
| 0.5 | 37.1 | PID CASPASE PATHWAY | Caspase cascade in apoptosis |
| 0.5 | 23.3 | PID TAP63 PATHWAY | Validated transcriptional targets of TAp63 isoforms |
| 0.5 | 21.9 | PID HNF3A PATHWAY | FOXA1 transcription factor network |
| 0.4 | 15.6 | PID CERAMIDE PATHWAY | Ceramide signaling pathway |
| 0.4 | 31.1 | PID SMAD2 3NUCLEAR PATHWAY | Regulation of nuclear SMAD2/3 signaling |
| 0.4 | 14.6 | PID TGFBR PATHWAY | TGF-beta receptor signaling |
| 0.4 | 15.8 | PID P53 REGULATION PATHWAY | p53 pathway |
| 0.4 | 18.1 | PID P38 ALPHA BETA DOWNSTREAM PATHWAY | Signaling mediated by p38-alpha and p38-beta |
| 0.3 | 8.6 | PID AJDISS 2PATHWAY | Posttranslational regulation of adherens junction stability and dissassembly |
| 0.3 | 109.6 | NABA SECRETED FACTORS | Genes encoding secreted soluble factors |
| 0.3 | 4.4 | ST G ALPHA S PATHWAY | G alpha s Pathway |
| 0.3 | 4.2 | PID CIRCADIAN PATHWAY | Circadian rhythm pathway |
| 0.3 | 8.6 | PID MAPK TRK PATHWAY | Trk receptor signaling mediated by the MAPK pathway |
| 0.3 | 4.4 | SA FAS SIGNALING | The TNF-type receptor Fas induces apoptosis on ligand binding. |
| 0.3 | 11.8 | PID RXR VDR PATHWAY | RXR and RAR heterodimerization with other nuclear receptor |
| 0.3 | 0.6 | PID ALK2 PATHWAY | ALK2 signaling events |
| 0.3 | 1.8 | PID TRAIL PATHWAY | TRAIL signaling pathway |
| 0.3 | 22.3 | PID CDC42 PATHWAY | CDC42 signaling events |
| 0.3 | 9.7 | PID ILK PATHWAY | Integrin-linked kinase signaling |
| 0.3 | 3.1 | PID FOXO PATHWAY | FoxO family signaling |
| 0.3 | 2.3 | PID VEGFR1 PATHWAY | VEGFR1 specific signals |
| 0.2 | 6.5 | PID IL1 PATHWAY | IL1-mediated signaling events |
| 0.2 | 0.7 | PID AR NONGENOMIC PATHWAY | Nongenotropic Androgen signaling |
| 0.2 | 2.5 | PID ANGIOPOIETIN RECEPTOR PATHWAY | Angiopoietin receptor Tie2-mediated signaling |
| 0.2 | 2.0 | PID NEPHRIN NEPH1 PATHWAY | Nephrin/Neph1 signaling in the kidney podocyte |
| 0.2 | 12.2 | WNT SIGNALING | Genes related to Wnt-mediated signal transduction |
| 0.2 | 10.7 | PID P73PATHWAY | p73 transcription factor network |
| 0.2 | 7.7 | PID VEGFR1 2 PATHWAY | Signaling events mediated by VEGFR1 and VEGFR2 |
| 0.2 | 1.0 | ST MYOCYTE AD PATHWAY | Myocyte Adrenergic Pathway is a specific case of the generalized Adrenergic Pathway. |
| 0.2 | 7.7 | PID HDAC CLASSII PATHWAY | Signaling events mediated by HDAC Class II |
| 0.2 | 1.9 | PID INSULIN GLUCOSE PATHWAY | Insulin-mediated glucose transport |
| 0.2 | 3.5 | ST WNT BETA CATENIN PATHWAY | Wnt/beta-catenin Pathway |
| 0.2 | 7.4 | PID CDC42 REG PATHWAY | Regulation of CDC42 activity |
| 0.2 | 4.6 | SIG REGULATION OF THE ACTIN CYTOSKELETON BY RHO GTPASES | Genes related to regulation of the actin cytoskeleton |
| 0.1 | 0.6 | SA B CELL RECEPTOR COMPLEXES | Antigen binding to B cell receptors activates protein tyrosine kinases, such as the Src family, which ultimate activate MAP kinases. |
| 0.1 | 2.4 | PID RAC1 PATHWAY | RAC1 signaling pathway |
| 0.1 | 3.4 | PID CONE PATHWAY | Visual signal transduction: Cones |
| 0.1 | 2.3 | PID HEDGEHOG 2PATHWAY | Signaling events mediated by the Hedgehog family |
| 0.1 | 0.6 | PID WNT NONCANONICAL PATHWAY | Noncanonical Wnt signaling pathway |
| 0.1 | 1.4 | PID PI3KCI AKT PATHWAY | Class I PI3K signaling events mediated by Akt |
| 0.1 | 0.4 | PID P38 ALPHA BETA PATHWAY | Regulation of p38-alpha and p38-beta |
| 0.1 | 4.7 | PID ERA GENOMIC PATHWAY | Validated nuclear estrogen receptor alpha network |
| 0.1 | 2.4 | PID FRA PATHWAY | Validated transcriptional targets of AP1 family members Fra1 and Fra2 |
| 0.1 | 0.9 | PID HIF1A PATHWAY | Hypoxic and oxygen homeostasis regulation of HIF-1-alpha |
| 0.1 | 3.1 | ST B CELL ANTIGEN RECEPTOR | B Cell Antigen Receptor |
| 0.1 | 0.4 | PID SYNDECAN 4 PATHWAY | Syndecan-4-mediated signaling events |
| 0.1 | 4.4 | PID NFAT TFPATHWAY | Calcineurin-regulated NFAT-dependent transcription in lymphocytes |
| 0.1 | 0.8 | PID NECTIN PATHWAY | Nectin adhesion pathway |
| 0.1 | 0.3 | ST GA13 PATHWAY | G alpha 13 Pathway |
| 0.1 | 0.3 | PID NFKAPPAB ATYPICAL PATHWAY | Atypical NF-kappaB pathway |
| 0.1 | 0.8 | PID EPHA FWDPATHWAY | EPHA forward signaling |
| 0.1 | 0.2 | PID IGF1 PATHWAY | IGF1 pathway |
| 0.0 | 1.0 | PID FAK PATHWAY | Signaling events mediated by focal adhesion kinase |
| 0.0 | 0.4 | ST P38 MAPK PATHWAY | p38 MAPK Pathway |
| 0.0 | 0.6 | PID ERBB1 RECEPTOR PROXIMAL PATHWAY | EGF receptor (ErbB1) signaling pathway |
| 0.0 | 0.2 | SIG PIP3 SIGNALING IN CARDIAC MYOCTES | Genes related to PIP3 signaling in cardiac myocytes |
Gene overrepresentation in curated gene sets: REACTOME pathways category:
| Log-likelihood per target | Total log-likelihood | Term | Description |
|---|---|---|---|
| 3.9 | 50.2 | REACTOME E2F ENABLED INHIBITION OF PRE REPLICATION COMPLEX FORMATION | Genes involved in E2F-enabled inhibition of pre-replication complex formation |
| 3.7 | 7.4 | REACTOME CDK MEDIATED PHOSPHORYLATION AND REMOVAL OF CDC6 | Genes involved in CDK-mediated phosphorylation and removal of Cdc6 |
| 3.0 | 98.3 | REACTOME SYNTHESIS AND INTERCONVERSION OF NUCLEOTIDE DI AND TRIPHOSPHATES | Genes involved in Synthesis and interconversion of nucleotide di- and triphosphates |
| 2.9 | 44.2 | REACTOME UNWINDING OF DNA | Genes involved in Unwinding of DNA |
| 2.5 | 27.5 | REACTOME CREATION OF C4 AND C2 ACTIVATORS | Genes involved in Creation of C4 and C2 activators |
| 2.3 | 55.7 | REACTOME HYALURONAN UPTAKE AND DEGRADATION | Genes involved in Hyaluronan uptake and degradation |
| 2.3 | 68.4 | REACTOME METABOLISM OF PORPHYRINS | Genes involved in Metabolism of porphyrins |
| 2.2 | 13.5 | REACTOME APC CDC20 MEDIATED DEGRADATION OF NEK2A | Genes involved in APC-Cdc20 mediated degradation of Nek2A |
| 2.2 | 139.9 | REACTOME STRIATED MUSCLE CONTRACTION | Genes involved in Striated Muscle Contraction |
| 2.1 | 84.1 | REACTOME DEGRADATION OF THE EXTRACELLULAR MATRIX | Genes involved in Degradation of the extracellular matrix |
| 2.0 | 36.1 | REACTOME REPAIR SYNTHESIS FOR GAP FILLING BY DNA POL IN TC NER | Genes involved in Repair synthesis for gap-filling by DNA polymerase in TC-NER |
| 1.9 | 34.7 | REACTOME SCFSKP2 MEDIATED DEGRADATION OF P27 P21 | Genes involved in SCF(Skp2)-mediated degradation of p27/p21 |
| 1.9 | 5.6 | REACTOME CDT1 ASSOCIATION WITH THE CDC6 ORC ORIGIN COMPLEX | Genes involved in CDT1 association with the CDC6:ORC:origin complex |
| 1.6 | 37.7 | REACTOME VIRAL MESSENGER RNA SYNTHESIS | Genes involved in Viral Messenger RNA Synthesis |
| 1.6 | 158.2 | REACTOME APC C CDH1 MEDIATED DEGRADATION OF CDC20 AND OTHER APC C CDH1 TARGETED PROTEINS IN LATE MITOSIS EARLY G1 | Genes involved in APC/C:Cdh1 mediated degradation of Cdc20 and other APC/C:Cdh1 targeted proteins in late mitosis/early G1 |
| 1.6 | 41.1 | REACTOME HORMONE SENSITIVE LIPASE HSL MEDIATED TRIACYLGLYCEROL HYDROLYSIS | Genes involved in Hormone-sensitive lipase (HSL)-mediated triacylglycerol hydrolysis |
| 1.6 | 102.4 | REACTOME GLUCONEOGENESIS | Genes involved in Gluconeogenesis |
| 1.5 | 131.7 | REACTOME RESPIRATORY ELECTRON TRANSPORT | Genes involved in Respiratory electron transport |
| 1.5 | 98.9 | REACTOME EXTRACELLULAR MATRIX ORGANIZATION | Genes involved in Extracellular matrix organization |
| 1.5 | 32.1 | REACTOME HDL MEDIATED LIPID TRANSPORT | Genes involved in HDL-mediated lipid transport |
| 1.5 | 40.6 | REACTOME KINESINS | Genes involved in Kinesins |
| 1.4 | 40.7 | REACTOME MRNA SPLICING MINOR PATHWAY | Genes involved in mRNA Splicing - Minor Pathway |
| 1.4 | 18.1 | REACTOME SIGNALING BY NOTCH3 | Genes involved in Signaling by NOTCH3 |
| 1.4 | 35.8 | REACTOME RETROGRADE NEUROTROPHIN SIGNALLING | Genes involved in Retrograde neurotrophin signalling |
| 1.4 | 10.8 | REACTOME RECYCLING PATHWAY OF L1 | Genes involved in Recycling pathway of L1 |
| 1.3 | 62.0 | REACTOME DOWNREGULATION OF SMAD2 3 SMAD4 TRANSCRIPTIONAL ACTIVITY | Genes involved in Downregulation of SMAD2/3:SMAD4 transcriptional activity |
| 1.3 | 42.9 | REACTOME FORMATION OF TUBULIN FOLDING INTERMEDIATES BY CCT TRIC | Genes involved in Formation of tubulin folding intermediates by CCT/TriC |
| 1.3 | 26.2 | REACTOME EXTENSION OF TELOMERES | Genes involved in Extension of Telomeres |
| 1.3 | 12.9 | REACTOME GAP JUNCTION DEGRADATION | Genes involved in Gap junction degradation |
| 1.3 | 171.0 | REACTOME CELL JUNCTION ORGANIZATION | Genes involved in Cell junction organization |
| 1.2 | 26.1 | REACTOME REGULATION OF INSULIN LIKE GROWTH FACTOR IGF ACTIVITY BY INSULIN LIKE GROWTH FACTOR BINDING PROTEINS IGFBPS | Genes involved in Regulation of Insulin-like Growth Factor (IGF) Activity by Insulin-like Growth Factor Binding Proteins (IGFBPs) |
| 1.2 | 47.3 | REACTOME PYRIMIDINE METABOLISM | Genes involved in Pyrimidine metabolism |
| 1.2 | 22.9 | REACTOME CYCLIN A B1 ASSOCIATED EVENTS DURING G2 M TRANSITION | Genes involved in Cyclin A/B1 associated events during G2/M transition |
| 1.2 | 32.0 | REACTOME SIGNALING BY HIPPO | Genes involved in Signaling by Hippo |
| 1.2 | 9.3 | REACTOME INITIAL TRIGGERING OF COMPLEMENT | Genes involved in Initial triggering of complement |
| 1.2 | 11.6 | REACTOME REGULATION OF ORNITHINE DECARBOXYLASE ODC | Genes involved in Regulation of ornithine decarboxylase (ODC) |
| 1.2 | 27.8 | REACTOME GLUCURONIDATION | Genes involved in Glucuronidation |
| 1.1 | 16.1 | REACTOME P130CAS LINKAGE TO MAPK SIGNALING FOR INTEGRINS | Genes involved in p130Cas linkage to MAPK signaling for integrins |
| 1.1 | 54.1 | REACTOME PYRUVATE METABOLISM AND CITRIC ACID TCA CYCLE | Genes involved in Pyruvate metabolism and Citric Acid (TCA) cycle |
| 1.1 | 59.1 | REACTOME MITOCHONDRIAL PROTEIN IMPORT | Genes involved in Mitochondrial Protein Import |
| 1.0 | 81.0 | REACTOME PHASE II CONJUGATION | Genes involved in Phase II conjugation |
| 1.0 | 3.1 | REACTOME AUTODEGRADATION OF THE E3 UBIQUITIN LIGASE COP1 | Genes involved in Autodegradation of the E3 ubiquitin ligase COP1 |
| 1.0 | 14.2 | REACTOME NEF MEDIATED DOWNREGULATION OF MHC CLASS I COMPLEX CELL SURFACE EXPRESSION | Genes involved in Nef mediated downregulation of MHC class I complex cell surface expression |
| 1.0 | 6.0 | REACTOME ABORTIVE ELONGATION OF HIV1 TRANSCRIPT IN THE ABSENCE OF TAT | Genes involved in Abortive elongation of HIV-1 transcript in the absence of Tat |
| 1.0 | 20.8 | REACTOME DEPOSITION OF NEW CENPA CONTAINING NUCLEOSOMES AT THE CENTROMERE | Genes involved in Deposition of New CENPA-containing Nucleosomes at the Centromere |
| 1.0 | 17.6 | REACTOME ZINC TRANSPORTERS | Genes involved in Zinc transporters |
| 1.0 | 45.7 | REACTOME METABOLISM OF NON CODING RNA | Genes involved in Metabolism of non-coding RNA |
| 0.9 | 14.9 | REACTOME TRANSCRIPTIONAL REGULATION OF WHITE ADIPOCYTE DIFFERENTIATION | Genes involved in Transcriptional Regulation of White Adipocyte Differentiation |
| 0.9 | 14.0 | REACTOME PURINE RIBONUCLEOSIDE MONOPHOSPHATE BIOSYNTHESIS | Genes involved in Purine ribonucleoside monophosphate biosynthesis |
| 0.9 | 15.6 | REACTOME VEGF LIGAND RECEPTOR INTERACTIONS | Genes involved in VEGF ligand-receptor interactions |
| 0.9 | 10.0 | REACTOME S PHASE | Genes involved in S Phase |
| 0.9 | 8.9 | REACTOME INTERACTIONS OF VPR WITH HOST CELLULAR PROTEINS | Genes involved in Interactions of Vpr with host cellular proteins |
| 0.9 | 36.2 | REACTOME MUSCLE CONTRACTION | Genes involved in Muscle contraction |
| 0.9 | 35.2 | REACTOME CHOLESTEROL BIOSYNTHESIS | Genes involved in Cholesterol biosynthesis |
| 0.9 | 21.9 | REACTOME GLOBAL GENOMIC NER GG NER | Genes involved in Global Genomic NER (GG-NER) |
| 0.9 | 28.3 | REACTOME DOWNREGULATION OF ERBB2 ERBB3 SIGNALING | Genes involved in Downregulation of ERBB2:ERBB3 signaling |
| 0.8 | 27.9 | REACTOME POST TRANSLATIONAL MODIFICATION SYNTHESIS OF GPI ANCHORED PROTEINS | Genes involved in Post-translational modification: synthesis of GPI-anchored proteins |
| 0.8 | 7.6 | REACTOME CYTOSOLIC TRNA AMINOACYLATION | Genes involved in Cytosolic tRNA aminoacylation |
| 0.8 | 19.9 | REACTOME ASSOCIATION OF TRIC CCT WITH TARGET PROTEINS DURING BIOSYNTHESIS | Genes involved in Association of TriC/CCT with target proteins during biosynthesis |
| 0.8 | 13.2 | REACTOME ACTIVATION OF GENES BY ATF4 | Genes involved in Activation of Genes by ATF4 |
| 0.8 | 17.1 | REACTOME ENDOSOMAL SORTING COMPLEX REQUIRED FOR TRANSPORT ESCRT | Genes involved in Endosomal Sorting Complex Required For Transport (ESCRT) |
| 0.8 | 5.6 | REACTOME APOPTOTIC CLEAVAGE OF CELL ADHESION PROTEINS | Genes involved in Apoptotic cleavage of cell adhesion proteins |
| 0.8 | 14.3 | REACTOME MTORC1 MEDIATED SIGNALLING | Genes involved in mTORC1-mediated signalling |
| 0.8 | 13.5 | REACTOME METABOLISM OF POLYAMINES | Genes involved in Metabolism of polyamines |
| 0.8 | 92.7 | REACTOME RESPONSE TO ELEVATED PLATELET CYTOSOLIC CA2 | Genes involved in Response to elevated platelet cytosolic Ca2+ |
| 0.8 | 15.6 | REACTOME SIGNAL ATTENUATION | Genes involved in Signal attenuation |
| 0.8 | 0.8 | REACTOME NEP NS2 INTERACTS WITH THE CELLULAR EXPORT MACHINERY | Genes involved in NEP/NS2 Interacts with the Cellular Export Machinery |
| 0.8 | 16.2 | REACTOME LIPID DIGESTION MOBILIZATION AND TRANSPORT | Genes involved in Lipid digestion, mobilization, and transport |
| 0.8 | 15.4 | REACTOME TGF BETA RECEPTOR SIGNALING ACTIVATES SMADS | Genes involved in TGF-beta receptor signaling activates SMADs |
| 0.8 | 3.1 | REACTOME NEGATIVE REGULATION OF THE PI3K AKT NETWORK | Genes involved in Negative regulation of the PI3K/AKT network |
| 0.8 | 8.3 | REACTOME COPI MEDIATED TRANSPORT | Genes involved in COPI Mediated Transport |
| 0.8 | 12.8 | REACTOME MITOCHONDRIAL FATTY ACID BETA OXIDATION | Genes involved in Mitochondrial Fatty Acid Beta-Oxidation |
| 0.7 | 8.2 | REACTOME ACTIVATION OF CHAPERONE GENES BY ATF6 ALPHA | Genes involved in Activation of Chaperone Genes by ATF6-alpha |
| 0.7 | 54.5 | REACTOME FORMATION OF THE TERNARY COMPLEX AND SUBSEQUENTLY THE 43S COMPLEX | Genes involved in Formation of the ternary complex, and subsequently, the 43S complex |
| 0.7 | 4.3 | REACTOME G1 S SPECIFIC TRANSCRIPTION | Genes involved in G1/S-Specific Transcription |
| 0.7 | 2.1 | REACTOME DESTABILIZATION OF MRNA BY BRF1 | Genes involved in Destabilization of mRNA by Butyrate Response Factor 1 (BRF1) |
| 0.7 | 6.9 | REACTOME PREFOLDIN MEDIATED TRANSFER OF SUBSTRATE TO CCT TRIC | Genes involved in Prefoldin mediated transfer of substrate to CCT/TriC |
| 0.7 | 8.2 | REACTOME MRNA DECAY BY 3 TO 5 EXORIBONUCLEASE | Genes involved in mRNA Decay by 3' to 5' Exoribonuclease |
| 0.7 | 8.0 | REACTOME GAMMA CARBOXYLATION TRANSPORT AND AMINO TERMINAL CLEAVAGE OF PROTEINS | Genes involved in Gamma-carboxylation, transport, and amino-terminal cleavage of proteins |
| 0.7 | 13.3 | REACTOME ADVANCED GLYCOSYLATION ENDPRODUCT RECEPTOR SIGNALING | Genes involved in Advanced glycosylation endproduct receptor signaling |
| 0.7 | 17.1 | REACTOME ADP SIGNALLING THROUGH P2RY12 | Genes involved in ADP signalling through P2Y purinoceptor 12 |
| 0.7 | 42.5 | REACTOME ACTIVATION OF CHAPERONE GENES BY XBP1S | Genes involved in Activation of Chaperone Genes by XBP1(S) |
| 0.6 | 26.1 | REACTOME SIGNAL TRANSDUCTION BY L1 | Genes involved in Signal transduction by L1 |
| 0.6 | 3.1 | REACTOME P53 INDEPENDENT G1 S DNA DAMAGE CHECKPOINT | Genes involved in p53-Independent G1/S DNA damage checkpoint |
| 0.6 | 16.9 | REACTOME BIOSYNTHESIS OF THE N GLYCAN PRECURSOR DOLICHOL LIPID LINKED OLIGOSACCHARIDE LLO AND TRANSFER TO A NASCENT PROTEIN | Genes involved in Biosynthesis of the N-glycan precursor (dolichol lipid-linked oligosaccharide, LLO) and transfer to a nascent protein |
| 0.6 | 3.1 | REACTOME INFLUENZA VIRAL RNA TRANSCRIPTION AND REPLICATION | Genes involved in Influenza Viral RNA Transcription and Replication |
| 0.6 | 14.5 | REACTOME COMPLEMENT CASCADE | Genes involved in Complement cascade |
| 0.6 | 11.4 | REACTOME SIGNALING BY NODAL | Genes involved in Signaling by NODAL |
| 0.6 | 5.3 | REACTOME POST CHAPERONIN TUBULIN FOLDING PATHWAY | Genes involved in Post-chaperonin tubulin folding pathway |
| 0.6 | 18.7 | REACTOME GLYCOSPHINGOLIPID METABOLISM | Genes involved in Glycosphingolipid metabolism |
| 0.6 | 10.5 | REACTOME ENOS ACTIVATION AND REGULATION | Genes involved in eNOS activation and regulation |
| 0.6 | 5.1 | REACTOME NFKB IS ACTIVATED AND SIGNALS SURVIVAL | Genes involved in NF-kB is activated and signals survival |
| 0.6 | 10.2 | REACTOME HOMOLOGOUS RECOMBINATION REPAIR OF REPLICATION INDEPENDENT DOUBLE STRAND BREAKS | Genes involved in Homologous recombination repair of replication-independent double-strand breaks |
| 0.6 | 10.0 | REACTOME SYNTHESIS SECRETION AND DEACYLATION OF GHRELIN | Genes involved in Synthesis, Secretion, and Deacylation of Ghrelin |
| 0.6 | 2.2 | REACTOME ACTIVATED TAK1 MEDIATES P38 MAPK ACTIVATION | Genes involved in activated TAK1 mediates p38 MAPK activation |
| 0.5 | 10.4 | REACTOME SIGNALING BY BMP | Genes involved in Signaling by BMP |
| 0.5 | 38.8 | REACTOME MITOTIC PROMETAPHASE | Genes involved in Mitotic Prometaphase |
| 0.5 | 1.0 | REACTOME MEMBRANE BINDING AND TARGETTING OF GAG PROTEINS | Genes involved in Membrane binding and targetting of GAG proteins |
| 0.5 | 25.2 | REACTOME AMINO ACID TRANSPORT ACROSS THE PLASMA MEMBRANE | Genes involved in Amino acid transport across the plasma membrane |
| 0.5 | 6.0 | REACTOME KERATAN SULFATE DEGRADATION | Genes involved in Keratan sulfate degradation |
| 0.5 | 1.9 | REACTOME DESTABILIZATION OF MRNA BY TRISTETRAPROLIN TTP | Genes involved in Destabilization of mRNA by Tristetraprolin (TTP) |
| 0.5 | 7.7 | REACTOME TRNA AMINOACYLATION | Genes involved in tRNA Aminoacylation |
| 0.5 | 8.2 | REACTOME XENOBIOTICS | Genes involved in Xenobiotics |
| 0.5 | 54.7 | REACTOME SRP DEPENDENT COTRANSLATIONAL PROTEIN TARGETING TO MEMBRANE | Genes involved in SRP-dependent cotranslational protein targeting to membrane |
| 0.5 | 11.0 | REACTOME PTM GAMMA CARBOXYLATION HYPUSINE FORMATION AND ARYLSULFATASE ACTIVATION | Genes involved in PTM: gamma carboxylation, hypusine formation and arylsulfatase activation |
| 0.5 | 12.8 | REACTOME EXTRINSIC PATHWAY FOR APOPTOSIS | Genes involved in Extrinsic Pathway for Apoptosis |
| 0.5 | 4.1 | REACTOME RNA POL III TRANSCRIPTION INITIATION FROM TYPE 3 PROMOTER | Genes involved in RNA Polymerase III Transcription Initiation From Type 3 Promoter |
| 0.5 | 14.0 | REACTOME G1 PHASE | Genes involved in G1 Phase |
| 0.4 | 19.6 | REACTOME CYTOCHROME P450 ARRANGED BY SUBSTRATE TYPE | Genes involved in Cytochrome P450 - arranged by substrate type |
| 0.4 | 4.0 | REACTOME APOPTOSIS INDUCED DNA FRAGMENTATION | Genes involved in Apoptosis induced DNA fragmentation |
| 0.4 | 7.0 | REACTOME GAP JUNCTION TRAFFICKING | Genes involved in Gap junction trafficking |
| 0.4 | 5.5 | REACTOME SYNTHESIS OF BILE ACIDS AND BILE SALTS VIA 7ALPHA HYDROXYCHOLESTEROL | Genes involved in Synthesis of bile acids and bile salts via 7alpha-hydroxycholesterol |
| 0.4 | 18.8 | REACTOME INTRINSIC PATHWAY FOR APOPTOSIS | Genes involved in Intrinsic Pathway for Apoptosis |
| 0.4 | 5.8 | REACTOME INTRINSIC PATHWAY | Genes involved in Intrinsic Pathway |
| 0.4 | 4.1 | REACTOME SIGNALLING TO P38 VIA RIT AND RIN | Genes involved in Signalling to p38 via RIT and RIN |
| 0.4 | 16.7 | REACTOME TRANSPORT OF VITAMINS NUCLEOSIDES AND RELATED MOLECULES | Genes involved in Transport of vitamins, nucleosides, and related molecules |
| 0.4 | 4.0 | REACTOME FORMATION OF FIBRIN CLOT CLOTTING CASCADE | Genes involved in Formation of Fibrin Clot (Clotting Cascade) |
| 0.4 | 4.0 | REACTOME SEMA3A PAK DEPENDENT AXON REPULSION | Genes involved in Sema3A PAK dependent Axon repulsion |
| 0.4 | 3.8 | REACTOME HORMONE LIGAND BINDING RECEPTORS | Genes involved in Hormone ligand-binding receptors |
| 0.4 | 1.9 | REACTOME G1 S TRANSITION | Genes involved in G1/S Transition |
| 0.4 | 3.3 | REACTOME PURINE CATABOLISM | Genes involved in Purine catabolism |
| 0.4 | 4.8 | REACTOME DESTABILIZATION OF MRNA BY AUF1 HNRNP D0 | Genes involved in Destabilization of mRNA by AUF1 (hnRNP D0) |
| 0.4 | 25.7 | REACTOME METABOLISM OF VITAMINS AND COFACTORS | Genes involved in Metabolism of vitamins and cofactors |
| 0.4 | 6.4 | REACTOME ALPHA LINOLENIC ACID ALA METABOLISM | Genes involved in alpha-linolenic acid (ALA) metabolism |
| 0.4 | 13.4 | REACTOME REGULATION OF GENE EXPRESSION IN BETA CELLS | Genes involved in Regulation of gene expression in beta cells |
| 0.3 | 6.2 | REACTOME ORGANIC CATION ANION ZWITTERION TRANSPORT | Genes involved in Organic cation/anion/zwitterion transport |
| 0.3 | 6.9 | REACTOME RNA POL III TRANSCRIPTION INITIATION FROM TYPE 2 PROMOTER | Genes involved in RNA Polymerase III Transcription Initiation From Type 2 Promoter |
| 0.3 | 1.7 | REACTOME RECYCLING OF BILE ACIDS AND SALTS | Genes involved in Recycling of bile acids and salts |
| 0.3 | 13.9 | REACTOME LATE PHASE OF HIV LIFE CYCLE | Genes involved in Late Phase of HIV Life Cycle |
| 0.3 | 51.0 | REACTOME METABOLISM OF AMINO ACIDS AND DERIVATIVES | Genes involved in Metabolism of amino acids and derivatives |
| 0.3 | 3.9 | REACTOME GLYCOLYSIS | Genes involved in Glycolysis |
| 0.3 | 3.3 | REACTOME IKK COMPLEX RECRUITMENT MEDIATED BY RIP1 | Genes involved in IKK complex recruitment mediated by RIP1 |
| 0.3 | 5.0 | REACTOME TIE2 SIGNALING | Genes involved in Tie2 Signaling |
| 0.3 | 8.9 | REACTOME HS GAG BIOSYNTHESIS | Genes involved in HS-GAG biosynthesis |
| 0.3 | 5.6 | REACTOME METABOLISM OF STEROID HORMONES AND VITAMINS A AND D | Genes involved in Metabolism of steroid hormones and vitamins A and D |
| 0.3 | 18.0 | REACTOME GOLGI ASSOCIATED VESICLE BIOGENESIS | Genes involved in Golgi Associated Vesicle Biogenesis |
| 0.3 | 4.9 | REACTOME ACYL CHAIN REMODELLING OF PI | Genes involved in Acyl chain remodelling of PI |
| 0.3 | 7.7 | REACTOME SYNTHESIS OF PC | Genes involved in Synthesis of PC |
| 0.3 | 8.6 | REACTOME SEMA4D INDUCED CELL MIGRATION AND GROWTH CONE COLLAPSE | Genes involved in Sema4D induced cell migration and growth-cone collapse |
| 0.3 | 27.2 | REACTOME PPARA ACTIVATES GENE EXPRESSION | Genes involved in PPARA Activates Gene Expression |
| 0.2 | 0.7 | REACTOME PLATELET AGGREGATION PLUG FORMATION | Genes involved in Platelet Aggregation (Plug Formation) |
| 0.2 | 2.8 | REACTOME ROLE OF SECOND MESSENGERS IN NETRIN1 SIGNALING | Genes involved in Role of second messengers in netrin-1 signaling |
| 0.2 | 8.4 | REACTOME AMYLOIDS | Genes involved in Amyloids |
| 0.2 | 3.0 | REACTOME RNA POL III TRANSCRIPTION TERMINATION | Genes involved in RNA Polymerase III Transcription Termination |
| 0.2 | 2.8 | REACTOME SIGNALING BY CONSTITUTIVELY ACTIVE EGFR | Genes involved in Signaling by constitutively active EGFR |
| 0.2 | 3.0 | REACTOME SYNTHESIS OF PIPS AT THE LATE ENDOSOME MEMBRANE | Genes involved in Synthesis of PIPs at the late endosome membrane |
| 0.2 | 6.1 | REACTOME ANTIVIRAL MECHANISM BY IFN STIMULATED GENES | Genes involved in Antiviral mechanism by IFN-stimulated genes |
| 0.2 | 0.8 | REACTOME INFLUENZA LIFE CYCLE | Genes involved in Influenza Life Cycle |
| 0.2 | 0.8 | REACTOME THROMBOXANE SIGNALLING THROUGH TP RECEPTOR | Genes involved in Thromboxane signalling through TP receptor |
| 0.2 | 0.8 | REACTOME SYNTHESIS OF PIPS AT THE EARLY ENDOSOME MEMBRANE | Genes involved in Synthesis of PIPs at the early endosome membrane |
| 0.2 | 3.4 | REACTOME MRNA DECAY BY 5 TO 3 EXORIBONUCLEASE | Genes involved in mRNA Decay by 5' to 3' Exoribonuclease |
| 0.2 | 1.2 | REACTOME SEMA4D IN SEMAPHORIN SIGNALING | Genes involved in Sema4D in semaphorin signaling |
| 0.2 | 5.6 | REACTOME TRANSLATION | Genes involved in Translation |
| 0.2 | 3.0 | REACTOME DEADENYLATION OF MRNA | Genes involved in Deadenylation of mRNA |
| 0.2 | 3.9 | REACTOME PRESYNAPTIC NICOTINIC ACETYLCHOLINE RECEPTORS | Genes involved in Presynaptic nicotinic acetylcholine receptors |
| 0.2 | 5.8 | REACTOME FATTY ACYL COA BIOSYNTHESIS | Genes involved in Fatty Acyl-CoA Biosynthesis |
| 0.2 | 1.0 | REACTOME YAP1 AND WWTR1 TAZ STIMULATED GENE EXPRESSION | Genes involved in YAP1- and WWTR1 (TAZ)-stimulated gene expression |
| 0.2 | 0.6 | REACTOME G BETA GAMMA SIGNALLING THROUGH PI3KGAMMA | Genes involved in G beta:gamma signalling through PI3Kgamma |
| 0.2 | 12.8 | REACTOME NUCLEAR RECEPTOR TRANSCRIPTION PATHWAY | Genes involved in Nuclear Receptor transcription pathway |
| 0.2 | 2.7 | REACTOME OXYGEN DEPENDENT PROLINE HYDROXYLATION OF HYPOXIA INDUCIBLE FACTOR ALPHA | Genes involved in Oxygen-dependent Proline Hydroxylation of Hypoxia-inducible Factor Alpha |
| 0.1 | 0.6 | REACTOME TRANSCRIPTION COUPLED NER TC NER | Genes involved in Transcription-coupled NER (TC-NER) |
| 0.1 | 5.8 | REACTOME NCAM1 INTERACTIONS | Genes involved in NCAM1 interactions |
| 0.1 | 1.1 | REACTOME MITOTIC G1 G1 S PHASES | Genes involved in Mitotic G1-G1/S phases |
| 0.1 | 1.5 | REACTOME REGULATION OF APOPTOSIS | Genes involved in Regulation of Apoptosis |
| 0.1 | 1.5 | REACTOME CRMPS IN SEMA3A SIGNALING | Genes involved in CRMPs in Sema3A signaling |
| 0.1 | 4.5 | REACTOME SIGNALING BY ROBO RECEPTOR | Genes involved in Signaling by Robo receptor |
| 0.1 | 1.2 | REACTOME N GLYCAN TRIMMING IN THE ER AND CALNEXIN CALRETICULIN CYCLE | Genes involved in N-glycan trimming in the ER and Calnexin/Calreticulin cycle |
| 0.1 | 2.6 | REACTOME GLUCOSE METABOLISM | Genes involved in Glucose metabolism |
| 0.1 | 1.0 | REACTOME CTNNB1 PHOSPHORYLATION CASCADE | Genes involved in Beta-catenin phosphorylation cascade |
| 0.1 | 1.1 | REACTOME BMAL1 CLOCK NPAS2 ACTIVATES CIRCADIAN EXPRESSION | Genes involved in BMAL1:CLOCK/NPAS2 Activates Circadian Expression |
| 0.1 | 6.5 | REACTOME LOSS OF NLP FROM MITOTIC CENTROSOMES | Genes involved in Loss of Nlp from mitotic centrosomes |
| 0.1 | 0.4 | REACTOME NFKB ACTIVATION THROUGH FADD RIP1 PATHWAY MEDIATED BY CASPASE 8 AND10 | Genes involved in NF-kB activation through FADD/RIP-1 pathway mediated by caspase-8 and -10 |
| 0.1 | 0.7 | REACTOME ERKS ARE INACTIVATED | Genes involved in ERKs are inactivated |
| 0.1 | 0.6 | REACTOME SHC1 EVENTS IN ERBB4 SIGNALING | Genes involved in SHC1 events in ERBB4 signaling |
| 0.1 | 1.7 | REACTOME P2Y RECEPTORS | Genes involved in P2Y receptors |
| 0.1 | 0.4 | REACTOME G BETA GAMMA SIGNALLING THROUGH PLC BETA | Genes involved in G beta:gamma signalling through PLC beta |
| 0.1 | 7.8 | REACTOME CLASS B 2 SECRETIN FAMILY RECEPTORS | Genes involved in Class B/2 (Secretin family receptors) |
| 0.1 | 1.1 | REACTOME SEROTONIN RECEPTORS | Genes involved in Serotonin receptors |
| 0.1 | 1.6 | REACTOME SYNTHESIS OF PA | Genes involved in Synthesis of PA |
| 0.1 | 1.2 | REACTOME MEIOTIC RECOMBINATION | Genes involved in Meiotic Recombination |
| 0.1 | 1.1 | REACTOME SYNTHESIS OF PIPS AT THE GOLGI MEMBRANE | Genes involved in Synthesis of PIPs at the Golgi membrane |
| 0.1 | 0.4 | REACTOME CROSS PRESENTATION OF SOLUBLE EXOGENOUS ANTIGENS ENDOSOMES | Genes involved in Cross-presentation of soluble exogenous antigens (endosomes) |
| 0.1 | 1.5 | REACTOME REGULATION OF AMPK ACTIVITY VIA LKB1 | Genes involved in Regulation of AMPK activity via LKB1 |
| 0.1 | 0.7 | REACTOME DOUBLE STRAND BREAK REPAIR | Genes involved in Double-Strand Break Repair |
| 0.1 | 0.4 | REACTOME REGULATION OF INSULIN SECRETION BY ACETYLCHOLINE | Genes involved in Regulation of Insulin Secretion by Acetylcholine |
| 0.1 | 0.4 | REACTOME METAL ION SLC TRANSPORTERS | Genes involved in Metal ion SLC transporters |
| 0.1 | 0.6 | REACTOME PEROXISOMAL LIPID METABOLISM | Genes involved in Peroxisomal lipid metabolism |
| 0.0 | 0.5 | REACTOME ETHANOL OXIDATION | Genes involved in Ethanol oxidation |
| 0.0 | 0.8 | REACTOME NONSENSE MEDIATED DECAY ENHANCED BY THE EXON JUNCTION COMPLEX | Genes involved in Nonsense Mediated Decay Enhanced by the Exon Junction Complex |
| 0.0 | 3.5 | REACTOME POST TRANSLATIONAL PROTEIN MODIFICATION | Genes involved in Post-translational protein modification |
| 0.0 | 3.0 | REACTOME INTERFERON ALPHA BETA SIGNALING | Genes involved in Interferon alpha/beta signaling |
| 0.0 | 0.2 | REACTOME TANDEM PORE DOMAIN POTASSIUM CHANNELS | Genes involved in Tandem pore domain potassium channels |